1
|
Hysing M, Harvey AG, Skrindo Knudsen AK, Skogen JC, Reneflot A, Sivertsen B. Mind at rest, mind at risk: A prospective population-based study of sleep and subsequent mental disorders. Sleep Med X 2025; 9:100138. [PMID: 39906718 PMCID: PMC11791349 DOI: 10.1016/j.sleepx.2025.100138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/16/2024] [Revised: 11/29/2024] [Accepted: 01/15/2025] [Indexed: 02/06/2025] Open
Abstract
Background Depression and anxiety disorders are highly prevalent among young adults, with evidence suggesting sleep problems as key risk factors. Objective This study aimed to examine the association between insomnia and sleep characteristics with major depressive episode (MDE) and anxiety disorders, and the association after accounting for baseline mental health symptoms. Methods We conducted a prospective cohort study using data from the Students' Health and Wellbeing Study (SHoT), surveying Norwegian higher education students aged 18 to 35 (N = 53,362). A diagnostic assessment of 10,460 participants was conducted in 2023. Self-reported insomnia, sleep duration, sleep onset latency, and wake after sleep onset were recorded in 2022. MDE and five types of anxiety disorders were assessed after one year using a self-administered CIDI 5.0. Analyses adjusted for age, sex, baseline mental health symptoms, and somatic conditions. Results Insomnia in young adults was associated with a significantly increased risk of MDE (adjusted RR = 3.50, 95 % CI = 3.18-3.84) and generalized anxiety disorder (GAD) (adjusted RR = 2.82, 95 % CI = 2.55-3.12) one year later. Sleep duration showed a reversed J-shaped association with mental disorders, with both short and, to a lesser extent, long sleep durations linked to elevated risks, even after adjusting for baseline mental health symptoms and somatic conditions. Although the associations were attenuated after adjustment, they remained statistically significant. Conclusion Sleep disturbances, including insomnia and abnormal sleep durations, predict mental health issues in young adults, even after accounting for baseline mental health and somatic health. Addressing sleep problems early may help prevent subsequent mental health conditions in this population.
Collapse
Affiliation(s)
- Mari Hysing
- Department of Psychosocial Science, University of Bergen, Bergen, Norway
| | - Allison G. Harvey
- Department of Psychology, University of California, Berkeley, CA, USA
| | | | - Jens C. Skogen
- Department of Health Promotion, Norwegian Institute of Public Health, Bergen, Norway
- Center for Alcohol & Drug Research, Stavanger University Hospital, Stavanger, Norway
- Centre for Evaluation of Public Health Measures, Norwegian Institute of Public Health, Oslo, Norway
| | - Anne Reneflot
- Department of Mental Health and Suicide, Norwegian Institute of Public Health, Oslo, Norway
| | - Børge Sivertsen
- Department of Health Promotion, Norwegian Institute of Public Health, Bergen, Norway
- Department of Research & Innovation, Helse-Fonna HF, Haugesund, Norway
| |
Collapse
|
2
|
Halladay J, Kershaw S, Devine EK, Grummitt L, Visontay R, Lynch SJ, Ji C, Scott L, Bower M, Mewton L, Sunderland M, Slade T. Covariates in studies examining longitudinal relationships between substance use and mental health problems among youth: A meta-epidemiologic review. Drug Alcohol Depend 2025; 271:112665. [PMID: 40222236 DOI: 10.1016/j.drugalcdep.2025.112665] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/11/2024] [Revised: 03/20/2025] [Accepted: 03/23/2025] [Indexed: 04/15/2025]
Abstract
INTRODUCTION This meta-epidemiological review examines covariate selection and reporting practices in observational studies analyzing longitudinal relationships between youth substance use and mental health problems (internalizing and externalizing). METHODS Sixty-nine studies published in high-impact journals from 2018 to 2023 were included. Studies were included if they explored prospective relationships between substance use and mental health among youth (12-25 years) and used repeated measures designs. Data extraction focused on study characteristics, covariates and their selection methods, and reporting practices. RESULTS There were 574 covariates included across studies; 33 were included as moderators and 18 were included as mediators. At the study level, the most common covariate domains included demographics (90 % of included studies had at least one demographic, mostly sex), substance-related variables (67 %; mostly alcohol or smoking), internalizing symptoms (39 %; mostly depression), family-related variables (29 %; mostly parental substance use or mental illness), and externalizing symptoms (19 %; mostly conduct). 93 % of studies had unique sets of lower-order covariates. Across all studies (n = 69), only 35 % provided details for how, and why, all covariates were selected with only 12 % reporting selecting covariates a priori, and none being pre-registered. Only 60 % mentioned confounding and only 13 % mentioned risk of confounding in their conclusions. CONCLUSIONS The findings highlight the need for improved covariate selection and reporting practices. Establishing a core set of covariates and adhering to standardized reporting guidelines would enhance the comparability and reliability of research findings in this field. Researchers can use this review to identify and justify the inclusion and exclusion of commonly reported covariates when analyzing relationships between youth substance use and mental health problems.
Collapse
Affiliation(s)
- Jillian Halladay
- McMaster University School of Nursing, 1280 Main St W, Hamilton, ON L8S 4L8, USA; The Peter Boris Centre for Addictions Research, McMaster University/St. Joseph's Healthcare Hamilton, 100 West 5Th St, Hamilton, ON L8N 3K7, Canada; The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Australia.
| | - Steph Kershaw
- The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Australia
| | - Emma K Devine
- The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Australia
| | - Lucinda Grummitt
- The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Australia
| | - Rachel Visontay
- The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Australia
| | - Samantha J Lynch
- University of Montreal, Faculty of Medicine, Department of Psychiatry and Addiction, Montreal, Canada; Azrieli Research Center of the CHU Ste Justine Mother-Child University Hospital, Montreal, Canada
| | - Chris Ji
- McMaster University School of Nursing, 1280 Main St W, Hamilton, ON L8S 4L8, USA
| | - Lauren Scott
- The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Australia
| | - Marlee Bower
- The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Australia
| | - Louise Mewton
- The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Australia
| | - Matthew Sunderland
- The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Australia
| | - Tim Slade
- The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Australia
| |
Collapse
|
3
|
Meyerbröker K, Emmelkamp P. Take a Look at Me Now: The Use of Virtual Reality in the Treatment of Social Anxiety Disorder. J Clin Psychol 2025; 81:494-502. [PMID: 40056467 PMCID: PMC12050102 DOI: 10.1002/jclp.23782] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2024] [Revised: 01/31/2025] [Accepted: 02/17/2025] [Indexed: 03/10/2025]
Abstract
In anxiety and related disorders, Virtual Reality Exposure Therapy (VRET) was one of the first steps toward integrating technology into psychological treatments. In this article, we discuss crucial therapeutical skills and provide a case conceptualisation for the treatment of social anxiety disorder with VRET. The case conceptualisation is based on evidence-based cognitive-behavioural treatment approaches. Social anxiety can be very challenging to treat with exposure in vivo, and virtual reality exposure offers the added benefit of being able to create social situations and real-time interactions within the therapeutic context. The case conceptualisation presented is worked out for a 23-year-old female with social anxiety disorder who is increasingly hindered by her anxiety in her professional and personal life. The treatment rationale of VRET, homework assignments, and progress of therapy are presented. Additionally, this paper discusses what steps to take if the first exposure experiences are not successful and how to progress in such cases. Therapeutic pitfalls are illustrated within this case and potential solutions on how to avoid these pitfalls are addressed.
Collapse
Affiliation(s)
- Katharina Meyerbröker
- Utrecht UniversityUtrechtNetherlands
- Altrecht Academic Anxiety CenterUtrechtNetherlands
| | | |
Collapse
|
4
|
Moneta MV, Haro JM, Plana-Ripoll O, Olaya B. Life expectancy associated with specific mental disorders and the contribution of causes of death: a population-based study in the region of Catalonia. Psychiatry Res 2025; 348:116480. [PMID: 40233563 DOI: 10.1016/j.psychres.2025.116480] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/05/2024] [Revised: 03/06/2025] [Accepted: 03/29/2025] [Indexed: 04/17/2025]
Abstract
There is strong evidence that people with mental disorders have a premature mortality, with physical diseases, as well as suicide, accounting for it in large part. However, there is a lack of studies focused on common mental disorders in Southern Europe. This study aims to calculate the reduction in life expectancy for different mental disorders according to all-cause mortality and for specific causes of death using national registers from Catalonia (Spain). This population register-based study includes clinical information on all adults over 18 years of age using the Catalan public healthcare system from January 2005 to December 2016 (355,540 females and 182,529 males with mental disorders). Mental disorders were classified into eleven categories, and causes of death were grouped as natural and unnatural and then further divided into nine groups. For each disorder, the life-years lost were estimated for all-cause mortality and for each specific cause of death in males and females. All mental disorders showed a shorter remaining life expectancy after diagnosis than the reference population of the same age. The disorders associated with the largest reduction in life expectancy were alcohol and drug dependence and abuse, and schizophrenia. Natural causes and, to a lesser extent, suicide, were the predominant contributors to excess mortality for all types of mental disorders. Our findings suggest that mental disorders are associated with premature mortality in Catalonia. Furthermore, natural causes are the primary contributors to premature mortality, indicating the need for better management of medical conditions in this population.
Collapse
Affiliation(s)
- Maria Victoria Moneta
- Epidemiology of Mental Health Disorders and Ageing Research Group, Sant Joan de Déu Research Institute, Esplugues de Llobregat, Spain; Research, Teaching, and Innovation Unit, Parc Sanitari Sant Joan de Déu, Carrer Doctor Antoni Pujada, 42, 08830 Sant Boi de Llobregat, Spain; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
| | - Josep Maria Haro
- Epidemiology of Mental Health Disorders and Ageing Research Group, Sant Joan de Déu Research Institute, Esplugues de Llobregat, Spain; Research, Teaching, and Innovation Unit, Parc Sanitari Sant Joan de Déu, Carrer Doctor Antoni Pujada, 42, 08830 Sant Boi de Llobregat, Spain; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
| | - Oleguer Plana-Ripoll
- Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Olof Palmes allé 43-45, 8200, Aarhus N, Denmark; National Centre for Register-based Research, Department of Public Health, Aarhus University, Aarhus, Denmark.
| | - Beatriz Olaya
- Epidemiology of Mental Health Disorders and Ageing Research Group, Sant Joan de Déu Research Institute, Esplugues de Llobregat, Spain; Research, Teaching, and Innovation Unit, Parc Sanitari Sant Joan de Déu, Carrer Doctor Antoni Pujada, 42, 08830 Sant Boi de Llobregat, Spain; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Department of Clinical and Health Psychology, Autonomous University of Barcelona, Bellaterra, Spain.
| |
Collapse
|
5
|
Weber H, Hettema JM, Deckert J, Erhardt-Lehmann A. Genomics of Anxiety Disorders. Psychiatr Clin North Am 2025; 48:377-401. [PMID: 40348424 DOI: 10.1016/j.psc.2025.01.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/14/2025]
Abstract
Anxiety disorders are the most prevalent psychiatric conditions in the general population. Despite the early observation of family aggregation of anxiety disorders with a heritability of 30% to 50%, their exact genetic structure is not yet determined. Evidence suggests a composition of common and rare genetic factors contributing to the etiology of anxiety disorders. Recent hypothesis-free genome-wide association studies in mega cohorts mostly with a broad anxiety phenotype rendered an increasing number of novel genetic loci. Epigenetic research is still in its infancy with first evidence showing dynamic changes in response to environmental influences and during the therapy course.
Collapse
Affiliation(s)
- Heike Weber
- Functional Genomics, Department of Psychiatry, Center of Mental Health, Psychosomatics, and Psychotherapy, University Hospital Würzburg, Margerete-Höppel-Platz 1, 97080 Würzburg, Germany
| | - John M Hettema
- Department of Psychiatry and Behavioral Sciences, Texas A&M University Health Sciences Center, 2900 East 29th Street, Suite 300, Bryan, TX 77802, USA
| | - Jürgen Deckert
- Center of Mental Health, Psychosomatics, and Psychotherapy, University Hospital Würzburg, Margerete-Höppel-Platz 1, 97080 Würzburg, Germany
| | - Angelika Erhardt-Lehmann
- Department of Psychiatry, Center of Mental Health, Psychosomatics, and Psychotherapy, University Hospital Würzburg, Margerete-Höppel-Platz 1, 97080 Würzburg, Germany; Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Margerete-Höppel-Platz 1, 97080 Würzburg, Germany.
| |
Collapse
|
6
|
Teesson M, Whiteford H, Bower M, Smout S, Burgess P, Harris MG, Pirkis J, Diminic S, Baillie A, Slade T, Chapman C. Policy implications of the 2020-22 Australian study of mental health and wellbeing. Aust N Z J Psychiatry 2025; 59:485-492. [PMID: 39508357 PMCID: PMC12102510 DOI: 10.1177/00048674241292961] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2024]
Abstract
The objective of this paper is to summarise the policy implications of key findings from the 2020-22 Australian National Study of Mental Health and Wellbeing (NSMHWB). We provide an analysis of policy implications of four papers in this issue of the journal from the 2020-22 NSMHWB (N = 15,893) and the 2007 NSMHWB (N = 8841). The 2020-2022 NSMHWB reported a lifetime prevalence rate of common mental disorders of 40.2% (95% confidence interval [CI] = 39.2-41.3) and 12-month prevalence rate of 20.2% (95% CI 19.5-21.0). Overall, adult Australians were significantly more likely to experience a 12-month mental disorder in 2020-22 compared with 2007, with the change most striking in among those aged 16-24 years (odds ratio [OR] 1.2, 95% CI 1.1-1.3). Individuals aged 16-24 years in 2020-22 were significantly more likely to experience a 12-month anxiety disorder (OR 2.9, 95% CI = 2.3-3.7, depressive disorder (OR 2.8 95% CI = 2.1-3.9) or comorbidity (relative risk [RR] = 1.4, 95% CI = 1.2-1.7) compared with those aged 16-24 years in 2007. In 2020-22, the proportion of Australians who had experienced suicidal ideation, suicide plans and suicide attempts in the past 12 months was 3.3%, 1.1% and 0.3%. Under half (46.5% 95% CI 44.1-48.8) of adults with a 12-month mental disorder sought treatment. Mental disorders remain an endemic feature of Australia's overall health landscape and appear to be increasing, especially in younger cohorts. While service use rates have improved over time, there is still some way to go. Epidemiological surveys such as the 2020-22 NSMHWB are important for understanding changing prevalence and the population not accessing services. Innovative prevention and treatment strategies will be needed to address the increasing rates of disorders in younger Australian adults. Equally innovative and bold policy responses will be essential.
Collapse
Affiliation(s)
- Maree Teesson
- The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, NSW, Australia
| | - Harvey Whiteford
- The University of Queensland, Brisbane, QLD, Australia
- Queensland Centre for Mental Health Research, Brisbane, QLD, Australia
| | - Marlee Bower
- The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, NSW, Australia
| | - Scarlett Smout
- The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, NSW, Australia
| | - Philip Burgess
- The University of Queensland, Brisbane, QLD, Australia
- Queensland Centre for Mental Health Research, Brisbane, QLD, Australia
| | - Meredith G. Harris
- The University of Queensland, Brisbane, QLD, Australia
- Queensland Centre for Mental Health Research, Brisbane, QLD, Australia
| | - Jane Pirkis
- Centre for Mental Health and Community Wellbeing, The University of Melbourne, Melbourne, VIC, Australia
| | - Sandra Diminic
- The University of Queensland, Brisbane, QLD, Australia
- Queensland Centre for Mental Health Research, Brisbane, QLD, Australia
| | - Andrew Baillie
- Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia
| | - Tim Slade
- The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, NSW, Australia
| | - Cath Chapman
- The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, NSW, Australia
| |
Collapse
|
7
|
Wu J, Wu X, Tarimo CS, Zhao W, Xia Q, Xu X, Wu C, Feng H, Miao Y, Liu R, Yang Y. Network analysis of Internet addiction and depression among Chinese adolescents. J Affect Disord 2025; 378:119-127. [PMID: 39988141 DOI: 10.1016/j.jad.2025.02.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/29/2024] [Revised: 02/07/2025] [Accepted: 02/17/2025] [Indexed: 02/25/2025]
Abstract
BACKGROUND Internet addiction (IA) and depression are common mental health concerns, with burgeoning empirical evidence highlighting their significant comorbid relationship among adolescents. We aimed to establish network structures for IA and depression among Chinese adolescents, and to identify the core and bridge symptoms. METHODS A total of 8176 participants were recruited from Henan Province, Central China. The 10-item Center for Epidemiological Studies Depression Scale (CESD) and 20-item Self-report Internet Addiction Test (IAT) was used to measure depression and IA, respectively. IA, depression and the co-occurrence network structures were constructed using network analysis. Strength, the centrality index, was used to identify the core symptoms. Bridge symptoms were assessed using the bridge strength. RESULTS Node CESD7 ("Could not get things going") was the most influential node in the depression network model, followed by CESD1 ("Felt sadness") and CESD2 ("Everything was an effort"). Node IAT16 ("Reluctant to be offline") was the most influential node in the IA network model, followed by IAT20 ("Web made you feel better"), IAT15 ("Fantasized about being on the web") and IAT2 ("Neglected household chores"). CESD7 ("Could not get things going") in the depression-IA network was the most key bridge symptom linking depression and IA, followed by CESD8 ("Trouble focus"). Significant gender difference in edge weights was observed (p = 0.002). LIMITATIONS This cross-sectional study collected data through self-report measures. CONCLUSIONS The core symptoms and key bridge symptoms in the networks are crucial for the precise intervention of adolescent depression and IA.
Collapse
Affiliation(s)
- Jian Wu
- Department of Social Science and Health Management, College of Public Health, Zhengzhou University, China
| | - Xiaoman Wu
- Department of Social Science and Health Management, College of Public Health, Zhengzhou University, China
| | - Clifford Silver Tarimo
- Department of Social Science and Health Management, College of Public Health, Zhengzhou University, China
| | - Weijia Zhao
- Department of Social Science and Health Management, College of Public Health, Zhengzhou University, China
| | - Qingyun Xia
- Department of Social Science and Health Management, College of Public Health, Zhengzhou University, China
| | - Xiaoqing Xu
- Department of Social Science and Health Management, College of Public Health, Zhengzhou University, China
| | - Cuiping Wu
- Department of Social Science and Health Management, College of Public Health, Zhengzhou University, China
| | - Haiyang Feng
- Department of Social Science and Health Management, College of Public Health, Zhengzhou University, China
| | - Yudong Miao
- Department of Social Science and Health Management, College of Public Health, Zhengzhou University, China
| | - Rongmei Liu
- Henan Key Laboratory for Health Management of Chronic Diseases, Central China Fuwai Hospital, Central China Fuwai Hospital of Zhengzhou University, China
| | - Yinmei Yang
- Department of Social Science and Health Management, College of Public Health, Zhengzhou University, China; Henan Key Laboratory of Chronic Disease Prevention and Therapy & Intelligent Health Management, Zhengzhou City, China.
| |
Collapse
|
8
|
Baird S, Choonara S, Azzopardi PS, Banati P, Bessant J, Biermann O, Capon A, Claeson M, Collins PY, De Wet-Billings N, Dogra S, Dong Y, Francis KL, Gebrekristos LT, Groves AK, Hay SI, Imbago-Jácome D, Jenkins AP, Kabiru CW, Kennedy EC, Li L, Lu C, Ma J, McGovern T, Mensa-Kwao A, Mojola SA, Nagata JM, Olumide AO, Omigbodun O, O'Sullivan M, Prost A, Requejo JH, Shawar YR, Shiffman J, Silverman A, Song Y, Swartz S, Tamambang R, Urdal H, Ward JL, Patton GC, Sawyer SM, Ezeh A, Viner RM. A call to action: the second Lancet Commission on adolescent health and wellbeing. Lancet 2025; 405:1945-2022. [PMID: 40409329 DOI: 10.1016/s0140-6736(25)00503-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/04/2024] [Revised: 02/03/2025] [Accepted: 03/11/2025] [Indexed: 05/25/2025]
Affiliation(s)
- Sarah Baird
- Department of Global Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.
| | | | - Peter S Azzopardi
- Adolescent Health, Murdoch Children's Research Institute, Parkville, VIC, Australia; Department of Paediatrics, University of Melbourne, Parkville, VIC Australia; Adolescent Health and Wellbeing Program, The Kids Research Institute of Australia, Perth, WA, Australia; National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT, Australia
| | - Prerna Banati
- Department of Maternal, Newborn, Child & Adolescent Health & Ageing, World Health Organization, Geneva, Switzerland
| | - Judith Bessant
- School of Global, Urban and Social Studies, RMIT University, Melbourne, VIC, Australia
| | - Olivia Biermann
- Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden
| | - Anthony Capon
- Monash Sustainable Development Institute, Monash University, Melbourne, VIC, Australia
| | - Mariam Claeson
- Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden
| | - Pamela Y Collins
- Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of Psychiatry & Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | | | - Surabhi Dogra
- Emerging Professionals Network, International Association for Adolescent Health, Gautam Buddha Nagar, India
| | - Yanhui Dong
- Institute of Child and Adolescent Health, School of Public Health, Peking University, Beijing, China; National Health Commission Key Laboratory of Reproductive Health, Beijing, China
| | - Kate L Francis
- Adolescent Health, Murdoch Children's Research Institute, Parkville, VIC, Australia; Department of Paediatrics, University of Melbourne, Parkville, VIC Australia
| | - Luwam T Gebrekristos
- Department of Epidemiology & Biostatistics, Drexel University Dornsife School of Public Health, Philadelphia, PA, USA
| | - Allison K Groves
- Community Health and Prevention, Drexel Dornsife School of Public Health, Philadelphia, PA, USA
| | - Simon I Hay
- Institute for Health Metrics and Evaluation and Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA
| | | | - Aaron P Jenkins
- Pacific Planetary Health Hub, Sydney Institute for Infectious Diseases, School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia; Centre for People, Place and Planet, School of Science, Edith Cowan University, Perth, WA, Australia; Pacific Planetary Health Research Centre, Fiji Institute of Pacific Health Research, Fiji National University, Suva, Fiji
| | - Caroline W Kabiru
- Sexual, Reproductive, Maternal, Newborn, Child and Adolescent Health Unit, African Population and Health Research Center, Nairobi, Kenya
| | - Elissa C Kennedy
- Adolescent Health, Murdoch Children's Research Institute, Parkville, VIC, Australia; Women's, Children's and Adolescents' Health Program, Burnet Institute, Melbourne, VIC, Australia
| | - Luo Li
- Adolescent Health, Murdoch Children's Research Institute, Parkville, VIC, Australia; Department of Paediatrics, University of Melbourne, Parkville, VIC Australia
| | - Chunling Lu
- Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA
| | - Jun Ma
- Institute of Child and Adolescent Health, School of Public Health, Peking University, Beijing, China; National Health Commission Key Laboratory of Reproductive Health, Beijing, China
| | - Terry McGovern
- City University of New York Graduate School of Public Health & Health Policy, New York, NY, USA
| | - Augustina Mensa-Kwao
- Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - Sanyu A Mojola
- Department of Sociology, School of Public and International Affairs, Princeton University, Princeton, NJ, USA
| | - Jason M Nagata
- Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA
| | - Adesola O Olumide
- Institute of Child Health, University of Ibadan, Ibadan, Nigeria; University College Hospital, Ibadan, Nigeria
| | - Olayinka Omigbodun
- Centre for Child and Adolescent Mental Health, College of Medicine, University of Ibadan, Ibadan, Nigeria
| | - Molly O'Sullivan
- Adolescent Health, Murdoch Children's Research Institute, Parkville, VIC, Australia
| | - Audrey Prost
- Institute for Global Health, University College London, London, UK
| | - Jennifer H Requejo
- Department of International Health, Johns Hopkins University, Baltimore, MD, USA; Global Financing Facility for Women, Children, and Adolescents, World Bank, Washington DC, USA
| | - Yusra R Shawar
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Paul H Nitze School of Advanced International Studies, Johns Hopkins University, Washington, DC, USA
| | - Jeremy Shiffman
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Paul H Nitze School of Advanced International Studies, Johns Hopkins University, Washington, DC, USA
| | | | - Yi Song
- Institute of Child and Adolescent Health, School of Public Health, Peking University, Beijing, China; National Health Commission Key Laboratory of Reproductive Health, Beijing, China; National Health Commission Key Laboratory of Reproductive Health, Beijing, China
| | - Sharlene Swartz
- Equitable Education and Economies, Human Sciences Research Council, Cape Town, South Africa; School of Education, University of Cape Town, Cape Town, South Africa
| | - Rita Tamambang
- Centre for Child and Adolescent Mental Health, College of Medicine, University of Ibadan, Ibadan, Nigeria
| | | | - Joseph L Ward
- Department of Women and Children's Health, King's College London, London, UK; Population Policy and Practice Research and Teaching Department, University College London Great Ormond Street Institute of Child Health, London, UK
| | - George C Patton
- Adolescent Health, Murdoch Children's Research Institute, Parkville, VIC, Australia; Centre for Adolescent Health, The Royal Children's Hospital, Parkville, VIC, Australia; Department of Paediatrics, University of Melbourne, Parkville, VIC Australia
| | - Susan M Sawyer
- Adolescent Health, Murdoch Children's Research Institute, Parkville, VIC, Australia; Centre for Adolescent Health, The Royal Children's Hospital, Parkville, VIC, Australia; Department of Paediatrics, University of Melbourne, Parkville, VIC Australia
| | - Alex Ezeh
- Community Health and Prevention, Drexel Dornsife School of Public Health, Philadelphia, PA, USA; Urban Health Collaborative, Drexel Dornsife School of Public Health, Philadelphia, PA, USA
| | - Russell M Viner
- Population Policy and Practice Research and Teaching Department, University College London Great Ormond Street Institute of Child Health, London, UK
| |
Collapse
|
9
|
Wong TY, Moore TM, Hillman N, Calkins ME, Shahriar S, Dietterich T, Ruparel K, Roalf DR, Wolf DH, Satterthwaite TD, Ered A, Gur RE, Gur RC. Longitudinal Development of Neurocognitive Functioning and Gray Matter Volume in Youths With Recurrent Psychosis Spectrum Symptoms. Schizophr Bull 2025:sbaf049. [PMID: 40382716 DOI: 10.1093/schbul/sbaf049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/20/2025]
Abstract
BACKGROUND AND HYPOTHESIS Neurodevelopmental risk-factor models of psychosis highlight the importance of early developmental deviations in the emergence of psychosis. However, few longitudinal studies map neurodevelopment and neurocognitive trajectories across age in preclinical psychosis. We investigated longitudinal trajectories in neurocognition and brain volume in a community cohort of adolescents with recurrent psychosis spectrum (PS) symptoms, tracking their development into young adulthood compared to their typically developing (TD) peers. STUDY DESIGN Utilizing the Philadelphia Neurodevelopmental Cohort, we analyzed data of 231 youths aged 8-30 with at least one follow-up assessment, including 88 with PS. STUDY RESULTS Individuals with PS showed similar developmental trajectories but demonstrated significant impairments in executive functioning (t = -2.81, q = 0.010), memory (t = -2.34, q = 0.019), complex cognition (t = -3.72, q = 0.001), social cognition (t = -2.73, q = 0.010), motor (t = -2.50, q = 0.015), and general cognition (t = -3.20, q = 0.004). Lower cortical (t = -2.46, P = .014) and subcortical (t = -2.41, P = .016) gray matter volume in the recurrent PS group compared to the TD group were documented with age-related group differences becoming less pronounced by young adulthood. Further analyses revealed age-by-group interactions (qs < 0.05) observed in a few temporal and frontal regions, with differences between groups at earlier ages. CONCLUSIONS These findings suggest that recurrent PS symptoms are linked to early neurocognitive and brain structure deficits, highlighting the need for interventions to reduce psychosis risk and support healthy neurodevelopment.
Collapse
Affiliation(s)
- Ting Yat Wong
- Department of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
- Department of Psychology, The Education University of Hong Kong, Hong Kong Special Administrative Region, 999077, China
- Center of Psychosocial Health, The Education University of Hong, Hong Kong Special Administrative Region, 999077, China
| | - Tyler M Moore
- Department of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
- Lifespan Brain Institute of the Children's Hospital of Philadelphia and Penn Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
| | - Noah Hillman
- Department of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
| | - Monica E Calkins
- Department of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
- Lifespan Brain Institute of the Children's Hospital of Philadelphia and Penn Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
| | - Sarah Shahriar
- Department of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
| | - Tyler Dietterich
- Department of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
- Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, 90095, United States
| | - Kosha Ruparel
- Department of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
- Lifespan Brain Institute of the Children's Hospital of Philadelphia and Penn Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
| | - David R Roalf
- Department of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
- Lifespan Brain Institute of the Children's Hospital of Philadelphia and Penn Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
| | - Daniel H Wolf
- Department of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
- Lifespan Brain Institute of the Children's Hospital of Philadelphia and Penn Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
| | - Theodore D Satterthwaite
- Department of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
- Lifespan Brain Institute of the Children's Hospital of Philadelphia and Penn Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
| | - Arielle Ered
- Department of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
| | - Raquel E Gur
- Department of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
- Lifespan Brain Institute of the Children's Hospital of Philadelphia and Penn Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
| | - Ruben C Gur
- Department of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
- Lifespan Brain Institute of the Children's Hospital of Philadelphia and Penn Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States
| |
Collapse
|
10
|
Ye H, Zhao Y, Li L, Qian Y, Zhu H, Bian G, Liu L. Ningbo Schizophrenia Cohort (NSC)-a longitudinal ambispective cohort based on electronic health records: cohort profile. BMJ Open 2025; 15:e091188. [PMID: 40379328 PMCID: PMC12083311 DOI: 10.1136/bmjopen-2024-091188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/15/2024] [Accepted: 04/30/2025] [Indexed: 05/19/2025] Open
Abstract
PURPOSE Electronic health records (EHR) passively generate large datasets on real-world patient populations in easily retrievable form, allowing the cost-efficient and timely execution of epidemiological cohorts on a broad array of topics. However, EHR-based cohorts specialising in mental disorders have not yet been reported. Ningbo has made significant achievements in healthcare data management in China. This study, relying on the Ningbo Mental Health Information System and the Ningbo Regional Health Information Platform, has established the Ningbo Schizophrenia Cohort (NSC), providing an exemplary study for cohort studies on schizophrenia. PARTICIPANTS This population-based ambispective cohort study included patients with schizophrenia aged 18-65 years at the time of diagnosis who were eligible for healthcare services in Ningbo, China. Participants were identified using the Ningbo Mental Health Information System between 1 January 2010, and 31 December 2023. Once an individual enters the NSC, they are followed up continuously until death or relocation. A total of 26 899 patients with schizophrenia are included in the NSC. FINDINGS TO DATE Among 26 899 patients, 55.4% were female and 53.1% had less than 7 years of education. Until 31 December 2023, 4505 deaths occurred, and 97.83% of patients had at least one electronic medical record. The median age at diagnosis for non-survivors (median (IQR): 40 (29-51) years) was higher than that of survivors (median (IQR): 34 (26-45) years). FUTURE PLANS The NSC will continue to collect longitudinal data to capture the full life cycle of schizophrenia, including pre-onset, diagnosis, follow-up, recovery or death. This will result in a continuous, complete and multidimensional EHR for patients with schizophrenia. Planned future research aims to generate new real-world evidence on the aetiology of schizophrenia, investigate comorbidities to facilitate co-management and develop predictive models for schizophrenia and related cardiovascular diseases. TRIAL REGISTRATION NUMBER NCT06370793.
Collapse
Affiliation(s)
- He Ye
- School of Public Health, Ningbo University Health Science Center, Ningbo, Zhejiang, China
| | - Yang Zhao
- Department of Biostatistics, Nanjing Medical University, Nanjing, Jiangsu, China
| | - Lian Li
- Department of Psychiatry, Ningbo Kangning Hospital, Ningbo, Zhejiang, China
- Department of Psychiatry, Affiliated Kangning Hospital of Ningbo University, Ningbo, Zhejiang, China
| | - Yi Qian
- School of Public Health, Ningbo University Health Science Center, Ningbo, Zhejiang, China
| | - Hangjie Zhu
- School of Public Health, Ningbo University Health Science Center, Ningbo, Zhejiang, China
| | - Guolin Bian
- Department of Psychiatry, Ningbo Kangning Hospital, Ningbo, Zhejiang, China
- Department of Psychiatry, Affiliated Kangning Hospital of Ningbo University, Ningbo, Zhejiang, China
| | - Liya Liu
- School of Public Health, Ningbo University Health Science Center, Ningbo, Zhejiang, China
- Department of Psychiatry, Ningbo Kangning Hospital, Ningbo, Zhejiang, China
- Department of Psychiatry, Affiliated Kangning Hospital of Ningbo University, Ningbo, Zhejiang, China
| |
Collapse
|
11
|
Kazdin AE. Perceived need for treatment for mental disorders: A review and critical evaluation. Clin Psychol Rev 2025; 119:102591. [PMID: 40381402 DOI: 10.1016/j.cpr.2025.102591] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2025] [Revised: 05/02/2025] [Accepted: 05/06/2025] [Indexed: 05/20/2025]
Abstract
Mental disorders are highly prevalent worldwide. Unfortunately, most people with these disorders do not receive any treatment. This is due in part to a large set of barriers that impede treatment delivery. An initial barrier is the perception that one does not need treatment. Perceived need for treatment (PNFT) refers to whether an individual sees a need to obtain an intervention for their mental health problem. Among individuals with a mental disorder, lack of perceived need is the most common reason people give for not initiating treatment. This article describes PNFT, its characteristics, correlates, and predictors. A critical evaluation of the concept challenges key notions such as whether meeting criteria for a disorder means that someone needs treatment, whether PNFT actually is the initial obstacle limiting treatment seeking, how people may seek an intervention but do not elect mental health treatment, and that PNFT is neither a necessary nor a sufficient condition for entering treatment. Several research priorities are discussed including the importance of perceived need among parents and other caregivers, evaluating whether increasing the rates of PNFT would actually increase service use, the need to study the treatment needs of many neglected groups, and considering whether PNFT influences other facets of the treatment process (e.g., adherence to treatment, dropping out early) where perceiving there no longer is a mental health problem may occur.
Collapse
Affiliation(s)
- Alan E Kazdin
- Department of Psychology, Yale University, Henry Koerner Center, 149 Elm Street, New Haven 06511, CT, USA.
| |
Collapse
|
12
|
Xu B, Li K, Wang X, Wang L, Man Y, Liu P. The epidemiological burden of major depressive disorder in women of childbearing age and its relationship with the sociodemographic index: A systematic analysis based on the global burden of disease study from 1990 to 2021. J Affect Disord 2025:S0165-0327(25)00806-7. [PMID: 40345446 DOI: 10.1016/j.jad.2025.05.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/13/2024] [Revised: 04/21/2025] [Accepted: 05/06/2025] [Indexed: 05/11/2025]
Abstract
BACKGROUND The global burden and trends of Major depressive disorder (MDD) among women of childbearing age (WCBA) remain unclear. METHODS This study utilized data from the Global Burden of Disease database to extract information on the prevalence, incidence, and disability-adjusted life years (DALYs) related to major depression among WCBA from 1990 to 2021. The study estimated the annual percentage change to assess trends in disease burden and calculated point estimates using 95 % uncertainty intervals. RESULTS Between 1990 and 2021, there was a significant increase in the incidence, prevalence, and number of DALYs associated with MDD among WCBA, with increases of 73 %, 73 %, and 72 %, respectively. In low Sociodemographic Index (SDI) regions, WCBA exhibited the highest prevalence, incidence, and DALYs of MDD, whereas high SDI regions had the highest prevalence. East Asia was the only region that reported a decline in the prevalence, incidence, and DALYs associated with MDD. The Central America region experienced the most substantial increases in incidence and DALYs, while East Asia showed the most notable declines in prevalence and DALYs. At the country level, Singapore had the largest global declines in prevalence, incidence, and DALYs, whereas Mexico exhibited the most significant rise. Age group analysis revealed that the most pronounced increase in cases of major depression was observed among women aged 45-49 years. CONCLUSION Over the past 32 years, the burden of MDD among WCBA has significantly increased worldwide, particularly in low SDI and high SDI regions, as well as among the 45-49 age group.
Collapse
Affiliation(s)
- Biwu Xu
- Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, China
| | - Kaiyuan Li
- Graduate School of Dalian Medical University, Dalian Medical University, Dalian, China
| | - Xiaowen Wang
- Nanjing University of Chinese Medicine, Nanjing 210000, China
| | - Lei Wang
- Department of Cardiology, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
| | - Yilong Man
- Department of Cardiology, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
| | - Peng Liu
- Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
| |
Collapse
|
13
|
Njamnshi AK, Fame Ndongo J, Ngoh Ngoh F, Mbella Mbella L, Ghogomu PM, Fouda SM, Ondoa Obama MTA, Tchuinte M, Ousmane Mey A, Manaouda M, Beti Assomo J, Sadi RE, Motaze LP, Nganou Djoumessi E, Li Likeng ML, Nalova Lyonga PE, Etoundi Ngoa LS, Foutsou M, Mouelle Kombi N, Tchiroma BI, Owona G, Ayissi HE, Balungeli CE, Hele P, Fuh CG, Fomundam Mbah Acha RN, Bidoung Kpwatt PI, Mbayu F, Tasong PN, Momo JDD, Doh JP, Bayaola B, Kilo VA, Abouem À Tchoyi D, Njeuma DL, Tamfu SF, Angwafo Iii FF, Chumbow SB, Etoua RM, Omgba RL, Ngomo Manga H, Tsafack Nanfosso R, Chan A, Etoa FX, Zambo JMB, Mah EM, Tommo Monthe M, Eheth S, Monono C, Biffot PP, Gabsa W, Cheka C, Echu G, Bella AE, Njock LR, Fongod AGN, Ndongo DU, Leke RFG, Pondi JE, Fieggen G, Shehu BB, Ayadi R, Merali Z, Yusuf S, Apeagyei AE, Ranchod K, Salama M, Atangana A, Ngokeu E, Ndifon W, Tiahou G, Tchoua R, Korsten L, Ibanez A, Singh G, Abdullah JM, Dhamija RK, Ihunwo AO, Mbarika VWA, Mbah D, Njamnshi WY, Ngarka L, Ahidjo N, Njitung C, Siewe Fodjo JN, Seke Etet PF, Tsiagadigui JG, Bissek ACZK, Bella AL, Mbanya JC, Ndjolo A, Djientcheu VDP, Ntone FE, Luma HN, Mboudou E, Kasia JM, Leke RJI, Um Meka EN, Ashuntantang G, Ngaroua, et alNjamnshi AK, Fame Ndongo J, Ngoh Ngoh F, Mbella Mbella L, Ghogomu PM, Fouda SM, Ondoa Obama MTA, Tchuinte M, Ousmane Mey A, Manaouda M, Beti Assomo J, Sadi RE, Motaze LP, Nganou Djoumessi E, Li Likeng ML, Nalova Lyonga PE, Etoundi Ngoa LS, Foutsou M, Mouelle Kombi N, Tchiroma BI, Owona G, Ayissi HE, Balungeli CE, Hele P, Fuh CG, Fomundam Mbah Acha RN, Bidoung Kpwatt PI, Mbayu F, Tasong PN, Momo JDD, Doh JP, Bayaola B, Kilo VA, Abouem À Tchoyi D, Njeuma DL, Tamfu SF, Angwafo Iii FF, Chumbow SB, Etoua RM, Omgba RL, Ngomo Manga H, Tsafack Nanfosso R, Chan A, Etoa FX, Zambo JMB, Mah EM, Tommo Monthe M, Eheth S, Monono C, Biffot PP, Gabsa W, Cheka C, Echu G, Bella AE, Njock LR, Fongod AGN, Ndongo DU, Leke RFG, Pondi JE, Fieggen G, Shehu BB, Ayadi R, Merali Z, Yusuf S, Apeagyei AE, Ranchod K, Salama M, Atangana A, Ngokeu E, Ndifon W, Tiahou G, Tchoua R, Korsten L, Ibanez A, Singh G, Abdullah JM, Dhamija RK, Ihunwo AO, Mbarika VWA, Mbah D, Njamnshi WY, Ngarka L, Ahidjo N, Njitung C, Siewe Fodjo JN, Seke Etet PF, Tsiagadigui JG, Bissek ACZK, Bella AL, Mbanya JC, Ndjolo A, Djientcheu VDP, Ntone FE, Luma HN, Mboudou E, Kasia JM, Leke RJI, Um Meka EN, Ashuntantang G, Ngaroua, Bum EN, Njoya O, Mbacham WF, Ongolo-Zogo P, Chabwine JN, Fongang B, Vulliemoz S, Perrig S, Sztajzel R, Etya'ale D, Annoni JM, Chakraborty S, Tishkoff S, Cavazos JE, Maestre G, Seshadri S, Park KB, Newton C, Sander JW, Sen A, Illes J, Hannan AJ, Winkler AS, Narayan V, McLaughlin C, Pyykko M, Occhipinti JA, Beck D, Hiromoto J, Adorjan K, Destrebecq F, Vradenburg G, Manes F, Cross H, Filipescu D, Hachinski V, Bassetti CLA, Scientific Technical Committee YD, Eyre HA. African leadership in brain diplomacy: The Yaoundé declaration advances the global brain economy playbook for better brain health. Neuroscience 2025; 577:161-174. [PMID: 40339899 DOI: 10.1016/j.neuroscience.2025.04.032] [Show More Authors] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2024] [Revised: 04/10/2025] [Accepted: 04/19/2025] [Indexed: 05/10/2025]
Abstract
Africa, the world's second-largest continent is home to 1.5 billion people, accounting for nearly 20% of the global population, (60% under age 25). By 2050, Africa's population will be 2.5 billion, and by 2035, more young Africans will be entering the workforce each year than in the rest of the world combined. Africa also hosts a rich social, cultural, and geopolitical diversity across its 5 geopolitical zones covering 54 countries. It is the most genetically, culturally, and linguistically diverse region on the planet. However, Africa's contribution to the global economy could be more significant if it urgently embraces the brain economy and leads in the development of new methodologies and approaches which can be exported around the world. In this paper, we explain our strategy to advance the Yaoundé Declaration for the Brain Economy, Brain Health, and Brain Capital. The Declaration has been endorsed by Cameroon's President, His Excellency Paul Biya, and demonstrates African leadership in global brain and society innovations, laying out a roadmap for how Africa can outcompete other economies by deftly deploying brain science-inspired policies and investments. We outline a new economic approach for African jobs, economic growth, sustainability, resilience, health, and well-being. The brain economy offers a broader framework than the current sustainable development goals (SDG) agenda. The Yaoundé Declaration is trans-disciplinary and cross-cutting across sectors: 32 sitting members of government from different sectors having co-authored this paper. It aligns with many aspects of the United Nations Pact for the Future and can accelerate the SDG.
Collapse
Affiliation(s)
- Alfred Kongnyu Njamnshi
- Brain Research Africa Initiative (BRAIN), Cameroon & Geneva, Switzerland, Society of Cameroonian Neurologists (SCAN), The University of Yaoundé I, Yaoundé, Cameroon, World Federation of Neurology Delegate for Cameroon, Cameroon.
| | - Jacques Fame Ndongo
- Office of the Minister of State, Minister of Higher Education, Yaoundé, Cameroon
| | - Ferdinand Ngoh Ngoh
- Office of the Minister of State, Secretary General, Presidency of The Republic of Cameroon, Yaoundé, Cameroon
| | | | - Paul M Ghogomu
- Office of the Minister i/c of Special Duties, Presidency of The Republic of Cameroon, Yaoundé, Cameroon
| | - Séraphin M Fouda
- Office of the Minister, Secretary General, Prime Minister's Office, Yaoundé, Cameroon
| | | | - Madeleine Tchuinte
- Office of the Minister of Scientific Research and Innovation, Yaoundé, Cameroon
| | - Alamine Ousmane Mey
- Office of the Minister of the Economy, Planning and Regional Development, Yaoundé, Cameroon
| | | | - Joseph Beti Assomo
- Office of the Minister Delegate, i/c of Defense, Presidency of The Republic of Cameroon, Yaoundé, Cameroon
| | - René E Sadi
- Office the Minister of Communication, Yaoundé, Cameroon
| | | | | | | | | | | | - Mounouna Foutsou
- Office the Minister of Youth and Civic Education, Yaoundé, Cameroon
| | | | | | - Grégoire Owona
- Office the Minister of Employment and Social Security, Yaoundé, Cameroon
| | - Henri Eyebe Ayissi
- Office the Minister of State Property and Land Tenure, Yaoundé, Cameroon
| | | | - Pierre Hele
- Office the Minister of Environment, Nature Protection and Sustainable Development, Yaoundé, Cameroon
| | - Calistus G Fuh
- Office the Minister of Mines, Energy and Technological Development, Yaoundé, Cameroon
| | - Rose N Fomundam Mbah Acha
- Office of the Minister Delegate, i/c of Supreme State Audit, Presidency of The Republic of Cameroon, Yaoundé, Cameroon
| | | | - Felix Mbayu
- Office of the Minister Delegate to the Minister of External Relations, i/c of Relations with the Commonwealth, Yaoundé, Cameroon
| | - Paul N Tasong
- Office of the Minister Delegate to the Minister of Economy, Planning and Regional Development i/c of Planning, Yaoundé, Cameroon
| | - Jean de Dieu Momo
- Office of the Minister Delegate to the Minister of Justice, Keeper of the Seal, Yaoundé, Cameroon
| | - Jérôme P Doh
- Office of the Secretary of State to the Minister of Justice, Keeper of the Seal, i/c of Penitentiary Administration, Yaoundé, Cameroon
| | - Boniface Bayaola
- Office of the Secretary of State to the Minister of Secondary Education, i/c of Teacher Training, Yaoundé, Cameroon
| | - Vivian A Kilo
- Office of the Secretary of State to the Minister of Basic Education, Yaoundé, Cameroon
| | | | | | - Simon F Tamfu
- National Commission for Bilingualism and Multiculturalism, Yaoundé, Cameroon
| | - Fru F Angwafo Iii
- Office of the Independent Public Conciliator, North-West Region, Bamenda, Cameroon
| | - Sammy B Chumbow
- Office of the President of the Regional Assembly, North-West Region, Bamenda, Cameroon
| | | | | | | | | | | | | | | | | | - Michel Tommo Monthe
- Office of the Ambassador/Permanent Representative, Permanent Mission of Cameroon to the United Nations, New York, USA
| | - Salomon Eheth
- Office of the Ambassador/Permanent Representative, Permanent Mission of Cameroon to the United Nations, Geneva, Switzerland
| | - Churchill Monono
- Office of the Ambassador, Permanent Mission of Cameroon to the African Union, and Embassy of Cameroon to Ethiopia, Addis Ababa, Ethiopia
| | - Paul P Biffot
- Office of the Ambassador, Dean of the Diplomatic Corps in Yaoundé, and High Commission of the Republic of Gabon to Cameroon, Yaoundé, Cameroon
| | - Wilfred Gabsa
- Office of the Secretary General, Ministry of Higher Education, Yaoundé, Cameroon
| | | | - George Echu
- General Secretariat, Presidency of The Republic of Cameroon, Yaoundé, Cameroon
| | | | | | | | - Daniel U Ndongo
- International Relations Institute of Cameroon (IRIC), Yaoundé, Cameroon
| | - Rose F G Leke
- Cameroon Academy of Science, and Brain Research African Initiative (BRAIN), Yaoundé, Cameroon
| | | | - Graham Fieggen
- University of Cape Town, Neuroscience Institute, Cape Town, South Africa
| | - Bello B Shehu
- Continental Association of African Neurosurgical Societies, Sokoto, Nigeria
| | - Rym Ayadi
- Euro-Mediterranean Economists Association (EMEA), Barcelona, Spain
| | - Zul Merali
- Brain and Mind Institute, Agha Khan University, Nairobi, Kenya
| | - Sadiq Yusuf
- Society of Neuroscientists of Africa (SONA), Nairobi, Kenya
| | - Angela Esi Apeagyei
- Institute of Health Metrics and Evaluation (IHME), University of Washington, Seatle, USA
| | - Kirti Ranchod
- Atlantic Fellow, Global Brain Health Institute, Johannesburg, South Africa
| | | | - Abdon Atangana
- Institute for Groundwater Studies, University of the Free State, Bloemfontein, South Africa
| | - Eddy Ngokeu
- Ministry of Scientific Research and Innovation, Yaoundé, Cameroon
| | - Wilfred Ndifon
- Ministry of Scientific Research and Innovation, Yaoundé, Cameroon
| | | | - Romain Tchoua
- Ecole d'Application de Service de Santé Militaire de Libreville, Libreville, Gabon
| | - Lise Korsten
- African Academy of Sciences, Nairobi, Kenya and University of Pretoria, Pretoria, South Africa
| | - Agustin Ibanez
- Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile
| | | | | | - Rajinder K Dhamija
- Institute of Human Behavior and Allied Sciences, and National Task Force on Brain Health Govt of India, New Delhi, India
| | - Amadi O Ihunwo
- University of the Witwatersrand, Johannesburg, South Africa
| | | | - David Mbah
- Cameroon Academy of Sciences, Yaoundé, Cameroon
| | - Wepnyu Y Njamnshi
- Brain Research Africa Initiative, Yaoundé, Cameroon; Division of Health Operations Research, Ministry of Public Health, Yaoundé, Cameroon; Global Brain Health Institute, University of California, San Francisco, USA
| | | | - Nene Ahidjo
- Brain Research Africa Initiative, Yaoundé, Cameroon
| | | | | | | | | | | | | | | | - Alexis Ndjolo
- Centre International de Référence Chantal Biya pour la recherche sur la prévention et la prise en charge du VIH/SIDA (CIRCB), Yaoundé, Cameroon
| | | | | | - Henry N Luma
- Gynaecologic, Obstetric and Paediatric Hospital, Douala, Cameroon
| | | | - Jean Marie Kasia
- Hospital Centre for Applied Research, Endoscopic Surgery and Human Reproduction (CHRACERH), Yaoundé, Cameroon
| | | | | | | | - Ngaroua
- Faculty of Medicine and Biomedical Sciences, The University of Yaoundé I, Yaoundé, Cameroon
| | | | - Oudou Njoya
- Cameroon Society of Gastro-Enterology, Yaoundé, Cameroon
| | - Wilfred F Mbacham
- Cameroon Academy of Sciences and Fobang Institutes for Innovations in Science and Technology (FINISTECH), Yaoundé, Cameroon
| | - Pierre Ongolo-Zogo
- Cochrane Cameroon, Centre for Best Practices in Health and The Yaoundé Central Hospital, Yaoundé, Cameroon
| | | | - Bernard Fongang
- Brain Research Africa Initiative, Yaoundé, Cameroon; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health, San Antonio, USA
| | | | | | | | | | | | - Sarbani Chakraborty
- Global Brain Health Partnership, Center for Global Health, School of Medicine and Health, Technical University of Munich, Munich, Germany
| | - Sarah Tishkoff
- Penn Center for Global Genomics & Health Equity, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
| | - Jose E Cavazos
- Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health, San Antonio, USA
| | - Gladys Maestre
- Alzheimer's disease Resource Center for Minority Aging Research, University of Texas Rio Grande Valley, Brownsville, USA
| | - Sudha Seshadri
- Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health, San Antonio, USA
| | - Kee B Park
- Program in Global Surgery and Social Change, Harvard Medical School, Harvard University, Boston, USA
| | | | - J W Sander
- Institute of Neurology, Queen square, London, UK
| | | | - Judy Illes
- International Brain Initiative (IBI), & Neuroethics Canada at University of British Columbia, Vancouver, Canada
| | - Anthony J Hannan
- International Brain Initiative (IBI), & Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
| | - Andrea S Winkler
- Department of Neurology, TUM University Hospital, and Center for Global Health, School of Medicine and Health, Technical University of Munich, Munich, Germany
| | | | | | - Mika Pyykko
- Finnish Brain Health Plan, Helsinki, Finland
| | - Jo-An Occhipinti
- Mental Wealth Initiative, Brain and Mind Centre, University of Sydney, Sydney, Australia
| | | | | | | | | | | | - Facundo Manes
- INECO Foundation for Research in Cognitive Neuroscience and Institute of Neurosciences, Favaloro Foundation, Buenos Aires, Argentina
| | - Helen Cross
- International League Against Epilepsy, London, UK
| | | | | | - Claudio L A Bassetti
- Faculty of Medicine, University of Bern, Bern, Switzerland; European Brain Council, Brussels, Belgium; Swiss Brain Health Plan, Bern, Switzerland
| | | | - Harris A Eyre
- Brain Capital Alliance, Baker Institute's Neuro-Policy Program at the Center for Health and Biosciences, Rice University, Houston, USA
| |
Collapse
|
14
|
Ishihara K, Kitajima T, Ota A, Yatsuya H, Iwata N. Association between eveningness and depressive symptoms in daytime workers: A cross-sectional analysis of the Aichi Workers' Cohort Study. FUJITA MEDICAL JOURNAL 2025; 11:64-69. [PMID: 40309001 PMCID: PMC12040487 DOI: 10.20407/fmj.2024-021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 06/28/2024] [Accepted: 09/12/2024] [Indexed: 05/02/2025]
Abstract
Objectives Eveningness (evening preference in chronotype) has been reported to be associated with a number of psychiatric problems. We examined a cross-sectional association between eveningness and depressive symptoms in daytime workers. Methods The subjects were 4410 civil servants (71.7% male, aged 18-69 years [mean, 43.5 years]) with no history of depressive disorder who did not perform shift work, and for whom there were no missing data. The association between eveningness, determined using the reduced Morningness-Eveningness Questionnaire, and depressive symptoms, determined using the shorter form of the Central Epidemiological Studies Depression scale, was assessed with logistic regression analysis adjusted for potential confounding factors (gender, income, living alone, breakfast intake, coffee consumption, drinking habits, exercise, smoking, working hours, sleep duration, and difficulty falling asleep). Results Of the subjects, 529 (12.0%) had eveningness, and 1408 (31.9%) reported depressive symptoms. Depressive symptoms were reported more frequently by those with eveningness than by those with other chronotypes (57.3% vs 28.5%). The association between eveningness and depression (gender- and age-adjusted odds ratio, 3.27; 95% confidence interval, 2.71-3.95) was significant after adjustment for the other confounding factors (odds ratio, 2.40; 95% confidence interval, 1.96-2.95). Conclusions Our results suggest that eveningness is associated with depressive symptoms among day workers and that this association is independent of potential confounding factors. Further longitudinal studies are needed to examine the causal relationship.
Collapse
Affiliation(s)
- Kazuhito Ishihara
- Department of Psychiatry, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan
| | - Tsuyoshi Kitajima
- Department of Psychiatry, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan
| | - Atsuhiko Ota
- Department of Public Health, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan
| | - Hiroshi Yatsuya
- Department of Public Health and Health System, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
| | - Nakao Iwata
- Department of Psychiatry, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan
| |
Collapse
|
15
|
Su KP. Harmonizing the inner orchestra: the impact of urbanization and evolution of stress, inflammation, diet, and lifestyles in depression. Curr Opin Psychiatry 2025; 38:209-216. [PMID: 39804221 DOI: 10.1097/yco.0000000000000986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/29/2025]
Abstract
PURPOSE OF REVIEW This review explores the intersection of urbanization, stress, inflammation, diet, lifestyle changes, and digital evolution as key factors influencing depression, emphasizing the necessity for integrative and evolutionary perspectives in mental health and intervention. RECENT FINDINGS Epidemiological studies reveal a dramatic increase in common mental disorders, particularly depression, alongside parallel increases in suicide, unemployment, and divorce rates. Evolutionary perspectives suggest that mechanisms once advantageous for survival, such as stress responses and inflammatory processes, may contribute to mental health challenges in modern urban environments. Moreover, the mental health crisis among generation Z underscores the impact of digital evolution, where the shift from play-based to phone-based childhood contributes significantly to rising depression rates. Recent research highlights the significant role of omega-3 fatty acids, circadian rhythm regulation, mindfulness, and anti-inflammatory lifestyle interventions in mitigating depressive symptoms. SUMMARY The interplay between our evolutionary heritage and rapid societal changes has created a "symphony" of factors contributing to depression. Understanding these evolutionary mismatches in stress responses, inflammatory processes, dietary shifts, circadian disruptions, and digitalization provides new insights into the etiology of depression. This holistic approach, conceptualized as "harmonizing the inner orchestra," offers promising avenues for prevention and treatment strategies that address the multifaceted nature of depression in our modern world.
Collapse
Affiliation(s)
- Kuan-Pin Su
- Mind-Body Interface Research Center (MBI-Lab), China Medical University Hospital
- College of Medicine, China Medical University, Taichung
- An-Nan Hospital, China Medical University, Tainan, Taiwan
| |
Collapse
|
16
|
Morishima R, Usami S, Kanehara A, Okada N, Noguchi H, Yagishita S, Fukuda M, Kasai K. Classroom-Level and Individual-Level Prosociality and Help-Seeking Behaviors Among Adolescents. JAMA Netw Open 2025; 8:e2510319. [PMID: 40372756 DOI: 10.1001/jamanetworkopen.2025.10319] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/16/2025] Open
Abstract
Importance Although individual prosociality, defined as voluntary behavior intended to benefit another, is known to promote help-seeking behaviors among adolescents, it remains unclear whether a prosocial community, such as the classroom, also facilitates these behaviors. Objective To investigate the associations of classroom-level and individual-level prosociality with help-seeking behaviors, considering age and gender, and to examine moderation effects of being bullied. Design, Setting, and Participants In this cross-sectional study, annual surveys were conducted via questionnaire among students in Japanese junior and senior high schools from 2020 to 2023. The first wave was administered from October 1 to November 7, 2020, followed by the second wave from June 4 to July 13, 2021, the third wave from June 17 to July 19, 2022, and the fourth wave from June 19 to July 28, 2023. Exposure Classroom-level prosociality was defined as the mean prosociality of all students within a classroom, while individual-level prosociality was measured as the deviation from this classroom mean. Prosociality was assessed using the prosocial subscale of the self-reported Strengths and Difficulties Questionnaire. Main Outcomes and Measures Generalized mixed-effects models estimated the associations of classroom-level and individual-level prosociality with help-seeking behaviors (including poor help-seeking and seeking help from friends, family members, homeroom teachers, and physicians) while considering subgroups based on grades and gender, as well as the moderation effect of being bullied. Help-seeking behaviors were evaluated by a question about seeking help for one's mental health problems ("Are you currently consulting anyone to discuss your psychological stress or mental health problems?"), with multiple options. The robustness of the main findings were tested by models stratified by survey year. Results The analysis included 21 845 participants (mean [SD] school grade, 10.4 [1.2]; 16.6% junior high school students and 83.4% senior high school students; 53.3% boys). Classroom-level prosociality was associated with a higher rate of help-seeking from friends among senior high school students (odds ratio [OR], 1.26, 95% CI, 1.17-1.35), which confirmed the robustness. No moderation effect of being bullied was found in this association. Higher individual-level prosociality was associated with increased help-seeking from various sources across nearly all models and subgroups, regardless of being bullied (friends: OR, 1.15 [95% CI, 1.13-1.17]; P < .001; family members: OR, 1.09 [95% CI, 1.07-1.11]; P < .001; homeroom teachers: OR, 1.15 [95% CI, 1.10-1.19]; P < .001; school nurses: OR, 1.19 [95% CI, 1.12-1.28]; P < .001; and physicians: OR, 1.14 [95% CI, 1.07-1.20]; P < .001). Conclusions and Relevance This cross-sectional study of 21 845 students found that both classroom-level and individual-level prosociality were associated with higher rates of help-seeking from peers among senior high school students, while accounting for individual characteristics. Enhancing classroom prosociality could foster help-seeking behaviors through reciprocal peer support, benefiting even those who experienced bullying.
Collapse
Affiliation(s)
- Ryo Morishima
- Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
- Department of Psychology, Faculty of Health and Medical Science, Teikyo Heisei University, Tokyo, Japan
- Waseda Institute of Social and Human Capital Studies, Tokyo, Japan
| | - Satoshi Usami
- Division of Educational Psychology, Graduate School of Education, The University of Tokyo, Tokyo, Japan
| | - Akiko Kanehara
- Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Naohiro Okada
- Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
- International Research Center for Neurointelligence, The University of Tokyo Institutes for Advanced Study, Tokyo, Japan
| | - Haruko Noguchi
- Waseda Institute of Social and Human Capital Studies, Tokyo, Japan
- Faculty of Political Science and Economics, Waseda University, Tokyo, Japan
| | - Sho Yagishita
- Department of Structural Physiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Masato Fukuda
- Department of Psychiatry and Neuroscience, Graduate School of Medicine, Gunma University, Gunma, Japan
| | - Kiyoto Kasai
- Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
- International Research Center for Neurointelligence, The University of Tokyo Institutes for Advanced Study, Tokyo, Japan
| |
Collapse
|
17
|
Wang J, Li S, Wang D, Gao Y, Wang Q, Wang T, Wang G, Peng D, Qiao Y, Zhou J, Feng L, Hu X, Wan C. Effects of Omega-3 PUFAs on lipid profiles and antioxidant response in depressed adolescents: A metabolomic and lipidomic study. Redox Biol 2025; 82:103617. [PMID: 40158256 PMCID: PMC11997347 DOI: 10.1016/j.redox.2025.103617] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2025] [Revised: 03/24/2025] [Accepted: 03/25/2025] [Indexed: 04/02/2025] Open
Abstract
Adolescent depression is a significant global health challenge, with many patients responding inadequately to antidepressant treatments. Omega-3 polyunsaturated fatty acids (ω3 PUFAs) have been proposed as a potential adjunctive treatment, but their precise mechanisms remain poorly understood. This study aimed to explore the mechanisms through which ω3 PUFAs exert their antidepressant effects and to identify potential biomarkers for their therapeutic response. A comprehensive assessment of plasma metabolomic and erythrocyte membrane lipidomic was performed on 51 depressed adolescents who were randomly assigned to received either ω3 PUFAs plus paroxetine (n = 27) or paroxetine alone (n = 24) for 12 weeks. Following ω3 PUFA supplementation, phospholipid metabolism emerged as the most significantly altered pathway. ω3 PUFAs markedly influenced the composition of membrane fatty acids, significantly increasing the ω3 PUFA content, decreasing the ω6/ω3 PUFA ratio, and increasing membrane fluidity. Notably, ω3 PUFAs reduced lipid peroxidation in both plasma and cell membranes while enhancing antioxidant capacity in the membranes. Moreover, alterations in phospholipids and membrane function were significantly correlated with improvements in depressive symptoms and cognitive function. Importantly, ω3 PUFA supplementation resulted in greater improvement in clinical symptoms compared to the non-supplemented group exclusively in the subgroup with high baseline oxidative damage levels. This study suggests that ω3 PUFAs promoted phospholipid integration and alleviated oxidative stress, which may account for their antidepressant effects. Lipid oxidation biomarkers could help identify patients likely to benefit from ω3 PUFA supplementation. These findings advance our understanding of the mechanism and clinical application of ω3 PUFAs in treating adolescent depression.
Collapse
Affiliation(s)
- Jinfeng Wang
- Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
| | - Shuhui Li
- Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
| | - Dandan Wang
- Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
| | - Yan Gao
- Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
| | - Qian Wang
- Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
| | - Tianqi Wang
- Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
| | - Guanghai Wang
- Department of Developmental and Behavioral Pediatrics, Pediatric Translational Medicine Institute, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
| | - Daihui Peng
- Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
| | - Yi Qiao
- Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
| | - Jiansong Zhou
- Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
| | - Lei Feng
- Instrumental Analysis Center, Shanghai Jiao Tong University, Shanghai, China.
| | - Xiaowen Hu
- Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
| | - Chunling Wan
- Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
| |
Collapse
|
18
|
Clarke A, McDowell C, Badcock P. Mental Ill-Health in young people with systemic autoinflammatory disease - a scoping review. Rheumatol Int 2025; 45:108. [PMID: 40249417 PMCID: PMC12008080 DOI: 10.1007/s00296-025-05864-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2024] [Accepted: 04/04/2025] [Indexed: 04/19/2025]
Abstract
Systemic autoinflammatory disorders (SAID), immune dysregulation disorders with onset frequently occurring in youth, are defined by unprovoked inflammation. Research suggest inflammation is associated with the pathogenesis of mental ill-health. Separately, research has identified that mental ill-health is prevalent in people with immune dysregulation disorders compared to healthy controls or those with other chronic diseases, and the psychosocial impacts of these diseases on quality of life can be debilitating. This review aimed to broadly identify the extent and nature of research involving young people with SAIDs and mental ill-health. A scoping review was conducted across 6 databases of peer-reviewed articles referring to SAIDs and mental ill-health in young people. Of 727 studies, 41 met the inclusion criteria. Thirty-seven were observational studies, including 18 case studies or series. Four studies were treatment trials. Fourteen observational studies investigated the prevalence of mental ill-health in a SAID population with large sample sizes. Most studies were conducted in Türkiye, involving Behçet's syndrome or familial Mediterranean fever and anxiety, depression, and psychosis were strongly represented. Findings suggest an association between mental ill-health and SAID activity in young people. Anxiety and depression were associated with some specific SAIDs duration, symptom severity, SAID flare recency and frequency, and SAID treatment effects. Co-occurrence and resolution of SAID flares and mental ill-health with treatment were frequent themes in case studies of some SAIDs. Further research is required on the prevalence and risk of developing mental ill-health among young people with SAIDs, along with associations between mental ill-health, other SAIDs and disease activity, other participant variables, and appropriate management of mental ill-health in this population.
Collapse
Affiliation(s)
- Amanda Clarke
- Centre for Youth Mental Health, The University of Melbourne, Victoria, Parkville, Australia
| | - Caitlin McDowell
- Centre for Youth Mental Health, The University of Melbourne, Victoria, Parkville, Australia.
- Orygen, Victoria, Parkville, Australia.
| | - Paul Badcock
- Centre for Youth Mental Health, The University of Melbourne, Victoria, Parkville, Australia
- Orygen, Victoria, Parkville, Australia
| |
Collapse
|
19
|
Caswell CB, Hosseini-Kamkar N, Cox SM, Prada NP, Iqbal M, Nikolic M, Banaschewski T, Barker GJ, Bokde AL, Brühl R, Desrivières S, Flor H, Garavan H, Gowland P, Grigis A, Heinz A, Martinot JL, Paillère Martinot ML, Artiges E, Nees F, Orfanos DP, Poustka L, Smolka MN, Hohmann S, Vaidya N, Walter H, Whelan R, Schumann G, Paus T, Leyton M, IMAGEN Consortium. A Novel Diathesis-Stress Model of Comorbid Early Onset Psychiatric Disorders. MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES 2025:2025.04.08.25325481. [PMID: 40297443 PMCID: PMC12036423 DOI: 10.1101/2025.04.08.25325481] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 04/30/2025]
Abstract
Importance Psychiatric comorbidity is the norm. Identifying transdiagnostic risk factors will inform our understanding of developmental pathways and early intervention targets. Objective We recently reported that many psychiatric outcomes are predicted by a three-factor model composed of adolescent externalizing (EXT) behaviors, early life adversity, and dopamine autoreceptor availability. Here, we investigated whether this model could be reproduced in a large population-based sample using functional magnetic resonance imaging (fMRI) instead of positron emission tomography. Design Data were collected by the IMAGEN consortium beginning in 2010 when cohort members were 14 years old, with follow-up testing at ages 16 and 19. These longitudinal data were used to predict psychiatric disorders by 19 years of age. Setting Participants were recruited from secondary schools across Europe. Participants Adolescents (n = 1338) with fMRI, behavioural, diagnostic, and early life trauma data. Main Outcomes and Measures Binary regression models tested whether a combination of EXT behaviors, childhood trauma, and mesocorticolimbic reward anticipation responses at age 14 or 19 predicted the presence of a disorder by age 19. Results A total of 1338 participants had the required data (52.4% female). In all models, EXT and adversity scores were significant predictors (p < 0.001). Reward anticipation responses in the ventral striatum, caudate, putamen, and anterior cingulate cortex (ACC) at age 14 (p ≤ 0.05) and in the ventral striatum at age 19 (p ≤ 0.029) were predictors in their respective models. The three-factor models overall were highly significant (p < 1.0 × 10-21), yielding greater predictive strength than each factor alone. They had an accuracy of nearly 75%, accounting for ≥ 11% (Nagelkerke R2) of the variance in psychiatric disorders. The relationship between trauma and diagnoses was partially mediated by higher EXT (indirect path B = 0.0535, 95% CI = 0.0301-0.0835), and moderated by fMRI responses in the ACC (p = 0.0038) and putamen (p = 0.0135) at age 14. Conclusions and Relevance The results extend our previous findings, increasing confidence in a novel diathesis-stress model of commonly comorbid early onset psychiatric disorders. The results have implications for diagnostic classification schemes and pleiotropic views of psychiatric disorder etiology.
Collapse
Affiliation(s)
| | - Niki Hosseini-Kamkar
- Atlas Institute for Veterans and Families, Ottawa Institute for Mental Health Research, Ottawa, ON Canada
| | - Sylvia M. Cox
- Department of Psychiatry, McGill University, Montréal, QC Canada
| | | | - Maisha Iqbal
- Department of Psychiatry, McGill University, Montréal, QC Canada
| | - Maja Nikolic
- Department of Psychiatry, McGill University, Montréal, QC Canada
| | - Tobias Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159 Mannheim, Germany; German Center for Mental Health (DZPG), partner site Mannheim-Heidelberg-Ulm
| | - Gareth J. Barker
- Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, United Kingdom
| | - Arun L.W. Bokde
- Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland
| | - Rüdiger Brühl
- Physikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Germany
| | - Sylvane Desrivières
- Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, United Kingdom
| | - Herta Flor
- Institute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany
- Department of Psychology, School of Social Sciences, University of Mannheim, 68131 Mannheim, Germany
| | - Hugh Garavan
- Departments of Psychiatry and Psychology, University of Vermont, 05405 Burlington, Vermont, USA
| | - Penny Gowland
- Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, United Kingdom
| | - Antoine Grigis
- NeuroSpin, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - Andreas Heinz
- Department of Psychiatry and Psychotherapy, University of Tübingen, Germany; German Center for Mental Health (DZPG), Site Tübingen, Germany
| | - Jean-Luc Martinot
- Institut National de la Santé et de la Recherche Médicale, INSERM U 1299 “Trajectoires Développementales & Psychiatrie”, Ecole Normale Supérieure Paris-Saclay, University Paris-Saclay, Département de mathématiques, Centre Borelli; UMR9010, Gif-sur-Yvette, France
| | - Maire-Laure Paillère Martinot
- Institut National de la Santé et de la Recherche Médicale, INSERM U 1299 “Trajectoires Développementales & Psychiatrie”, Ecole Normale Supérieure Paris-Saclay, University Paris-Saclay, Département de mathématiques, Centre Borelli; UMR9010, Gif-sur-Yvette, France
- AP-HP. Sorbonne Université, Department of Child and Adolescent Psychiatry, Pitié-Salpêtrière Hospital, Paris, France
| | - Eric Artiges
- Institut National de la Santé et de la Recherche Médicale, INSERM U 1299 “Trajectoires Développementales & Psychiatrie”, Ecole Normale Supérieure Paris-Saclay, University Paris-Saclay, Département de mathématiques, Centre Borelli; UMR9010, Gif-sur-Yvette, France
- Psychiatry Department, EPS Barthélémy Durand, Etampes, France
| | - Frauke Nees
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159 Mannheim, Germany; German Center for Mental Health (DZPG), partner site Mannheim-Heidelberg-Ulm
- Institute of Medical Psychology and Medical Sociology, University Medical Center Schleswig Holstein, Kiel University, Kiel, Germany
| | | | - Luise Poustka
- Department of Child and Adolescent Psychiatry, Center for Psychosocial Medicine, University Hospital Heidelberg, Heidelberg, Germany
| | - Michael N. Smolka
- Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany
| | - Sarah Hohmann
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159 Mannheim, Germany; German Center for Mental Health (DZPG), partner site Mannheim-Heidelberg-Ulm
| | - Nilakshi Vaidya
- Centre for Population Neuroscience and Stratified Medicine (PONS), Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Germany
| | - Henrik Walter
- Department of Psychiatry and Psychotherapy, University of Tübingen, Germany; German Center for Mental Health (DZPG), Site Tübingen, Germany
| | - Robert Whelan
- School of Psychology and Global Brain Health Institute, Trinity College Dublin, Ireland
| | - Gunter Schumann
- Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany
- Centre for Population Neuroscience and Precision Medicine (PONS), Institute for Science and Technology of Brain-inspired Intelligence (ISTBI), Fudan University, Shanghai, China
| | - Tomáš Paus
- Departments of Psychiatry and Neuroscience, Faculty of Medicine and Centre Hospitalier Universitaire Sainte-Justine, University of Montreal, Montreal, Quebec, Canada
| | - Marco Leyton
- Department of Psychiatry, McGill University, Montréal, QC Canada
| | | |
Collapse
|
20
|
Caglayan S, Høye A, Andreassen OA, Grønli OK. Association of Psychological Problems for Which Help Was Sought With Physical Illness. Am J Prev Med 2025; 68:656-664. [PMID: 39667710 DOI: 10.1016/j.amepre.2024.12.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/17/2024] [Revised: 12/02/2024] [Accepted: 12/04/2024] [Indexed: 12/14/2024]
Abstract
INTRODUCTION Persons with mental disorders are at increased risk for physical illness. Individuals who seek help for psychological problems might benefit from timely support and interventional approaches. This study aimed to explore the associations between psychological problems for which help was sought and physical illness. METHODS The 7th survey of the Tromsø Study, which included 21,083 participants aged ≥40 years, was used in the study. The main exposure was psychological problems for which help was sought. Main outcomes were lifetime prevalence and time to onset of physical illness. Associations between psychological problems and physical illness were analyzed using logistic regression and survival analysis and adjusted for sex, birth year, smoking, education, and income. Data were collected in 2015-2016 and analyzed in 2023-2024. RESULTS Psychological problems were associated with smoking and having lower income but higher educational attainment. Psychological problems were associated with lifetime prevalence of hypertension, coronary artery disease, heart failure, atrial fibrillation, stroke, kidney disease, chronic obstructive pulmonary disease, asthma, arthrosis, migraine, chronic pain, and cancer; ORs ranged from 1.15 (95% CI=1.04, 1.27) to 2.15 (95% CI=1.76, 2.62). Survival analysis demonstrated that individuals with psychological problems are at increased risk for subsequent physical illness; hazard ratios ranged from 1.18 (95% CI=1.06, 1.32) to 2.74 (95% CI=2.06, 3.65). CONCLUSIONS This study found that psychological problems with or without a diagnosis of mental disorder might be an important marker of increased risk for physical illness.
Collapse
Affiliation(s)
- Safak Caglayan
- Division of Mental Health and Substance Abuse, University Hospital of North Norway, Tromsø, Norway.
| | - Anne Høye
- Division of Mental Health and Substance Abuse, University Hospital of North Norway, Tromsø, Norway; Department of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway
| | - Ole A Andreassen
- NORMENT: Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Ole K Grønli
- Division of Mental Health and Substance Abuse, University Hospital of North Norway, Tromsø, Norway; Department of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway
| |
Collapse
|
21
|
Martella F, Caporali A, Macellaro M, Cafaro R, De Pasquale F, Dell'Osso B, D'Addario C. Biomarker identification in bipolar disorder. Pharmacol Ther 2025; 268:108823. [PMID: 39965667 DOI: 10.1016/j.pharmthera.2025.108823] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2024] [Revised: 02/04/2025] [Accepted: 02/14/2025] [Indexed: 02/20/2025]
Abstract
Bipolar disorder (BD) is a severe psychiatric condition whose pathophysiology is complex and multifactorial. Genetic, environmental and social risk factors play a role in its development as well as in its progressive course. Research is currently focusing on the identification of the biological basis underlying these processes in order to suggest novel biomarkers capable to predict BD etiopathogenesis and staging. Staging has been recognized as of great value for the treatment and management of many illnesses and might also be suitable for mental health issues, particularly in disorders like BD, which progress from an initial mild phase to a more severe and thus difficult-to-treat situation. Thus, it would be of great help the characterization of to suggest better treatment requirements and improve prognosis across the different stages of the illness. Here, we summarize current research on the biological hypotheses of BD and the biomarkers associated with its progression, reviewing clinical studies available in the literature.
Collapse
Affiliation(s)
- Francesca Martella
- Department of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, Teramo, Italy
| | - Andrea Caporali
- Department of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, Teramo, Italy; International School of Advanced Studies, University of Camerino, Camerino, Italy
| | - Monica Macellaro
- Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, Milan, Italy; CRC "Aldo Ravelli" for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Milan, Italy
| | - Rita Cafaro
- Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, Milan, Italy
| | - Francesco De Pasquale
- Faculty of Veterinary Medicine, University of Teramo, Teramo, Italy; IRCCS Fondazione Santa Lucia, Roma, Italy
| | - Bernardo Dell'Osso
- Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, Milan, Italy; CRC "Aldo Ravelli" for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Milan, Italy; Department of Psychiatry and Behavioural Sciences, Stanford University, Stanford, CA, USA
| | - Claudio D'Addario
- Department of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, Teramo, Italy; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
| |
Collapse
|
22
|
Hamaoui J, Pocuca N, Ditoma M, Héguy C, Simard C, Aubin R, Lucic A, Castellanos-Ryan N. Age of onset of cannabis use and substance use problems: A systematic review of prospective studies. Addict Behav 2025; 163:108259. [PMID: 39799660 DOI: 10.1016/j.addbeh.2025.108259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2024] [Revised: 12/10/2024] [Accepted: 01/08/2025] [Indexed: 01/15/2025]
Abstract
BACKGROUND The association between the age of cannabis use (CU) onset and substance use (SU) problems has been extensively studied, yet findings remain inconsistent. AIMS This systematic review aimed to examine prospective studies on the association between age of CU onset and later SU problems, controlling for key individual, social, and SU-related risk factors. METHODS PsycINFO, Web of Science and PubMed were searched for studies published between January 2000 and December 2024. Studies were included if they: 1) were prospective; 2) measured CU onset during adolescence; 3) measured CU or SU problems after CU onset, 4) examined whole plant or phytocannabinoids. Studies were excluded if they exclusively focused on high-risk samples. Risk of bias was assessed using the Risk of Bias in Non-randomised Studies-of Interventions tool. The review was registered with PROSPERO, number CRD42022332092. RESULTS Sixteen studies met eligibility criteria. Earlier age of CU onset was associated with CU disorder (CUD) and CU negative consequences, with mixed findings for other SU problems (e.g., alcohol). CU frequency accounted for a significant portion of the risk for CU negative consequences, but the association with CUD remained independent of frequency. Only one study had low risk of bias, while seven had some concerns, and eight had a high or very high risk of bias. CONCLUSIONS Findings suggest that early age of CU onset is a specific risk factor in the development of CUD, but not other SU problems. Prevention approaches should aim to delay the onset and reduce the frequency of CU among youth to reduce risk of the development of CUD.
Collapse
Affiliation(s)
- Jad Hamaoui
- Azrieli Research Center of Sainte-Justine University Hospital, Montreal, Canada; School of Psychoeducation, University of Montreal, Montreal, Canada.
| | - Nina Pocuca
- School of Psychology, The University of Queensland, Brisbane, Australia.
| | - Mikaela Ditoma
- Faculty of Psychology, University of Montreal, Montreal, Canada.
| | - Camille Héguy
- Faculty of Psychology, McGill University, Montreal, Canada.
| | - Cléa Simard
- School of Psychoeducation, University of Montreal, Montreal, Canada.
| | - Raphael Aubin
- School of Psychoeducation, University of Montreal, Montreal, Canada.
| | - Anastasia Lucic
- Faculty of Psychology, University of Montreal, Montreal, Canada.
| | - Natalie Castellanos-Ryan
- Azrieli Research Center of Sainte-Justine University Hospital, Montreal, Canada; School of Psychoeducation, University of Montreal, Montreal, Canada.
| |
Collapse
|
23
|
Koike S, Tanaka SC, Hayashi T. Beyond case-control study in neuroimaging for psychiatric disorders: Harmonizing and utilizing the brain images from multiple sites. Neurosci Biobehav Rev 2025; 171:106063. [PMID: 40020797 DOI: 10.1016/j.neubiorev.2025.106063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2024] [Revised: 01/15/2025] [Accepted: 02/09/2025] [Indexed: 03/03/2025]
Abstract
Recent magnetic resonance imaging (MRI) research has advanced our understanding of brain pathophysiology in psychiatric disorders. This progress necessitates re-evaluation of the diagnostic system for psychiatric disorders based on MRI-based biomarkers, with implications for precise clinical diagnosis and optimal therapeutics. To achieve this goal, large-scale multi-site studies are essential to develop a standardized MRI database, with the analysis of several thousands of images and the incorporation of new data. A critical challenge in these studies is to minimize sampling and measurement biases in MRI studies to accurately capture the diversity of disease-derived biomarkers. Various techniques have been employed to consolidate datasets from multiple sites in case-control studies. Traveling subject harmonization stands out as a powerful tool that can differentiate measurement bias from sample variety and sampling bias. A non-linear statistical model for a normative trajectory across the lifespan also strengthens the database to mitigate sampling bias from known factors such as age and sex. These approaches can enhance the alterations between psychiatric disorders and integrate new data and follow-up scans into existing life-course trajectory, enhancing the reliability of machine learning classification and subtyping. Although this approach has been developed using T1-weighted structural image features, future research may extend this framework to other modalities and measures. The required sample size and methodological establishment are needed for future investigations, leading to novel insights into the brain pathophysiology of psychiatric disorders and the development of optimal therapeutics for bedside clinical applications. Sharing big data and their findings also need to be considered.
Collapse
Affiliation(s)
- Shinsuke Koike
- University of Tokyo Institute for Diversity and Adaptation of Human Mind, The University of Tokyo, Tokyo 153-8902, Japan; Center for Evolutionary Cognitive Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Tokyo 153-8902, Japan; The International Research Center for Neurointelligence (WPI-IRCN), The University of Tokyo Institutes for Advanced Study (UTIAS), Tokyo 113-8654, Japan.
| | - Saori C Tanaka
- Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International, Kyoto 619-0288 Japan; Division of Information Science, Nara Institute of Science and Technology, Nara 630-0192, Japan
| | - Takuya Hayashi
- Laboratory for Brain Connectomics Imaging, RIKEN Center for Biosystems Dynamics Research, Hyogo 351-0198, Japan; Department of Brain Connectomics, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan
| |
Collapse
|
24
|
Wang Y, Qin C, Chen H, Liang W, Liu M, Liu J. Global, regional, and national burden of major depressive disorders in adults aged 60 years and older from 1990 to 2021, with projections of prevalence to 2050: Analyses from the Global Burden of Disease Study 2021. J Affect Disord 2025; 374:486-494. [PMID: 39837462 DOI: 10.1016/j.jad.2025.01.086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/15/2024] [Revised: 01/13/2025] [Accepted: 01/18/2025] [Indexed: 01/23/2025]
Abstract
AIMS To estimate the burden of major depressive disorder (MDD) among older adults and project its prevalence through 2050. METHODS Using data from the Global Burden of Disease Study 2021, we calculated age-standardized rates (ASRs) for the incidence, prevalence, and years lived with disability (YLDs) of MDD among people aged ≥60 years from 1990 to 2021. Trends were analyzed using average annual percentage changes (AAPCs). Polynomial regressions were utilized to assess the relationship between economic levels and MDD burden. Prevalence of MDD was forecasted to 2050 using a mixed-effects model with Socio-demographic Index as the predictor. RESULTS Globally, the ASRs for incidence, prevalence and YLDs of MDD in older adults increased annually by 0.24 % (95 % CI: 0.18-0.31), 0.25 % (0.19-0.30), and 0.24 % (0.18-0.30), respectively. The fastest growth was observed in adults aged 60-69 years. The burden of MDD among females was approximately 1.5 times higher than males, although rates grew faster among males. Lower-income countries, particularly in sub-Saharan Africa, exhibited the highest burden and growth rates. By 2050, global MDD cases are projected to reach 97.04 million (95 % uncertainty interval [UI]: 71.27-129.85), with an ASR of 4.53 % (3.33-6.07). CONCLUSIONS The global burden of MDD among older adults has increased since 1990 and its prevalence is projected to continue increasing through 2050. Increments were faster in males, younger-old adults and people living in lower-income countries. Comprehensive and integrated management systems at nation, community and individual levels for MDD among older adults are essential to mitigate this growing burden and promote healthy aging.
Collapse
Affiliation(s)
- Yaping Wang
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, No.38, Xueyuan Road, Haidian District, Beijing 100191, China; Health Emergency Management Center, Peking University, No.38, Xueyuan Road, Haidian District, Beijing 100191, China; Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, No.38, Xueyuan Road, Haidian District, Beijing 100191, China
| | - Chenyuan Qin
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, No.38, Xueyuan Road, Haidian District, Beijing 100191, China; Health Emergency Management Center, Peking University, No.38, Xueyuan Road, Haidian District, Beijing 100191, China; Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, No.38, Xueyuan Road, Haidian District, Beijing 100191, China
| | - Hongguang Chen
- Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health, Peking University, No.35, Xueyuan Road, Haidian District, Beijing 100191, China; National Clinical Research Center for Mental Disorders, Peking University Sixth Hospital, No.35, Xueyuan Road, Haidian District, Beijing 100191, China
| | - Wannian Liang
- Vanke School of Public Health, Tsinghua University, No.30, Shuangqing Road, Haidian District, 100084 Beijing, China.
| | - Min Liu
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, No.38, Xueyuan Road, Haidian District, Beijing 100191, China; Health Emergency Management Center, Peking University, No.38, Xueyuan Road, Haidian District, Beijing 100191, China; Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, No.38, Xueyuan Road, Haidian District, Beijing 100191, China.
| | - Jue Liu
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, No.38, Xueyuan Road, Haidian District, Beijing 100191, China; Health Emergency Management Center, Peking University, No.38, Xueyuan Road, Haidian District, Beijing 100191, China; Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, No.38, Xueyuan Road, Haidian District, Beijing 100191, China; Institute for Global Health and Development, Peking University, No.5 Yiheyuan Road, Haidian District, Beijing 100871, China.
| |
Collapse
|
25
|
Qosja A, Çumashi R, Burazeri G, Bukli M, Qirjako G. Prevalence and socio-demographic correlates of mental health indices among schoolchildren in Albania. Scand J Public Health 2025:14034948251326827. [PMID: 40119488 DOI: 10.1177/14034948251326827] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/24/2025]
Abstract
AIM Our objective was to assess the prevalence and socio-demographic distribution of a wide range of mental health indices among Albanian children. METHODS A cross-sectional study was conducted in Albania in 2022, including a nationwide representative sample of 5454 schoolchildren aged 11, 13 and 15 years (~52% girls; response rate 96%). Data on 10 mental health indices were gathered, along with socio-demographic factors of schoolchildren. General linear model and binary logistic regression were employed for assessing the associations of mental health indices with socio-demographic factors. RESULTS Overall, the prevalence of poorer mental health indices was 5.2% for not good health, 61% for feeling low, 59% for irritability, 56% for nervousness, 33% for sleep difficulties, 31% for loneliness, 16% for low mood, 36% for low self-efficacy, 15% for anxiety and 35% for negative COVID-19 impact on mental health. Girls, older schoolchildren and those whose fathers were unemployed exhibited a significantly higher prevalence of poorer mental health for most of the indices. Children from rural areas and those from less affluent families had a higher prevalence of poorer self-rated health. CONCLUSIONS Our study sheds light on the concerning prevalence of various mental health indices among Albanian children. The main findings underscore the need for targeted interventions to address these challenges, particularly among vulnerable groups such as girls, older children and those from economically disadvantaged backgrounds. Urgent action is necessary to support the mental well-being of all children, especially those who are at the highest risk.
Collapse
Affiliation(s)
- Alketa Qosja
- Faculty of Medicine, University of Medicine, Albania
| | | | - Genc Burazeri
- Faculty of Medicine, University of Medicine, Albania
- Department of International Health, CAPHRI (Care and Public Health Research Institute), Maastricht University, The Netherlands
| | - Mariana Bukli
- Health and Nutrition Specialist, United Nations Children's Fund (UNICEF), Albania
| | - Gentiana Qirjako
- Faculty of Medicine, University of Medicine, Albania
- Institute of Public Health, Albania
| |
Collapse
|
26
|
Strid C, Lindfors P, Andersson C, Berman AH. Eating disorders and psychiatric comorbidity among first-year university students in Sweden: Prevalence and risk factors. J Eat Disord 2025; 13:52. [PMID: 40114279 PMCID: PMC11924712 DOI: 10.1186/s40337-025-01230-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/03/2024] [Accepted: 02/25/2025] [Indexed: 03/22/2025] Open
Abstract
BACKGROUND This study explored eating disorders (ED) prevalences, comorbidity of ED with other mental disorders, and risk factors for ED among university students. ED included binge eating disorder (BED), bulimia nervosa (BN), or other specified feeding and eating disorders (OSFED). METHODS A total of 3425 first-year university students in Sweden completed an online survey covering a range of criteria for psychiatric diagnoses, within the World Mental Health International College Student (WMH-ICS) initiative. Pearson's χ2 -tests were used to compare algorithm-based diagnostic prevalences for eating disorders and other comorbid psychiatric disorders between three groups: students with ED with or without other comorbid psychiatric disorders (A), students with psychiatric disorders but no ED comorbidity (B), and students with no psychiatric disorders (C). Multinomial logistic regression was used to calculate between-group comparisons of odds ratios for independent risk factors, where group B served as the reference group for comparisons with groups A and C. RESULTS Of the total sample, 75% had at least one psychiatric disorder and 28% had at least one lifetime ED diagnosis. Students with ED (group A) reported higher prevalences for comorbid anxiety disorders, depression, suicidal behavior, and non-suicidal self-injury compared to students with psychiatric disorders but no ED (group B). Group A participants exhibited a higher risk of hazardous drinking, were more likely to have received medical treatment, and to identify as bisexual. Compared to group B, students with no psychiatric disorders (group C) were more likely to report better mental and physical health, but less likely to engage in hazardous drinking, and to have sought mental health treatment. CONCLUSIONS A large proportion of students with ED had additional psychiatric disorders, indicating that individuals with ED suffer from multiple mental health problems. It is crucial that student health services acquire competency to offer effective ED assessment and treatment.
Collapse
Affiliation(s)
| | - Petra Lindfors
- Department of Psychology, Stockholm University, Stockholm, Sweden
| | | | - Anne H Berman
- Department of Psychology, Uppsala University, Uppsala, Sweden
| |
Collapse
|
27
|
Rodwin AH, Layman D, Finnerty M, Patel SY, Jeong J, Chen Q, Munson MR. Prevalence and Geographic Variation of Serious Mental Illness Among Young Adults Enrolled in Medicaid in New York State. J Adolesc Health 2025:S1054-139X(25)00040-0. [PMID: 40100185 DOI: 10.1016/j.jadohealth.2025.01.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/02/2024] [Revised: 11/29/2024] [Accepted: 01/03/2025] [Indexed: 03/20/2025]
Abstract
PURPOSE To estimate the prevalence and geographic variation of serious mental illness (SMI) among young adults enrolled in Medicaid and to identify individual and community-level factors associated with SMI. METHODS We used New York Medicaid data for over 1.6 million young adults aged 18-34 years with continuous Medicaid enrollment from April 2021 through March 2022. We merged 3 additional county and zip code-level datasets, including the Distressed Communities Index, Area Health Resource File, and New York homelessness data. We used descriptive analyses, data visualization methods, and multivariable logistic regression to estimate the prevalence of SMI and identify individual- (sex, race and ethnicity, age, disability aid, and homelessness) and community-level (geography, community distress, number of hospital beds, and community mental health centers per capita) factors associated with SMI. RESULTS The 12-month prevalence of SMI was 8.3% in New York State, with wide geographic variation by zip codes, ranging from 0% to 39%. Young adults identifying as Asian, Black, and Latinx (compared to White), and those living in zip codes with the most community distress were associated with lower odds of SMI, odds ratios (OR) ranged from 0.47 (Asian) (95% confidence interval [CI] [0.46-0.49]) to 0.95 (Latinx) (CI [0.93-0.97]). Young adults identifying as female (compared to male), receiving disability, experiencing homelessness, and rural residence were associated with higher odds of SMI, ORs ranged from 1.64 (female) (95% CI [1.62-1.66]) to 5.49 (homelessness) (95% CI [5.33-5.66]). DISCUSSION SMI prevalence varies by individual- and community-level factors, including homelessness and rural residence, signaling the need for specific interventions and policies.
Collapse
Affiliation(s)
- Aaron H Rodwin
- Silver School of Social Work, New York University, New York, New York
| | - Deborah Layman
- Office of Population Health and Evaluation, New York State Office of Mental Health, New York, New York
| | - Molly Finnerty
- Office of Population Health and Evaluation, New York State Office of Mental Health, New York, New York; Department of Child and Adolescent Psychiatry, Grossman School of Medicine, New York University, New York, New York
| | - Sadiq Y Patel
- Clinical Product Development, Waymark, San Francisco, California; School of Social Policy and Practice, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Junghye Jeong
- Office of Population Health and Evaluation, New York State Office of Mental Health, New York, New York
| | - Qingxian Chen
- Office of Population Health and Evaluation, New York State Office of Mental Health, New York, New York
| | - Michelle R Munson
- Silver School of Social Work, New York University, New York, New York.
| |
Collapse
|
28
|
Buric I, Žderić L, Koch P, de Bruin C. Mindfulness-Based Integrative Programme: The effectiveness, acceptability, and predictors of responses to a novel low-dose mindfulness-based intervention. J Affect Disord 2025; 373:99-106. [PMID: 39716674 DOI: 10.1016/j.jad.2024.12.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/17/2024] [Revised: 11/13/2024] [Accepted: 12/20/2024] [Indexed: 12/25/2024]
Abstract
Mindfulness-Based Interventions (MBIs) have shown promising results in improving mental health in the general population. However, traditional MBIs require substantial time and effort due to the high dose of mindfulness practice, which makes them inaccessible to many individuals. This study aimed to (1) test the effectiveness of a novel low-dose MBI-Mindfulness-Based Integrative Programme (MBIP)-delivered synchronously online, on mental health symptom severity, emotion regulation, and trait mindfulness in the general population; (2) test the acceptability of this intervention; and (3) identify baseline characteristics that may predict changes in emotion regulation. A non-randomised controlled trial design was used to compare pre- to post-intervention change scores in trait mindfulness (FFMQ), mental health symptom severity (SCL-90-R GSI), and emotion dysregulation (DERS) between a self-selected and self-paid experimental group (n = 116) and a passive control group (n = 115). The experimental group showed significant increases in trait mindfulness and reductions in mental health symptom severity and emotion dysregulation, with effect sizes ranging from small to large, which is comparable to traditional in-person MBIs. Baseline trait mindfulness and mental health symptom severity significantly predicted intervention outcomes, with greater improvements in emotion regulation among participants with lower baseline scores. Participants demonstrated high levels of engagement and reported high satisfaction with the intervention. These findings support the acceptability and effectiveness of a novel low-dose, synchronous online MBI for the general population.
Collapse
Affiliation(s)
- Ivana Buric
- Department of Psychology, University of Amsterdam, the Netherlands.
| | - Lucija Žderić
- Department of Psychology, University of Amsterdam, the Netherlands; Department of Psychology, University of Zagreb, Croatia
| | - Pia Koch
- Department of Psychology, University of Amsterdam, the Netherlands
| | | |
Collapse
|
29
|
Hadebe NF, Rasesemola RM. Resilience of young adults living with mental disorders in the City of Tshwane, South Africa. Health SA 2025; 30:2857. [PMID: 40183024 PMCID: PMC11966673 DOI: 10.4102/hsag.v30i0.2857] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2024] [Accepted: 12/11/2024] [Indexed: 04/05/2025] Open
Abstract
Background The challenges that young adults encounter today present greater risks to their mental wellbeing compared to those experienced by previous generations. For those young adults living with mental health disorders, they suffer even more when having to deal with its burdens. Many of these young adults face floods of negative and powerful emotions, discrimination and isolation; however, they are likely to cope well with these difficult situations if they are resilient. Aim This study purported to report on resilience among young adults living with mental disorders in the City of Tshwane. Setting The study was conducted in Atteridgeville in the City of Tshwane, Gauteng province in South Africa. Methods A qualitative exploratory and descriptive research was conducted among 10 purposefully sampled young adults aged between 18 years and 34 years old. Data were collected using individual, semi-structured interviews in primary healthcare clinics and analysed using Tesch's method. Results Two themes, namely, harnessing purpose in building resilience and confidence enhances positive interactions along with four related sub-theme emerged from the results. The themes indicated how a sense of purposefulness and confidence help young adults living with mental health disorders build resilience. Conclusion For young adults to be resilient, approaches such as psychotherapy for treating mental health issues need to incorporate strategies to develop a sense of purpose and confidence. Contribution This study elucidated the role of purposefulness and confidence in building resilience, and further provided some suggestions on strategies that could be used to build resilience in conjunction with medical management of mental health disorders among young adults.
Collapse
Affiliation(s)
- Nok'khanya F Hadebe
- Department of Emergency Medical Care, Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa
| | - Richard M Rasesemola
- Department of Nursing, Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa
| |
Collapse
|
30
|
Polyvianaia M, Yachnik Y, Fegert JM, Sitarski E, Stepanova N, Pinchuk I. Mental health of university students twenty months after the beginning of the full-scale Russian-Ukrainian war. BMC Psychiatry 2025; 25:236. [PMID: 40075321 PMCID: PMC11905627 DOI: 10.1186/s12888-025-06654-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/28/2024] [Accepted: 02/21/2025] [Indexed: 03/14/2025] Open
Abstract
BACKGROUND Russia's full-scale military invasion of Ukraine on February 24, 2022 led to an increase of anxiety and depressive states, psychosomatic manifestations, and a tendency to abuse alcohol and psychoactive substances in the population. The aim of this paper is to examine the mental health burden among university students twenty months after war and to identify risk and protective factors for mental health problems. METHODS A cross-sectional study was conducted among Ukrainian students in October 2023 (n = 1398). The online survey included sociodemographic data collection, evaluation of psychological well-being and measured depression, anxiety, PTSD symptoms and insomnia. Normality of included variables was verified by Kolmogorov-Smirnov test. An independent-samples t-test, Mann-Whitney U-test, χ2 test and analysis of variance were used to compare the data. Differences in PHQ-9 and GAD-7 levels based on sociodemographic characteristics were analyzed using ANOVA. Correlation between variables was calculated with Pearson correlation, adjusted with Benjamini-Hochberg procedure. To develop the predictive model the XGBoost algorithm was employed, additionally, the SHAP algorithm was utilized. RESULTS Symptoms of PTSD, as well as moderate and severe symptoms of anxiety, depression, and insomnia, were reported by 48.1%, 34.1%, 33.6%, and 19.3% of students, respectively. The severity of these symptoms varied based on factors such as sex, age, prior trauma experiences, and living conditions. Additionally, the type of relocation (within Ukraine or abroad) significantly influenced mental health outcomes. A majority of participants (68.5%) reported the experience of war-related traumatic events. Factors linked to higher depression symptom scores included lower initial well-being, greater social media use, female gender, exposure to multiple traumatic events, experiences of assault or sexual violence, the loss of a loved one, pre-existing and ongoing mental health treatment during the war, and the use of psychotropic medications. CONCLUSIONS Ukrainian university students face a significant mental health burden due to the ongoing war, with high rates of reported PTSD, anxiety, depression, and insomnia symptoms. These findings highlight the importance of tailored mental health interventions through different stakeholders that take into account individual needs, past experiences, burdens and social media usage.
Collapse
Affiliation(s)
- Marina Polyvianaia
- Institute of Psychiatry, Taras Shevchenko National University of Kyiv, Zdanovska str., 36, Kyiv, 03022, Ukraine
| | - Yulia Yachnik
- Institute of Psychiatry, Taras Shevchenko National University of Kyiv, Zdanovska str., 36, Kyiv, 03022, Ukraine
| | - Jörg M Fegert
- Department of Child and Adolescent Psychiatry/Psychotherapy, University Hospital Ulm, Ulm, Germany
- Competence Area Mental Health Prevention in the Competence Network Preventive Medicine Baden-Württemberg, Ulm, Germany
- German Center for Mental Health (DZPG), partner site Ulm, Ulm, Germany
| | - Emily Sitarski
- Department of Child and Adolescent Psychiatry/Psychotherapy, University Hospital Ulm, Ulm, Germany
- Competence Area Mental Health Prevention in the Competence Network Preventive Medicine Baden-Württemberg, Ulm, Germany
- German Center for Mental Health (DZPG), partner site Ulm, Ulm, Germany
| | - Nataliia Stepanova
- Institute of Psychiatry, Taras Shevchenko National University of Kyiv, Zdanovska str., 36, Kyiv, 03022, Ukraine
| | - Irina Pinchuk
- Institute of Psychiatry, Taras Shevchenko National University of Kyiv, Zdanovska str., 36, Kyiv, 03022, Ukraine.
- Ukrainian Psychiatric Association, Kyiv, Ukraine.
| |
Collapse
|
31
|
Stein DJ, Ruscio AM, Altwaijri Y, Chiu WT, Sampson NA, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Chardoul S, Gureje O, Hu C, Karam EG, McGrath JJ, Navarro-Mateu F, Scott KM, Stagnaro JC, Torres Y, Vladescu C, Wciórka J, Xavier M, Kessler RC. Obsessive-compulsive disorder in the World Mental Health surveys. RESEARCH SQUARE 2025:rs.3.rs-6090427. [PMID: 40092437 PMCID: PMC11908341 DOI: 10.21203/rs.3.rs-6090427/v1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/19/2025]
Abstract
Background National surveys have suggested that obsessive-compulsive disorder (OCD) is a prevalent and impairing condition. However, there are few cross-national data on OCD, with data particularly scarce in low- and middle-income countries. Here we employ data from the World Mental Health surveys to characterize the onset, course, severity, and treatment of OCD across a range of countries in different geographic regions of the world. Methods Data came from general population surveys carried out in 10 countries using a consistent research protocol and interview. A total of 26,136 adults were assessed for OCD in face-to-face interviews and were included in the present analyses. We examined lifetime and 12-month prevalence as well as age of onset, persistence, severity, and treatment of DSM-IV OCD in six high-income countries (HICs) and four low- or middle-income countries (LMICs). We also investigated socio-demographic variables and temporally prior mental disorders as predictors of OCD onset, persistence, severity, and treatment. Results Across the 10 countries surveyed, OCD has a combined lifetime prevalence of 4.1%. The 12-month prevalence (3.0%) is nearly as high, suggesting a highly persistent course of illness. Age of onset is early, with more than 80% of OCD cases beginning by early adulthood. Most OCD cases in the community are mild (47.0%) or very mild (27.5%), with a smaller percentage designated as moderate (22.9%) or severe (2.7%) by the Yale-Brown Obsessive-Compulsive Scale. Only 19.8% of respondents with OCD received any mental health treatment in the past year, with treatment rates much higher in HICs (40.5%) than LMICs (7.0%). Cross-nationally, OCD commonly emerges in adolescence or early adulthood against a backdrop of earlier-occurring mental disorders. With few exceptions (e.g., marital status, prior social phobia), the socio-demographic and psychopathological risk factors for OCD onset, persistence, severity, and treatment are distinct. Conclusions These cross-national data underscore clinical lessons regarding the importance of early diagnosis of OCD and comprehensive evaluation of comorbidity; draw attention to OCD as an undertreated disorder, particularly in LMIC contexts; and emphasize the public health significance of this often-overlooked condition.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - Jordi Alonso
- Hospital del Mar Medical Research Institute (IMIM)
| | | | | | - Chiyi Hu
- Shenzhen Institute of Mental Health & Shenzhen Kangning Hospital
| | | | | | | | | | | | | | | | | | - Miguel Xavier
- Lisbon Institute of Global Mental Health, Universidade Nova de Lisboa
| | | |
Collapse
|
32
|
Carey A, Tibbs M, Warren‐Perry A, Petrie N, Kathryn S, McCrum S, Duffy J. Amplify and Advocate: Implementing a Youth Mental Health Advocacy Project, a Collaborative Rights-Based Approach Using COM-B, APEASE, and the Lundy Model. JOURNAL OF COMMUNITY PSYCHOLOGY 2025; 53:e70009. [PMID: 40253629 PMCID: PMC12009556 DOI: 10.1002/jcop.70009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/02/2024] [Revised: 03/04/2025] [Accepted: 04/08/2025] [Indexed: 04/22/2025]
Abstract
The Amplify and Advocate programme was designed to implement youth-led advocacy campaigns across Ireland, addressing gaps in early intervention, service accessibility and youth participation in mental health policy. Grounded in participatory, rights-based approaches, the project aimed to empower young people to influence mental health services and policies. Using the Lundy Model of Participation, World Café methodology, and COM-B and APEASE frameworks, the programme delivered co-designed advocacy training and supported young people in developing and implementing community-based campaigns. Participants engaged in local needs assessments, action planning, stakeholder engagement and policy advocacy. Eleven youth-led advocacy campaigns were launched, focusing on early intervention, equitable access, community collaboration, service integration, increased funding and amplifying youth voice. Evaluations indicated improved advocacy skills, increased engagement in policy discussions, and strengthened partnerships with service providers and policymakers. Findings demonstrate the effectiveness of participatory, youth-led advocacy in shaping mental health services and influencing policy. The project highlights the importance of structured advocacy training, stakeholder collaboration and sustainability planning to maintain long-term impact. Recommendations focus on integrating youth-led advocacy within policy frameworks and ensuring ongoing investment in participatory mental health initiatives.
Collapse
Affiliation(s)
- Alexis Carey
- JigsawNational Centre for Youth Mental HealthDublinIreland
- Rehab GroupPark West Business ParkDublinIreland
| | - Maria Tibbs
- JigsawNational Centre for Youth Mental HealthDublinIreland
- School of PsychologyUniversity College DublinDublinIreland
| | | | - Niamh Petrie
- JigsawNational Centre for Youth Mental HealthDublinIreland
| | - Sophie Kathryn
- JigsawNational Centre for Youth Mental HealthDublinIreland
| | - Síofra McCrum
- JigsawNational Centre for Youth Mental HealthDublinIreland
| | - Joseph Duffy
- JigsawNational Centre for Youth Mental HealthDublinIreland
| |
Collapse
|
33
|
Smith A, Hachen S, Weinberg A, Falkai P, Guttormsen S, Liebrenz M. The weight of office? A scoping review of mental health issues and risk factors in elected politicians across democratic societies. Int J Soc Psychiatry 2025; 71:223-238. [PMID: 39535138 DOI: 10.1177/00207640241291523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2024]
Abstract
BACKGROUND The mental health and capacity to govern of democratically-elected politicians have become burgeoning topics of interest. Notably, in fulfilling demanding and high-stress roles, political officeholders could encounter distinctive risk factors, yet existing research literature about these subpopulations remains underexplored. AIMS This scoping review aimed to systematically examine the breadth of available evidence on mental health issues and risk factors affecting democratically-elected politicians internationally and to identify future research needs. METHODS Using pre-defined eligibility criteria based on JBI guidelines, a systematic keyword search was conducted in May 2024 of MEDLINE, Scopus, and APA PsycNet, supplemented by snowballing techniques. Only those studies reporting primary, empirical evidence on mental ill-health or risk factors with psychological correlates from serving politicians in "Full" or "Flawed" democracies (per Democracy Index) were included from 1999 to 2024. Titles and abstracts were screened and the full-texts of potentially eligible literature were assessed before extraction and synthesis. RESULTS Eighteen sources met the eligibility criteria, cumulatively encompassing ~3,500 national, state, and municipal politicians across seven democracies (Australia, Canada, the Netherlands, Norway, New Zealand, the United Kingdom, and the United States). Cross-sectional surveys were predominantly utilized, with lesser use of mixed-methods approaches, qualitative interviews, and longitudinal cohorts. Violence emerged as a key concept, with twelve sources (66.7%) underlining its psychological toll and certain data indicating a disproportionate impact on female officeholders. Furthermore, four sources (22.2%) explored general psychopathology trends, revealing varying but sizeable mental ill-health and high-risk alcohol consumption rates, and two studies (11.1%) demonstrated adverse effects from specific occupational conditions. CONCLUSIONS Current literature suggests that democratically-elected politicians can face complex mental health challenges. However, significant research gaps remain, including a paucity of prevalence estimates, longitudinal data, and intervention studies. Equally, the underrepresentation of most democratic countries accentuates the need for a more diverse evidence-base to better support the mental wellbeing of politicians worldwide.
Collapse
Affiliation(s)
- Alexander Smith
- Department of Forensic Psychiatry, University of Bern, Switzerland
- Graduate School for Health Sciences, University of Bern, Switzerland
| | - Stefanie Hachen
- Department of Forensic Psychiatry, University of Bern, Switzerland
| | | | - Peter Falkai
- Ludwig-Maximilians-University Munich Clinic for Psychiatry and Psychotherapy, Germany
| | | | - Michael Liebrenz
- Department of Forensic Psychiatry, University of Bern, Switzerland
| |
Collapse
|
34
|
Jadhav KK, Daouk J, Kurkinen K, Kraav SL, Eriksson P, Tolmunen T, Kanninen KM. Blood cytokines in major depressive disorder in drug-naïve adolescents: A systematic review and meta-analysis. J Affect Disord 2025; 372:48-55. [PMID: 39603515 DOI: 10.1016/j.jad.2024.11.071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/06/2024] [Revised: 11/01/2024] [Accepted: 11/23/2024] [Indexed: 11/29/2024]
Abstract
BACKGROUND Major depressive disorder (MDD) is the most common mental health problem worldwide. Increased levels of inflammation are associated with MDD, though this relationship has been suggested to be bidirectional. The first incidence of a depressive episode usually occurs during adolescence. Hence, examining depressed, drug-naïve adolescents is important to understand the role of inflammation in the pathophysiology of MDD. Cytokines might play a crucial role in inflammation associated with MDD. Therefore, this article aims to investigate the changes in the levels of peripheral blood cytokines in adolescents with MDD. METHODS We conducted a systematic review and meta-analysis to assess the changes in peripheral blood cytokines in drug-naïve adolescents (10-18 years) with MDD. A comprehensive search across four databases was performed to identify original research articles. Studies in which the diagnosis of MDD was set by semi-structured interview were included. RESULTS Of 2291 articles, 12 met the inclusion criteria for the review, with seven suitable for meta-analysis & including up to five studies per cytokine. The meta-analysis revealed significant associations between tumor necrosis factor (TNF)-α (n = 222, Hedge's g = 0.51, p <0.01) and MDD in adolescents compared to healthy individuals. However, other blood cytokines, including interleukin (IL)-1β, IL-4, IL-6, IL-8, and interferon (IFN)-γ, did not significantly correlate with MDD in adolescents. CONCLUSION TNF-α was significantly elevated in drug-naïve adolescents with MDD. To further understand the role of TNF-α in MDD, a thorough investigation is required, taking into account the diversity, subtypes, chronicity, and severity of MDD.
Collapse
Affiliation(s)
- Kaustubh Kishor Jadhav
- A. I. Virtanen Institute for Molecular Sciences, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland
| | - Joud Daouk
- A. I. Virtanen Institute for Molecular Sciences, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland
| | - Karoliina Kurkinen
- Institute of Clinical Medicine, Department of Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland
| | - Siiri-Liisi Kraav
- Department of Social Sciences, Faculty of Social Sciences and Business Studies, University of Eastern Finland, Kuopio, Finland
| | - Päivi Eriksson
- Business School, Faculty of Social Sciences and Business Studies, University of Eastern Finland, Kuopio, Finland
| | - Tommi Tolmunen
- Institute of Clinical Medicine, Department of Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland; Kuopio University Hospital, Department of Adolescent Psychiatry, Kuopio, Finland
| | - Katja M Kanninen
- A. I. Virtanen Institute for Molecular Sciences, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.
| |
Collapse
|
35
|
González-Caballero J. Mental health in organizations: Some reflections from an occupational health nursing perspective. Work 2025; 80:956-961. [PMID: 40297882 DOI: 10.1177/10519815241290289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/30/2025] Open
Affiliation(s)
- Javier González-Caballero
- National Institute of Social Security, Bilbao, Spain
- National School of Occupational Medicine, Madrid, Spain
- Academy of Nursing Sciences of Bizkaia, Bilbao, Spain
- Research Center of Social Inequality and Governance, University of La Laguna, Canary Islands, Spain
| |
Collapse
|
36
|
O'Connell KS, Koromina M, van der Veen T, Boltz T, David FS, Yang JMK, Lin KH, Wang X, Coleman JRI, Mitchell BL, McGrouther CC, Rangan AV, Lind PA, Koch E, Harder A, Parker N, Bendl J, Adorjan K, Agerbo E, Albani D, Alemany S, Alliey-Rodriguez N, Als TD, Andlauer TFM, Antoniou A, Ask H, Bass N, Bauer M, Beins EC, Bigdeli TB, Pedersen CB, Boks MP, Børte S, Bosch R, Brum M, Brumpton BM, Brunkhorst-Kanaan N, Budde M, Bybjerg-Grauholm J, Byerley W, Cabana-Domínguez J, Cairns MJ, Carpiniello B, Casas M, Cervantes P, Chatzinakos C, Chen HC, Clarence T, Clarke TK, Claus I, Coombes B, Corfield EC, Cruceanu C, Cuellar-Barboza A, Czerski PM, Dafnas K, Dale AM, Dalkner N, Degenhardt F, DePaulo JR, Djurovic S, Drange OK, Escott-Price V, Fanous AH, Fellendorf FT, Ferrier IN, Forty L, Frank J, Frei O, Freimer NB, Fullard JF, Garnham J, Gizer IR, Gordon SD, Gordon-Smith K, Greenwood TA, Grove J, Guzman-Parra J, Ha TH, Hahn T, Haraldsson M, Hautzinger M, Havdahl A, Heilbronner U, Hellgren D, Herms S, Hickie IB, Hoffmann P, Holmans PA, Huang MC, Ikeda M, Jamain S, Johnson JS, Jonsson L, Kalman JL, Kamatani Y, Kennedy JL, Kim E, Kim J, Kittel-Schneider S, et alO'Connell KS, Koromina M, van der Veen T, Boltz T, David FS, Yang JMK, Lin KH, Wang X, Coleman JRI, Mitchell BL, McGrouther CC, Rangan AV, Lind PA, Koch E, Harder A, Parker N, Bendl J, Adorjan K, Agerbo E, Albani D, Alemany S, Alliey-Rodriguez N, Als TD, Andlauer TFM, Antoniou A, Ask H, Bass N, Bauer M, Beins EC, Bigdeli TB, Pedersen CB, Boks MP, Børte S, Bosch R, Brum M, Brumpton BM, Brunkhorst-Kanaan N, Budde M, Bybjerg-Grauholm J, Byerley W, Cabana-Domínguez J, Cairns MJ, Carpiniello B, Casas M, Cervantes P, Chatzinakos C, Chen HC, Clarence T, Clarke TK, Claus I, Coombes B, Corfield EC, Cruceanu C, Cuellar-Barboza A, Czerski PM, Dafnas K, Dale AM, Dalkner N, Degenhardt F, DePaulo JR, Djurovic S, Drange OK, Escott-Price V, Fanous AH, Fellendorf FT, Ferrier IN, Forty L, Frank J, Frei O, Freimer NB, Fullard JF, Garnham J, Gizer IR, Gordon SD, Gordon-Smith K, Greenwood TA, Grove J, Guzman-Parra J, Ha TH, Hahn T, Haraldsson M, Hautzinger M, Havdahl A, Heilbronner U, Hellgren D, Herms S, Hickie IB, Hoffmann P, Holmans PA, Huang MC, Ikeda M, Jamain S, Johnson JS, Jonsson L, Kalman JL, Kamatani Y, Kennedy JL, Kim E, Kim J, Kittel-Schneider S, Knowles JA, Kogevinas M, Kranz TM, Krebs K, Kushner SA, Lavebratt C, Lawrence J, Leber M, Lee HJ, Liao C, Lucae S, Lundberg M, MacIntyre DJ, Maier W, Maihofer AX, Malaspina D, Manchia M, Maratou E, Martinsson L, Mattheisen M, McGregor NW, McInnis MG, McKay JD, Medeiros H, Meyer-Lindenberg A, Millischer V, Morris DW, Moutsatsou P, Mühleisen TW, O'Donovan C, Olsen CM, Panagiotaropoulou G, Papiol S, Pardiñas AF, Park HY, Perry A, Pfennig A, Pisanu C, Potash JB, Quested D, Rapaport MH, Regeer EJ, Rice JP, Rivera M, Schulte EC, Senner F, Shadrin A, Shilling PD, Sigurdsson E, Sindermann L, Sirignano L, Siskind D, Slaney C, Sloofman LG, Smeland OB, Smith DJ, Sobell JL, Soler Artigas M, Stein DJ, Stein F, Su MH, Sung H, Świątkowska B, Terao C, Tesfaye M, Tesli M, Thorgeirsson TE, Thorp JG, Toma C, Tondo L, Tooney PA, Tsai SJ, Tsermpini EE, Vawter MP, Vedder H, Vreeker A, Walters JTR, Winsvold BS, Witt SH, Won HH, Ye R, Young AH, Zandi PP, Zillich L, 23andMe Research Team, Adolfsson R, Alda M, Alfredsson L, Backlund L, Baune BT, Bellivier F, Bengesser S, Berrettini WH, Biernacka JM, Boehnke M, Børglum AD, Breen G, Carr VJ, Catts S, Cichon S, Corvin A, Craddock N, Dannlowski U, Dikeos D, Etain B, Ferentinos P, Frye M, Fullerton JM, Gawlik M, Gershon ES, Goes FS, Green MJ, Grigoroiu-Serbanescu M, Hauser J, Henskens FA, Hjerling-Leffler J, Hougaard DM, Hveem K, Iwata N, Jones I, Jones LA, Kahn RS, Kelsoe JR, Kircher T, Kirov G, Kuo PH, Landén M, Leboyer M, Li QS, Lissowska J, Lochner C, Loughland C, Luykx JJ, Martin NG, Mathews CA, Mayoral F, McElroy SL, McIntosh AM, McMahon FJ, Medland SE, Melle I, Milani L, Mitchell PB, Morken G, Mors O, Mortensen PB, Müller-Myhsok B, Myers RM, Myung W, Neale BM, Nievergelt CM, Nordentoft M, Nöthen MM, Nurnberger JI, O'Donovan MC, Oedegaard KJ, Olsson T, Owen MJ, Paciga SA, Pantelis C, Pato CN, Pato MT, Patrinos GP, Pawlak JM, Ramos-Quiroga JA, Reif A, Reininghaus EZ, Ribasés M, Rietschel M, Ripke S, Rouleau GA, Roussos P, Saito T, Schall U, Schalling M, Schofield PR, Schulze TG, Scott LJ, Scott RJ, Serretti A, Smoller JW, Squassina A, Stahl EA, Stefansson H, Stefansson K, Stordal E, Streit F, Sullivan PF, Turecki G, Vaaler AE, Vieta E, Vincent JB, Waldman ID, Weickert CS, Weickert TW, Werge T, Whiteman DC, Zwart JA, Edenberg HJ, McQuillin A, Forstner AJ, Mullins N, Di Florio A, Ophoff RA, Andreassen OA, Bipolar Disorder Working Group of the Psychiatric Genomics Consortium. Genomics yields biological and phenotypic insights into bipolar disorder. Nature 2025; 639:968-975. [PMID: 39843750 DOI: 10.1038/s41586-024-08468-9] [Show More Authors] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Collaborators] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2023] [Accepted: 11/28/2024] [Indexed: 01/24/2025]
Abstract
Bipolar disorder is a leading contributor to the global burden of disease1. Despite high heritability (60-80%), the majority of the underlying genetic determinants remain unknown2. We analysed data from participants of European, East Asian, African American and Latino ancestries (n = 158,036 cases with bipolar disorder, 2.8 million controls), combining clinical, community and self-reported samples. We identified 298 genome-wide significant loci in the multi-ancestry meta-analysis, a fourfold increase over previous findings3, and identified an ancestry-specific association in the East Asian cohort. Integrating results from fine-mapping and other variant-to-gene mapping approaches identified 36 credible genes in the aetiology of bipolar disorder. Genes prioritized through fine-mapping were enriched for ultra-rare damaging missense and protein-truncating variations in cases with bipolar disorder4, highlighting convergence of common and rare variant signals. We report differences in the genetic architecture of bipolar disorder depending on the source of patient ascertainment and on bipolar disorder subtype (type I or type II). Several analyses implicate specific cell types in the pathophysiology of bipolar disorder, including GABAergic interneurons and medium spiny neurons. Together, these analyses provide additional insights into the genetic architecture and biological underpinnings of bipolar disorder.
Collapse
Affiliation(s)
- Kevin S O'Connell
- Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
- Center for Precision Psychiatry, University of Oslo, Oslo, Norway.
| | - Maria Koromina
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | | | - Toni Boltz
- Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
| | - Friederike S David
- Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany
- Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany
| | - Jessica Mei Kay Yang
- Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| | | | - Xin Wang
- 23andMe Inc., Sunnyvale, CA, USA
| | - Jonathan R I Coleman
- Social, Genetic and Developmental Psychiatry Centre, King's College London, London, UK
- NIHR Maudsley BRC, King's College London, London, UK
| | - Brittany L Mitchell
- Mental Health and Neuroscience, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
- School of Biomedical Sciences and Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia
| | | | - Aaditya V Rangan
- New York University, New York, NY, USA
- Flatiron Institute, New York, NY, USA
| | - Penelope A Lind
- Mental Health and Neuroscience, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
- School of Biomedical Sciences and Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia
- School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia
| | - Elise Koch
- Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
- Center for Precision Psychiatry, University of Oslo, Oslo, Norway
| | - Arvid Harder
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Nadine Parker
- Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
- Center for Precision Psychiatry, University of Oslo, Oslo, Norway
| | - Jaroslav Bendl
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Kristina Adorjan
- Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany
- Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany
- University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland
| | - Esben Agerbo
- iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark
- National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark
- Centre for Integrated Register-based Research, Aarhus University, Aarhus, Denmark
| | - Diego Albani
- Department of Neuroscience, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy
| | - Silvia Alemany
- Instituto de Salud Carlos III, Biomedical Network Research Centre on Mental Health (CIBERSAM), Madrid, Spain
- Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain
- Psychiatric Genetics Unit, Group of Psychiatry Mental Health and Addictions, Vall d'Hebron Research Institut (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Ney Alliey-Rodriguez
- Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA
- Northwestern University, Chicago, IL, USA
| | - Thomas D Als
- iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark
- iSEQ, Center for Integrative Sequencing, Aarhus University, Aarhus, Denmark
- Department of Biomedicine-Human Genetics, Aarhus University, Aarhus, Denmark
| | - Till F M Andlauer
- Department of Neurology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany
| | - Anastasia Antoniou
- National and Kapodistrian University of Athens, 2nd Department of Psychiatry, Attikon General Hospital, Athens, Greece
| | - Helga Ask
- PsychGen Centre for Genetic Epidemiology and Mental Health, Norwegian Institute of Public Health, Oslo, Norway
- PROMENTA Research Centre, Department of Psychology, University of Oslo, Oslo, Norway
| | - Nicholas Bass
- Division of Psychiatry, University College London, London, UK
| | - Michael Bauer
- Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - Eva C Beins
- Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany
| | - Tim B Bigdeli
- Department of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, Brooklyn, NY, USA
- VA NY Harbor Healthcare System, Brooklyn, NY, USA
- Institute for Genomics in Health, SUNY Downstate Health Sciences University, Brooklyn, NY, USA
- Department of Epidemiology and Biostatistics, School of Public Health, SUNY Downstate Health Sciences University, Brooklyn, NY, USA
| | - Carsten Bøcker Pedersen
- iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark
- National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark
- Centre for Integrated Register-based Research, Aarhus University, Aarhus, Denmark
| | - Marco P Boks
- Psychiatry, Brain Center UMC Utrecht, Utrecht, The Netherlands
| | - Sigrid Børte
- Research and Communication Unit for Musculoskeletal Health, Division of Clinical Neuroscience, Oslo University Hospital, Ullevål, Oslo, Norway
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- HUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
| | - Rosa Bosch
- Instituto de Salud Carlos III, Biomedical Network Research Centre on Mental Health (CIBERSAM), Madrid, Spain
- Programa SJD MIND Escoles, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain
| | - Murielle Brum
- Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany
| | - Ben M Brumpton
- K. G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
| | - Nathalie Brunkhorst-Kanaan
- Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany
| | - Monika Budde
- Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany
| | - Jonas Bybjerg-Grauholm
- iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark
- Center for Neonatal Screening, Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark
| | - William Byerley
- Psychiatry, University of California San Francisco, San Francisco, CA, USA
| | - Judit Cabana-Domínguez
- Instituto de Salud Carlos III, Biomedical Network Research Centre on Mental Health (CIBERSAM), Madrid, Spain
- Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain
- Psychiatric Genetics Unit, Group of Psychiatry Mental Health and Addictions, Vall d'Hebron Research Institut (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Murray J Cairns
- School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, New South Wales, Australia
- Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton, New South Wales, Australia
| | - Bernardo Carpiniello
- Section of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
| | - Miquel Casas
- Programa SJD MIND Escoles, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain
- Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
- Fundació Privada d'Investigació Sant Pau (FISP), Barcelona, Spain
| | - Pablo Cervantes
- Department of Psychiatry, Mood Disorders Program, McGill University Health Center, Montreal, Québec, Canada
| | - Chris Chatzinakos
- Department of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, Brooklyn, NY, USA
- Institute for Genomics in Health, SUNY Downstate Health Sciences University, Brooklyn, NY, USA
| | - Hsi-Chung Chen
- Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan
- Department of Psychiatry, College of Medicine, National Taiwan University, Taipei, Taiwan
| | - Tereza Clarence
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Toni-Kim Clarke
- Division of Psychiatry, University of Edinburgh, Edinburgh, UK
| | - Isabelle Claus
- Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany
| | - Brandon Coombes
- Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA
| | - Elizabeth C Corfield
- PsychGen Centre for Genetic Epidemiology and Mental Health, Norwegian Institute of Public Health, Oslo, Norway
- Nic Waals Institute, Lovisenberg Diaconal Hospital, Oslo, Norway
- Department of Genetics and Bioinformatics, Norwegian Institute of Public Health, Oslo, Norway
| | - Cristiana Cruceanu
- Department of Psychiatry, Mood Disorders Program, McGill University Health Center, Montreal, Québec, Canada
- Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
| | - Alfredo Cuellar-Barboza
- Department of Psychiatry, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico
- Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA
| | - Piotr M Czerski
- Department of Psychiatry, Laboratory of Psychiatric Genetics, Poznan University of Medical Sciences, Poznan, Poland
| | - Konstantinos Dafnas
- National and Kapodistrian University of Athens, 2nd Department of Psychiatry, Attikon General Hospital, Athens, Greece
| | - Anders M Dale
- Center for Multimodal Imaging and Genetics, Departments of Neurosciences, Radiology, and Psychiatry, University of California, San Diego, CA, USA
| | - Nina Dalkner
- Division of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria
| | - Franziska Degenhardt
- Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany
- Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany
| | - J Raymond DePaulo
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Srdjan Djurovic
- Department of Medical Genetics, Oslo University Hospital Ullevål, Oslo, Norway
- Department of Clinical Science, University of Bergen, Bergen, Norway
| | - Ole Kristian Drange
- Center for Precision Psychiatry, University of Oslo, Oslo, Norway
- Department of Psychiatry, Sørlandet Hospital, Kristiansand, Norway
| | - Valentina Escott-Price
- Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| | - Ayman H Fanous
- Department of Psychiatry, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA
- Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ, USA
- Banner-University Medical Center, Phoenix, AZ, USA
| | - Frederike T Fellendorf
- Division of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria
| | - I Nicol Ferrier
- Academic Psychiatry, Newcastle University, Newcastle upon Tyne, UK
| | - Liz Forty
- Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| | - Josef Frank
- Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Oleksandr Frei
- Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Nelson B Freimer
- Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA
- Department of Psychiatry and Biobehavioral Science, Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
| | - John F Fullard
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Julie Garnham
- Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada
| | - Ian R Gizer
- Department of Psychological Sciences, University of Missouri, Columbia, MO, USA
| | - Scott D Gordon
- Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
| | | | - Tiffany A Greenwood
- Department of Psychiatry, University of California San Diego, La Jolla, CA, USA
| | - Jakob Grove
- iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark
- Department of Biomedicine and the iSEQ Center, Aarhus University, Aarhus, Denmark
- Center for Genomics and Personalized Medicine, CGPM, Aarhus, Denmark
- Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark
| | - José Guzman-Parra
- Mental Health Department, University Regional Hospital, Biomedicine Institute (IBIMA), Málaga, Spain
| | - Tae Hyon Ha
- Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
- Department of Neuropsychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Tim Hahn
- Institute for Translational Psychiatry, University of Münster, Münster, Germany
| | - Magnus Haraldsson
- Faculty of Medicine, Department of Psychiatry, School of Health Sciences, University of Iceland, Reykjavik, Iceland
- Landspitali University Hospital, Reykjavik, Iceland
| | - Martin Hautzinger
- Department of Psychology, Eberhard Karls Universität Tübingen, Tubingen, Germany
| | - Alexandra Havdahl
- PsychGen Centre for Genetic Epidemiology and Mental Health, Norwegian Institute of Public Health, Oslo, Norway
- PROMENTA Research Centre, Department of Psychology, University of Oslo, Oslo, Norway
- Nic Waals Institute, Lovisenberg Diaconal Hospital, Oslo, Norway
| | - Urs Heilbronner
- Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany
| | - Dennis Hellgren
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Stefan Herms
- Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany
- Department of Biomedicine, University of Basel, Basel, Switzerland
- Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland
| | - Ian B Hickie
- Brain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia
| | - Per Hoffmann
- Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany
- Department of Biomedicine, University of Basel, Basel, Switzerland
- Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland
| | - Peter A Holmans
- Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| | - Ming-Chyi Huang
- Department of Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan
| | - Masashi Ikeda
- Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan
- Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan
| | - Stéphane Jamain
- Université Paris Est Créteil, INSERM, IMRB, Translational Neuropsychiatry, Créteil, France
| | - Jessica S Johnson
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Psychiatry, UNC Chapel Hill School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Lina Jonsson
- Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
| | - Janos L Kalman
- Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany
- Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany
| | - Yoichiro Kamatani
- Laboratory of Complex Trait Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
- Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
| | - James L Kennedy
- Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
- Neurogenetics Section, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
- Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada
| | - Euitae Kim
- Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
- Department of Neuropsychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea
- Department of Brain and Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, Republic of Korea
| | - Jaeyoung Kim
- Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
- Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea
| | - Sarah Kittel-Schneider
- Department of Psychiatry and Neurobehavioral Science, University College Cork, Cork, Ireland
- Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital Würzburg, Würzburg, Germany
| | - James A Knowles
- Human Genetics Institute of New Jersey, Rutgers University, Piscataway, NJ, USA
| | | | - Thorsten M Kranz
- Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany
| | - Kristi Krebs
- Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia
| | - Steven A Kushner
- Department of Psychiatry, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
| | - Catharina Lavebratt
- Translational Psychiatry, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
- Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
| | - Jacob Lawrence
- Psychiatry, North East London NHS Foundation Trust, Ilford, UK
| | - Markus Leber
- Clinic for Psychiatry and Psychotherapy, University Hospital Cologne, Cologne, Germany
| | - Heon-Jeong Lee
- Department of Psychiatry, Korea University College of Medicine, Seoul, Republic of Korea
| | - Calwing Liao
- Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA
- Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA
| | - Susanne Lucae
- Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany
| | - Martin Lundberg
- Translational Psychiatry, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
- Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
| | - Donald J MacIntyre
- Division of Psychiatry, Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK
| | - Wolfgang Maier
- Department of Psychiatry and Psychotherapy, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany
| | - Adam X Maihofer
- Department of Psychiatry, University of California San Diego, La Jolla, CA, USA
- Research/Psychiatry, Veterans Affairs San Diego Healthcare System, San Diego, CA, USA
| | - Dolores Malaspina
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Mirko Manchia
- Section of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
- Unit of Clinical Psychiatry, University Hospital Agency of Cagliari, Cagliari, Italy
| | - Eirini Maratou
- National and Kapodistrian University of Athens, Medical School, Clinical Biochemistry Laboratory, Attikon General Hospital, Athens, Greece
| | - Lina Martinsson
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Centre for Psychiatry Research, SLSO Region Stockholm, Stockholm, Sweden
| | - Manuel Mattheisen
- iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark
- iSEQ, Center for Integrative Sequencing, Aarhus University, Aarhus, Denmark
- Department of Biomedicine-Human Genetics, Aarhus University, Aarhus, Denmark
- Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital Würzburg, Würzburg, Germany
- Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden
| | - Nathaniel W McGregor
- Human and Systems Genetics Working Group, Department of Genetics, Stellenbosch University, Stellenbosch, South Africa
| | - Melvin G McInnis
- Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA
| | - James D McKay
- Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France
| | - Helena Medeiros
- Institute for Genomic Health, SUNY Downstate Medical Center College of Medicine, Brooklyn, NY, USA
| | - Andreas Meyer-Lindenberg
- Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
- German Centre for Mental Health (DZPG), partner site Mannheim-Heidelberg-Ulm, Mannheim, Germany
| | - Vincent Millischer
- Translational Psychiatry, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
- Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
- Department of Psychiatry and Psychotherapy, Clinical Division of General Psychiatry, Medical University of Vienna, Vienna, Austria
- Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria
| | - Derek W Morris
- Centre for Neuroimaging and Cognitive Genomics (NICOG), School of Biological and Chemical Sciences, University of Galway, Galway, Ireland
| | - Paraskevi Moutsatsou
- National and Kapodistrian University of Athens, Medical School, Clinical Biochemistry Laboratory, Attikon General Hospital, Athens, Greece
| | - Thomas W Mühleisen
- Department of Biomedicine, University of Basel, Basel, Switzerland
- Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, Jülich, Germany
| | - Claire O'Donovan
- Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada
| | - Catherine M Olsen
- Population Health, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
| | | | - Sergi Papiol
- Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany
- Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany
- Instituto de Salud Carlos III, Biomedical Network Research Centre on Mental Health (CIBERSAM), Madrid, Spain
| | - Antonio F Pardiñas
- Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| | - Hye Youn Park
- Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
- Department of Neuropsychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Amy Perry
- Psychological Medicine, University of Worcester, Worcester, UK
| | - Andrea Pfennig
- Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - Claudia Pisanu
- Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy
| | - James B Potash
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Digby Quested
- Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK
- Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK
| | - Mark H Rapaport
- Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA
| | - Eline J Regeer
- Outpatient Clinic for Bipolar Disorder, Altrecht, Utrecht, The Netherlands
| | - John P Rice
- Department of Psychiatry, Washington University in Saint Louis, Saint Louis, MO, USA
| | - Margarita Rivera
- Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, University of Granada, Granada, Spain
- Institute of Neurosciences 'Federico Olóriz', Biomedical Research Center (CIBM), University of Granada, Granada, Spain
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
| | - Eva C Schulte
- Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany
- Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany
- Department of Psychiatry and Psychotherapy, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany
| | - Fanny Senner
- Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany
- Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany
| | - Alexey Shadrin
- Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
- Center for Precision Psychiatry, University of Oslo, Oslo, Norway
- KG Jebsen Centre for Neurodevelopmental disorders, University of Oslo, Oslo, Norway
| | - Paul D Shilling
- Department of Psychiatry, University of California San Diego, La Jolla, CA, USA
| | - Engilbert Sigurdsson
- Faculty of Medicine, Department of Psychiatry, School of Health Sciences, University of Iceland, Reykjavik, Iceland
- Landspitali University Hospital, Reykjavik, Iceland
| | - Lisa Sindermann
- Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany
| | - Lea Sirignano
- Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Dan Siskind
- Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia
| | - Claire Slaney
- Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada
| | - Laura G Sloofman
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Olav B Smeland
- Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
- Center for Precision Psychiatry, University of Oslo, Oslo, Norway
| | - Daniel J Smith
- Division of Psychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
| | - Janet L Sobell
- Psychiatry and the Behavioral Sciences, University of Southern California, Los Angeles, CA, USA
| | - Maria Soler Artigas
- Instituto de Salud Carlos III, Biomedical Network Research Centre on Mental Health (CIBERSAM), Madrid, Spain
- Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain
- Psychiatric Genetics Unit, Group of Psychiatry Mental Health and Addictions, Vall d'Hebron Research Institut (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain
- Department of Genetics, Microbiology, and Statistics, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain
| | - Dan J Stein
- SAMRC Unit on Risk and Resilience in Mental Disorders, Dept of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa
| | - Frederike Stein
- Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany
| | - Mei-Hsin Su
- Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA, USA
| | - Heejong Sung
- Human Genetics Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA
| | - Beata Świątkowska
- Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Lodz, Poland
| | - Chikashi Terao
- Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
| | - Markos Tesfaye
- Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
- Center for Precision Psychiatry, University of Oslo, Oslo, Norway
- Department of Clinical Science, University of Bergen, Bergen, Norway
| | - Martin Tesli
- Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
- Center for Precision Psychiatry, University of Oslo, Oslo, Norway
- Department of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway
| | | | - Jackson G Thorp
- Mental Health and Neuroscience, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
| | - Claudio Toma
- Neuroscience Research Australia, Sydney, New South Wales, Australia
- Discipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia
- Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid and CSIC, Madrid, Spain
| | - Leonardo Tondo
- Department of Psychiatry, Harvard Medical School, Boston, MA, USA
| | - Paul A Tooney
- School of Biomedical Science and Pharmacy, University of Newcastle, Newcastle, New South Wales, Australia
| | - Shih-Jen Tsai
- Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan
- Division of Psychiatry, National Yang Ming Chiao Tung University, Taipei, Taiwan
| | | | - Marquis P Vawter
- Department of Psychiatry and Human Behavior, School of Medicine, University of California, Irvine, CA, USA
| | - Helmut Vedder
- Psychiatry, Psychiatrisches Zentrum Nordbaden, Wiesloch, Germany
| | - Annabel Vreeker
- Psychiatry, Brain Center UMC Utrecht, Utrecht, The Netherlands
- Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC Sophia Children Hospital, Erasmus University, Rotterdam, The Netherlands
- Department of Psychology Education and Child Studies, Erasmus School of Social and Behavioral Sciences, Erasmus University Rotterdam, Rotterdam, The Netherlands
| | - James T R Walters
- Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| | - Bendik S Winsvold
- HUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
- Department of Research, Innovation and Education, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway
- Department of Neurology, Oslo University Hospital, Oslo, Norway
| | - Stephanie H Witt
- Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Hong-Hee Won
- Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea
- Samsung Genome Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
| | - Robert Ye
- Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA
- Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA
| | - Allan H Young
- Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Kent, UK
| | - Peter P Zandi
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Lea Zillich
- Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | | | - Rolf Adolfsson
- Department of Clinical Sciences, Psychiatry, Umeå University Medical Faculty, Umeå, Sweden
| | - Martin Alda
- Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada
- National Institute of Mental Health, Klecany, Czech Republic
| | - Lars Alfredsson
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Lena Backlund
- Translational Psychiatry, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
- Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
| | - Bernhard T Baune
- Department of Psychiatry, University of Münster, Münster, Germany
- Department of Psychiatry, Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia
- The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia
| | - Frank Bellivier
- Université Paris Cité, INSERM, Optimisation Thérapeutique en Neuropsychopharmacologie, UMRS-1144, Paris, France
- APHP Nord, DMU Neurosciences, GHU Saint Louis-Lariboisière-Fernand Widal, Département de Psychiatrie et de Médecine Addictologique, Paris, France
| | - Susanne Bengesser
- Division of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria
| | | | - Joanna M Biernacka
- Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA
- Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA
| | - Michael Boehnke
- Center for Statistical Genetics and Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA
| | - Anders D Børglum
- iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark
- Department of Biomedicine and the iSEQ Center, Aarhus University, Aarhus, Denmark
- Center for Genomics and Personalized Medicine, CGPM, Aarhus, Denmark
| | - Gerome Breen
- Social, Genetic and Developmental Psychiatry Centre, King's College London, London, UK
- NIHR Maudsley BRC, King's College London, London, UK
| | - Vaughan J Carr
- Discipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia
| | - Stanley Catts
- University of Queensland, Brisbane, Queensland, Australia
| | - Sven Cichon
- Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany
- Department of Biomedicine, University of Basel, Basel, Switzerland
- Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland
- Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, Jülich, Germany
| | - Aiden Corvin
- Neuropsychiatric Genetics Research Group, Department of Psychiatry and Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland
| | - Nicholas Craddock
- Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| | - Udo Dannlowski
- Institute for Translational Psychiatry, University of Münster, Münster, Germany
| | - Dimitris Dikeos
- National and Kapodistrian University of Athens, 1st Department of Psychiatry, Eginition Hospital, Athens, Greece
| | - Bruno Etain
- Université Paris Cité, INSERM, Optimisation Thérapeutique en Neuropsychopharmacologie, UMRS-1144, Paris, France
- APHP Nord, DMU Neurosciences, GHU Saint Louis-Lariboisière-Fernand Widal, Département de Psychiatrie et de Médecine Addictologique, Paris, France
| | - Panagiotis Ferentinos
- Social, Genetic and Developmental Psychiatry Centre, King's College London, London, UK
- National and Kapodistrian University of Athens, 2nd Department of Psychiatry, Attikon General Hospital, Athens, Greece
| | - Mark Frye
- Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA
| | - Janice M Fullerton
- Neuroscience Research Australia, Sydney, New South Wales, Australia
- School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia
| | - Micha Gawlik
- Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital Würzburg, Würzburg, Germany
| | - Elliot S Gershon
- Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA
- Department of Human Genetics, University of Chicago, Chicago, IL, USA
| | - Fernando S Goes
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Melissa J Green
- Neuroscience Research Australia, Sydney, New South Wales, Australia
- Discipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia
| | - Maria Grigoroiu-Serbanescu
- Biometric Psychiatric Genetics Research Unit, Alexandru Obregia Clinical Psychiatric Hospital, Bucharest, Romania
| | - Joanna Hauser
- Department of Psychiatric Genetics, Poznan University of Medical Sciences, Poznan, Poland
| | - Frans A Henskens
- School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia
| | - Jens Hjerling-Leffler
- Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
| | - David M Hougaard
- iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark
- Center for Neonatal Screening, Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark
| | - Kristian Hveem
- K. G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
- HUNT Research Center, Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
| | - Nakao Iwata
- Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan
| | - Ian Jones
- Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| | - Lisa A Jones
- Psychological Medicine, University of Worcester, Worcester, UK
| | - René S Kahn
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Psychiatry, Brain Center UMC Utrecht, Utrecht, The Netherlands
| | - John R Kelsoe
- Department of Psychiatry, University of California San Diego, La Jolla, CA, USA
| | - Tilo Kircher
- Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany
| | - George Kirov
- Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| | - Po-Hsiu Kuo
- Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan
- Department of Public Health and Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan
| | - Mikael Landén
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
- Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
| | - Marion Leboyer
- Université Paris Est Créteil, INSERM, IMRB, Translational Neuropsychiatry, Créteil, France
| | - Qingqin S Li
- Neuroscience Therapeutic Area, Janssen Research and Development, Titusville, NJ, USA
- JRD Data Science, Janssen Research and Development, Titusville, NJ, USA
| | - Jolanta Lissowska
- Cancer Epidemiology and Prevention, M. Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
| | - Christine Lochner
- SA MRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry, Stellenbosch University, Stellenbosch, South Africa
| | | | - Jurjen J Luykx
- Department of Psychiatry, Amsterdam University Medical Center, Amsterdam, The Netherlands
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands
| | - Nicholas G Martin
- Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
- School of Psychology, The University of Queensland, Brisbane, Queensland, Australia
| | - Carol A Mathews
- Department of Psychiatry, University of Florida, Gainesville, FL, USA
| | - Fermin Mayoral
- Mental Health Department, University Regional Hospital, Biomedicine Institute (IBIMA), Málaga, Spain
| | | | - Andrew M McIntosh
- Division of Psychiatry, Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK
| | - Francis J McMahon
- Human Genetics Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA
| | - Sarah E Medland
- Mental Health and Neuroscience, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
- School of Psychology, The University of Queensland, Brisbane, Queensland, Australia
- School of Psychology and Counselling, Queensland University of Technology, Brisbane, Queensland, Australia
| | - Ingrid Melle
- Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
- Division of Mental Health and Addiction, University of Oslo, Institute of Clinical Medicine, Oslo, Norway
| | - Lili Milani
- Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia
| | - Philip B Mitchell
- Discipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia
| | - Gunnar Morken
- Department of Mental Health, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
- Psychiatry, St Olavs University Hospital, Trondheim, Norway
| | - Ole Mors
- iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark
- Psychosis Research Unit, Aarhus University Hospital-Psychiatry, Risskov, Denmark
| | - Preben Bo Mortensen
- iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark
- NCRR and CIRRAU, Aarhus BSS, Aarhus University, Aarhus, Denmark
| | - Bertram Müller-Myhsok
- Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany
- Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
- University of Liverpool, Liverpool, UK
| | - Richard M Myers
- HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA
| | - Woojae Myung
- Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
- Department of Neuropsychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Benjamin M Neale
- Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA
- Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA
- Medical and Population Genetics, Broad Institute, Cambridge, MA, USA
| | - Caroline M Nievergelt
- Department of Psychiatry, University of California San Diego, La Jolla, CA, USA
- Research/Psychiatry, Veterans Affairs San Diego Healthcare System, San Diego, CA, USA
| | - Merete Nordentoft
- iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark
- Mental Health Services in the Capital Region of Denmark, Mental Health Center Copenhagen, University of Copenhagen, Copenhagen, Denmark
| | - Markus M Nöthen
- Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany
| | - John I Nurnberger
- Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Michael C O'Donovan
- Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| | - Ketil J Oedegaard
- Division of Psychiatry, Haukeland Universitetssjukehus, Bergen, Norway
- Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway
| | - Tomas Olsson
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Center for Molecular Medicine, Stockholm, Sweden
| | - Michael J Owen
- Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| | - Sara A Paciga
- Human Genetics and Computational Biomedicine, Pfizer Global Research and Development, Groton, CT, USA
| | - Christos Pantelis
- The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia
- Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia
- Monash Institute of Pharmaceutical Sciences (MIPS), Monash University, Parkville, Victoria, Australia
| | - Carlos N Pato
- Rutgers Health, Rutgers University, Piscataway, NJ, USA
| | | | - George P Patrinos
- University of Patras, School of Health Sciences, Department of Pharmacy, Laboratory of Pharmacogenomics and Individualized Therapy, Patras, Greece
- Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates
- Zayed Center for Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates
- Department of Pathology, Faculty of Medicine and Health Sciences, Clinical Bioinformatics Unit, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
| | - Joanna M Pawlak
- Department of Psychiatric Genetics, Poznan University of Medical Sciences, Poznan, Poland
| | - Josep Antoni Ramos-Quiroga
- Instituto de Salud Carlos III, Biomedical Network Research Centre on Mental Health (CIBERSAM), Madrid, Spain
- Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain
- Psychiatric Genetics Unit, Group of Psychiatry Mental Health and Addictions, Vall d'Hebron Research Institut (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain
- Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Andreas Reif
- Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany
| | - Eva Z Reininghaus
- Division of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria
| | - Marta Ribasés
- Instituto de Salud Carlos III, Biomedical Network Research Centre on Mental Health (CIBERSAM), Madrid, Spain
- Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain
- Psychiatric Genetics Unit, Group of Psychiatry Mental Health and Addictions, Vall d'Hebron Research Institut (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain
- Department of Genetics, Microbiology, and Statistics, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain
| | - Marcella Rietschel
- Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Stephan Ripke
- Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA
- Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA
- Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany
| | - Guy A Rouleau
- Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, Québec, Canada
- Montreal Neurological Institute and Hospital, McGill University, Montréal, Québec, Canada
| | - Panos Roussos
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Center for Precision Medicine and Translational Therapeutics, James J. Peters VA Medical Center, Bronx, NY, USA
| | - Takeo Saito
- Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan
| | - Ulrich Schall
- Centre for Brain and Mental Health Research, The University of Newcastle, Newcastle, New South Wales, Australia
- Hunter Medical Research Institute, New Lambtion Heights, New South Wales, Australia
| | - Martin Schalling
- Translational Psychiatry, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
- Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
| | - Peter R Schofield
- Neuroscience Research Australia, Sydney, New South Wales, Australia
- School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia
| | - Thomas G Schulze
- Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
- Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany
- Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, NY, USA
| | - Laura J Scott
- Center for Statistical Genetics and Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA
| | - Rodney J Scott
- The School of Biomedical Sciences and Pharmacy, Faculty of Medicine, Health and Wellbeing, University of Newcastle, Newcastle, New South Wales, Australia
- Cancer Detection and Therapies Program, Hunter Medical Research Institute, University of Newcastle, Newcastle, New South Wales, Australia
| | - Alessandro Serretti
- Department of Medicine and Surgery, Kore University of Enna, Enna, Italy
- Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy
- Oasi Research Institute-IRCCS, Troina, Italy
| | - Jordan W Smoller
- Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA
- Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA
- Psychiatric and Neurodevelopmental Genetics Unit (PNGU), Massachusetts General Hospital, Boston, MA, USA
| | - Alessio Squassina
- Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy
| | - Eli A Stahl
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Medical and Population Genetics, Broad Institute, Cambridge, MA, USA
| | | | - Kari Stefansson
- deCODE Genetics/Amgen, Reykjavik, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - Eystein Stordal
- Department of Psychiatry, Hospital Namsos, Namsos, Norway
- Department of Neuroscience, Norges Teknisk Naturvitenskapelige Universitet Fakultet for naturvitenskap og teknologi, Trondheim, Norway
| | - Fabian Streit
- Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
- Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
- Hector Institute for Artificial Intelligence in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Patrick F Sullivan
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
- Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Gustavo Turecki
- Department of Psychiatry, McGill University, Montreal, Québec, Canada
| | - Arne E Vaaler
- Department of Psychiatry, Sankt Olavs Hospital Universitetssykehuset i Trondheim, Trondheim, Norway
| | - Eduard Vieta
- Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain
| | - John B Vincent
- Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Irwin D Waldman
- Department of Psychology, Emory University, Atlanta, GA, USA
| | - Cynthia S Weickert
- Neuroscience Research Australia, Sydney, New South Wales, Australia
- Discipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia
- Department of Neuroscience, SUNY Upstate Medical University, Syracuse, NY, USA
| | - Thomas W Weickert
- Neuroscience Research Australia, Sydney, New South Wales, Australia
- Discipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia
- Department of Neuroscience, SUNY Upstate Medical University, Syracuse, NY, USA
| | - Thomas Werge
- iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark
- Institute of Biological Psychiatry, Mental Health Services, Copenhagen University Hospital, Copenhagen, Denmark
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
- Center for GeoGenetics, GLOBE Institute, University of Copenhagen, Copenhagen, Denmark
| | - David C Whiteman
- Population Health, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
| | - John-Anker Zwart
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- HUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
- Department of Research, Innovation and Education, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway
| | - Howard J Edenberg
- Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA
- Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA
| | | | - Andreas J Forstner
- Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany
- Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, Jülich, Germany
- Centre for Human Genetics, University of Marburg, Marburg, Germany
| | - Niamh Mullins
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Arianna Di Florio
- Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
- Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Roel A Ophoff
- Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
- Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA
- Department of Psychiatry and Biobehavioral Science, Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
| | - Ole A Andreassen
- Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
- Center for Precision Psychiatry, University of Oslo, Oslo, Norway.
| | | |
Collapse
Collaborators
Byung-Chul Lee, Ji-Woong Kim, Young Kee Lee, Joon Ho Kang, Myeong Jae Cheon, Dong Jun Kim, Mihaela Aslan, Philip D Harvey, Grant D Huang,
Collapse
|
37
|
Dunn IBJMD, Power E, Casey LJ, Wootton BM. Cognitive behavioural therapy for internalizing symptoms in LGBTQ+ people: a preliminary meta-analysis. Cogn Behav Ther 2025; 54:246-275. [PMID: 39625808 DOI: 10.1080/16506073.2024.2434021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2024] [Accepted: 11/15/2024] [Indexed: 01/29/2025]
Abstract
Internalizing disorders are common in lesbian, gay, bisexual, transgender, queer, questioning, and otherwise non-heterosexual or non-cisgender (LGBTQ+) people. Few studies have evaluated the efficacy of cognitive behavior therapy (CBT), a well-established treatment for internalizing disorders, in LGBTQ+ people. The current study quantitatively synthesized outcomes from existing trials of CBT for internalizing disorders in LGBTQ+ people. Seven databases were searched, identifying 14 relevant studies with a total of 414 participants. A medium within-group effect size was found for depressive symptoms from pre-treatment to post-treatment (k = 14; g = 0.60; 95% CI: 0.44-0.76; I2 = 71.59) and pre-treatment to 2-6-month follow-up (k = 7; g = 0.63; 95% CI: 0.40-0.86; I2 = 71.59). For anxiety and related disorder symptoms, a medium within-group effect size was found from both pre-treatment to post-treatment (k = 10; g = 0.73; 95% CI: 0.47-0.99; I2 = 71.59) and to 3-9-month follow-up (k = 5; g = 0.70; 95% CI: 0.54-0.87; I2 = 36.04). Exploratory analyses indicated small between-group effects at post-treatment between intervention and control groups. Effect sizes were comparable to those in the general population, indicating preliminary support for treating internalizing disorders in LGBTQ+ people with CBT.
Collapse
Affiliation(s)
- Isaac B J M D Dunn
- Discipline of Clinical Psychology, Graduate School of Health, University of Technology, Sydney, NSW, Australia
| | - Emma Power
- Department of Speech Pathology, Graduate School of Health, University of Technology, Sydney, NSW, Australia
| | - Liam J Casey
- Discipline of Clinical Psychology, Graduate School of Health, University of Technology, Sydney, NSW, Australia
| | - Bethany M Wootton
- Discipline of Clinical Psychology, Graduate School of Health, University of Technology, Sydney, NSW, Australia
| |
Collapse
|
38
|
Mason A, Rapsey C, Sampson N, Lee S, Albor Y, Al-Hadi AN, Alonso J, Al-Saud N, Altwaijri Y, Andersson C, Atwoli L, Auerbach RP, Ayuya C, Báez-Mansur PM, Ballester L, Bantjes J, Baumeister H, Bendtsen M, Benjet C, Berman AH, Bootsma E, Chan SCN, Cohut I, Covarrubias Díaz Couder MA, Cuijpers P, David O, Dong D, Ebert DD, Nobrega MF, Gaete J, Forero CG, Gili M, Gutiérrez-García R, Haro JM, Hasking P, Hudec K, Hunt X, Hurks P, Husky M, Jaguga F, Jansen L, Kählke F, Klinkenberg E, Küchler AM, Langer ÁI, Léniz I, Liu Y, Mac-Ginty S, Martínez V, Mathai M, McLafferty M, Miranda-Mendizabal A, Murray E, Musyoka CM, Nedelcea C, Ngai CH, Núñez D, O'Neill S, Piqueras JA, Popescu CA, Robinson K, Rodriguez-Jimenez T, Scarf D, Siu OL, Stein DJ, Struijs SY, Tomoiaga C, Valdés-García KP, van Luenen S, Vigo DV, Wang AY, Wiers R, Wong SYS, Kessler RC, Bruffaerts R. Prevalence, age-of-onset, and course of mental disorders among 72,288 first-year university students from 18 countries in the World Mental Health International College Student (WMH-ICS) initiative. J Psychiatr Res 2025; 183:225-236. [PMID: 40010072 PMCID: PMC11926851 DOI: 10.1016/j.jpsychires.2025.02.016] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/04/2024] [Revised: 01/15/2025] [Accepted: 02/11/2025] [Indexed: 02/28/2025]
Abstract
BACKGROUND The college years are a developmentally sensitive period for mental disorder onset. Reliable epidemiological data are critical for informing public health responses. This study aimed to estimate prevalence and socio-demographic distributions of common DSM-5 mental disorders among first-year university students from 77 universities across 18 countries. METHODS Data were collected 2017-2023 in the World Mental Health International College Student Initiative with n = 72,288 university students. Online surveys assessed alcohol use, attention-deficit/hyperactivity, bipolar, drug use, generalized anxiety, major depression, panic, and post-traumatic stress disorders with validated screening scales. Socio-demographics included student age, sex at birth, gender modality, sexual orientation, and parent education. RESULTS The weighted mean response rate was 20.8%. Data were calibrated for differential response rates by sex at birth and age. 65.2% of respondents screened positive for lifetime mental disorders and 57.4% for 12-month mental disorders. Females had higher prevalence of internalizing disorders and males of substance and attention-deficit/hyperactivity disorders. Older age was associated with lower prevalence of most 12-month but not lifetime mental disorders. Non-heterosexual sexual orientation and identifying as transgender were associated with highest prevalence of most mental disorders. Parent education was for the most part uncorrelated with prevalence. CONCLUSIONS Although prevalence might have been overestimated due to the low response rate and possible screening scale miscalibration, results nonetheless suggest that mental disorders are highly prevalent among first-year university students worldwide and are widely distributed with respect to socio-demographic characteristics. These findings highlight the need to implement effective interventions to better support first-year university student mental health.
Collapse
Affiliation(s)
- Andre Mason
- Department of Psychological Medicine, University of Otago, 135 Park St, Dunedin, 9016, New Zealand; School of Psychological and Social Sciences, University of Waikato, Private Bag 3105, Hamilton 3240, New Zealand.
| | - Charlene Rapsey
- Department of Psychological Medicine, University of Otago, 135 Park St, Dunedin, 9016, New Zealand.
| | - Nancy Sampson
- Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA, 02115, USA.
| | - Sue Lee
- Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA, 02115, USA.
| | - Yesica Albor
- Center for Global Mental Health, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Av. Ramón de la Fuente 495, Mexico City, C.P. 14370, Mexico.
| | - Ahmad N Al-Hadi
- Department of Psychiatry, & SABIC Psychological Health Research & Applications Chair (SPHRAC), College of Medicine, King Saud University, P.O. Box 2925, Riyadh, 11461, Saudi Arabia.
| | - Jordi Alonso
- Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, C/ del Doctor Aiguader, 88 08003, Barcelona, Spain; Department of Medicine and Life Sciences, Pompeu Fabra University (UPF), Carrer del Doctor Aiguader, 88 08003, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Carrer del Doctor Aiguader, 88 08003, Barcelona, Spain.
| | - Nouf Al-Saud
- Biostatistics, Epidemiology and Scientific Computing Department, King Faisal Specialist Hospital and Research Center, P.O. Box 3354, Riyadh, 11211, Saudi Arabia.
| | - Yasmin Altwaijri
- Biostatistics, Epidemiology and Scientific Computing Department, King Faisal Specialist Hospital and Research Center, P.O. Box 3354, Riyadh, 11211, Saudi Arabia.
| | - Claes Andersson
- Department of Criminology, Malmö University, Nordenskiöldsgatan 10, 211 19, Malmö, Sweden.
| | - Lukoye Atwoli
- Brain and Mind Institute and Medical College of East Africa, The Aga Khan University, 3rd Parklands Avenue, Nairobi, Kenya.
| | - Randy P Auerbach
- Department of Psychiatry, Columbia University, 1051 Riverside Dr, New York, NY, 10032, USA.
| | - Caroline Ayuya
- Department of Psychology & Counselling, Daystar University, P.O. Box 10195, Nairobi, Kenya.
| | - Patricia M Báez-Mansur
- Coordinación de Desarrollo Académico y Servicios Educativos, Universidad la Salle Ciudad Victoria, Av. Universidad 300, Ciudad Victoria, Tamaulipas, C.P. 87000, Mexico.
| | - Laura Ballester
- Department of Medicine and Life Sciences, Pompeu Fabra University (UPF), Carrer del Doctor Aiguader, 88 08003, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Carrer del Doctor Aiguader, 88 08003, Barcelona, Spain.
| | - Jason Bantjes
- Mental Health, Alcohol, Substance Use and Tobacco (MAST) Research Unit, South African Medical Research Council, Francie van Zijl Dr, Cape Town, 7500, South Africa; Department of Psychiatry and Mental Health, University of Cape Town, P.O. Box 19070, Observatory, 7725, Cape Town, South Africa.
| | - Harald Baumeister
- Department of Clinical Psychology and Psychotherapy, Ulm University, Helmut-G.-Walther-Str. 3, 89081, Ulm, Germany.
| | - Marcus Bendtsen
- Department of Health, Medicine and Caring Sciences, Linköping University, 581 83, Linköping, Sweden.
| | - Corina Benjet
- Center for Global Mental Health, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Av. Ramón de la Fuente 495, Mexico City, C.P. 14370, Mexico.
| | - Anne H Berman
- Department of Psychology, Uppsala University, Villavägen 16, 752 36, Uppsala, Sweden.
| | - Erik Bootsma
- Center for Public Health Psychiatry, Universitair Psychiatrisch Centrum - Katholieke Universiteit, Leuven, Herestraat 49, 3000, Leuven, Belgium.
| | - Silver C N Chan
- Counseling and Wellness Center, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong Special Administrative Region of China.
| | - Irina Cohut
- Career Counseling and Guidance Center, Technical University of Cluj-Napoca, Str. Memorandumului 28, 400114, Cluj-Napoca, Romania.
| | | | - Pim Cuijpers
- Department of Clinical, Neuro- and Developmental Psychology, Vrije Universiteit Amsterdam, Van der Boechorstraat 7, 1081 BT, Amsterdam, the Netherlands.
| | - Oana David
- Department of Clinical Psychology and Psychotherapy, Babeş-Bolyai University, Str. Treboniu Laurian, 400271, Cluj-Napoca, Romania.
| | - Dong Dong
- School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, N.T, Hong Kong Special Administrative Region of China.
| | - David D Ebert
- Professorship Psychology and Digital Mental Health Care, Technical University of Munich, Ismaninger Str. 22, 81675, München, Germany.
| | - Mireia Felez Nobrega
- Sant Joan de Déu Research Institute, Carrer de Santa Rosa, 39-57, 08950, Esplugues del Llobregat, Spain; Centro de Investigación Biomédica en Red (CIBERSAM), Paseo del Prado, 20 28014, Madrid, Spain.
| | - Jorge Gaete
- Millennium Nucleus to Improve the Mental Health of Adolescents and Youths (Imhay), Av. Presidente Kennedy, 5700, Santiago, Chile; Centro de Investigación en Salud Mental Estudiantil (ISME), Universidad de los Andes, Av. Presidente Kennedy, Las Condes, 5700, Santiago, Chile.
| | - Carlos García Forero
- Departamento de Medicina, Universitat Internacional de Catalunya, Carrer de Urgell 236, 08036, Barcelona, Spain.
| | - Margalida Gili
- Universitat Illes Balears (UIB), Crta. de Valldemossa, Km 7.5, 07122, Palma, Mallorca, Spain.
| | - Raúl Gutiérrez-García
- Universidad De La Salle Bajío, Campus Salamanca, Carr. a la Victoria, km 1.5, Salamanca, Gto, 36810, Mexico.
| | - Josep Maria Haro
- Sant Joan de Déu Research Institute, Carrer de Santa Rosa, 39-57, 08950, Esplugues del Llobregat, Spain; Centro de Investigación Biomédica en Red (CIBERSAM), Paseo del Prado, 20 28014, Madrid, Spain.
| | - Penelope Hasking
- School of Population Health, Faculty of Health Sciences, Curtin University, Kent St, Bentley, WA, 6102, Perth, Australia.
| | - Kristen Hudec
- Department of Psychiatry, Faculty of Medicine, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada.
| | - Xanthe Hunt
- Institute for Life Course Health Research, Department of Global Health, Stellenbosch University, 7600, Stellenbosch, South Africa.
| | - Petra Hurks
- Faculty of Psychology and Neuroscience, Maastricht University, Universiteitssingel 50, 6229 ER, Maastricht, the Netherlands.
| | - Mathilde Husky
- INSERM U1219, Bordeaux Population Health Research Center, ACTIVE Team, University of Bordeaux, 146 Rue Léo Saignat, 33076, Bordeaux, France.
| | - Florence Jaguga
- Department of Alcohol and Drug Abuse Rehabilitation Services, Moi Teaching and Referral Hospital, P.O. Box 3, 30100, Eldoret, Kenya.
| | - Leontien Jansen
- Center for Public Health Psychiatry, Universitair Psychiatrisch Centrum - Katholieke Universiteit, Leuven, Herestraat 49, 3000, Leuven, Belgium.
| | - Fanny Kählke
- Professorship Psychology and Digital Mental Health Care, Technical University of Munich, Ismaninger Str. 22, 81675, München, Germany.
| | - Elisabeth Klinkenberg
- Department of Education and Innovation, in Holland University of Applied Sciences, Molenweide 24, 2034 ZH, Haarlem, the Netherlands.
| | - Ann-Marie Küchler
- Department of Clinical Psychology and Psychotherapy, Ulm University, Helmut-G.-Walther-Str. 3, 89081, Ulm, Germany.
| | - Álvaro I Langer
- Millennium Nucleus to Improve the Mental Health of Adolescents and Youths (Imhay), Av. Presidente Kennedy, 5700, Santiago, Chile; Facultad de Psicología y Humanidades, Universidad San Sebastián, Avenida Picarte 1610, Valdivia, Chile.
| | - Irene Léniz
- Dirección de Salud Mental, Universidad de O'Higgins, Av. O'Higgins 130, Rancagua, Chile.
| | - Yan Liu
- School of Public Health, Jining Medical University, 25 South Zhongshan Rd, Jining, Shandong, China.
| | - Scarlett Mac-Ginty
- Millennium Nucleus to Improve the Mental Health of Adolescents and Youths (Imhay), Av. Presidente Kennedy, 5700, Santiago, Chile; Department of Health Service & Population Research, King's College London, 125 Coldharbour Ln, London, SE5 9NP, United Kingdom.
| | - Vania Martínez
- Millennium Nucleus to Improve the Mental Health of Adolescents and Youths (Imhay), Av. Presidente Kennedy, 5700, Santiago, Chile; Facultad de Medicina, Universidad de Chile, Av. Libertador Bernardo O'Higgins 1058, Santiago, Chile.
| | - Muthoni Mathai
- Department of Psychiatry, School of Medicine, University of Nairobi, P.O. Box 30197, Nairobi, Kenya.
| | - Margaret McLafferty
- School of Medicine, Ulster University, 100 University Ave, Derry/Londonderry, Derry, BT47 6AL, United Kingdom.
| | - Andrea Miranda-Mendizabal
- Sant Joan de Déu Research Institute, Carrer de Santa Rosa, 39-57, 08950, Esplugues del Llobregat, Spain; rather Than Parc Sanitari Sant Joan de Déu, IRSJD, Carrer del Celler, 08130, Sant Boi de Llobregat, Spain.
| | - Elaine Murray
- Personalised Medicine Centre, School of Medicine, Ulster University, C-TRIC, Altnagelvin Hospital, Derry, 100 University Ave, Derry, BT47 6AL, United Kingdom.
| | - Catherine M Musyoka
- Department of Psychiatry, School of Medicine, University of Nairobi, P.O. Box 30197, Nairobi, Kenya.
| | - Catalin Nedelcea
- Department of Psychology and Cognitive Sciences, University of Bucharest, Str. Bdul. Regina Elisabeta 4-12, 030018, Bucharest, Romania.
| | - Chun Ho Ngai
- School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, N.T, Hong Kong Special Administrative Region of China.
| | - Daniel Núñez
- Millennium Nucleus to Improve the Mental Health of Adolescents and Youths (Imhay), Av. Presidente Kennedy, 5700, Santiago, Chile; Faculty of Psychology, Universidad de Talca, Av. Marcelino Núñez 045, Talca, Chile.
| | - Siobhan O'Neill
- School of Psychology, Ulster University, Cromore Road, Coleraine, BT52 1SA, United Kingdom.
| | - Jose A Piqueras
- Universidad Miguel Hernandez (UMH), Elche, 03202, Alicante, Spain.
| | - Codruta A Popescu
- Department of Human Sciences, ''Iuliu Hatieganu'' University of Medicine and Pharmacy, Str. Victor Babeș 8, 400012, Cluj-Napoca, Romania.
| | - Kealagh Robinson
- School of Psychology, Massey University, Private Bag 11 222, Palmerston North, 4442, New Zealand.
| | | | - Damian Scarf
- Department of Psychology, University of Otago, 135 Park Street, Dunedin, 9016, New Zealand.
| | - Oi Ling Siu
- Department of Psychology, Lingnan University, 8 Castle Peak Road, Tuen Mun, Hong Kong Special Administrative Region of China.
| | - Dan J Stein
- Department of Psychiatry and Mental Health, University of Cape Town, P.O. Box 19070, Observatory, 7725, Cape Town, South Africa; South African Medical Research Council (SAMRC) Unit on Risk and Resilience in Mental Disorders, University of Cape Town, P.O. Box 19070, Observatory, 7725, South Africa.
| | - Sascha Y Struijs
- Department of Clinical, Neuro- and Developmental Psychology, Vrije Universiteit Amsterdam, Van der Boechorstraat 7, 1081 BT, Amsterdam, the Netherlands.
| | - Cristina Tomoiaga
- Department of Clinical Psychology and Psychotherapy, Babeş-Bolyai University, Str. Treboniu Laurian, 400271, Cluj-Napoca, Romania.
| | - Karla Patricia Valdés-García
- Facultad de Psicología, Universidad Autónoma de Coahuila, Av. Universidad 250, Ciudad Universitaria, 25280, Saltillo, Coahuila, Mexico.
| | - Sanne van Luenen
- Department of Clinical Psychology, Leiden University, Wassenaarseweg 52, 2333 AK, Leiden, the Netherlands.
| | - Daniel V Vigo
- Department of Psychiatry, Faculty of Medicine, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada.
| | - Angel Y Wang
- Department of Psychiatry, Faculty of Medicine, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada.
| | - Reinout Wiers
- Department of Developmental Psychology, University of Amsterdam, Roetersstraat 15, 1018 WB, Amsterdam, the Netherlands.
| | - Samuel Y S Wong
- School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, N.T, Hong Kong Special Administrative Region of China.
| | - Ronald C Kessler
- Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA, 02115, USA.
| | - Ronny Bruffaerts
- Center for Public Health Psychiatry, Universitair Psychiatrisch Centrum - Katholieke Universiteit, Leuven, Herestraat 49, 3000, Leuven, Belgium.
| |
Collapse
|
39
|
Wang W, Xia J, Chen W, Ye J, Xie K, Zhang Z, Binti Mohamad SM, Shuid AN. Exploring the interplay of mental health knowledge, stigma, and social distance among clinical nurses: a study in Liaoning, China. Front Psychiatry 2025; 16:1478690. [PMID: 40092465 PMCID: PMC11906470 DOI: 10.3389/fpsyt.2025.1478690] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/10/2024] [Accepted: 02/10/2025] [Indexed: 03/19/2025] Open
Abstract
Background Stigma related to mental health conditions has a negative impact on both the nursing staff and their patients. Most of the current research on stigma explores the impact of single factors on stigma and does not explore the relationship between knowledge, social distance and stigma among clinical nurses. Methods A convenience sampling method was used to conduct a questionnaire survey among 628 nurses from five hospitals in Liaoning Province in March 2021 and June 2021 using a combination of online and offline methods. To study the negative attitudes toward patients with mental illness among clinical nurses and to analyze the relationship between mental ill health stigma, social distancing, and mental health knowledge among nurses. The questionnaire includes Sociodemographic data, Scale for Assessing the Stigma of Mental Illness in Nursing (score range: 20~100, the higher the score, the less stigma attached to mental ill health), Mental Illness Social Distance Scale (score range: 6~30, the higher the score, the greater the social distance) and Mental Health and Mental Health Knowledge Questionnaire (score range: 0~25, the higher the score, the higher the knowledge level). Results The nurses' mental ill health stigma score was 58.96 ± 9.38 points, the mean scores of psychiatric and general nurses were 58.86 ± 9.33 and 59.41 ± 9.58 points, respectively. Willingness to become a psychiatric nurse is a factor influencing the stigma of mental illness. The stigma of mental ill health, social distance and mental health knowledge of nurses are positively correlated (P<0.01). The mediation analysis demonstrated that mental health stigma significantly mediated the relationship between mental health knowledge and social distance (a= 0.599, P<0.001; b= -0.194, P<0.001). After accounting for stigma, the direct effect of mental health knowledge on social distance was no longer significant (c'=-0.007, P=0.078), highlighting the central role of stigma in this relationship. Conclusions Nurses mental ill health stigma is moderate and is the main mediating effect between mental health knowledge and social distancing. The pivotal role of mental health knowledge in shaping nurses' attitudes and behaviors pertaining to social distancing in the context of mental illness. By combating stigma and enhancing mental health literacy among healthcare practitioners, we can foster environments that promote inclusive and compassionate care practices, thereby ameliorating patient outcomes and redressing disparities in mental health treatment.
Collapse
Affiliation(s)
- Weiwei Wang
- Medical College, Nanchang Institute Technology, Nanchang, China
| | - Junhong Xia
- Medical College, Nanchang Institute Technology, Nanchang, China
| | - Wei Chen
- Institut Perubatan dan Pergigian Termaju, Universiti Sains Malaysia, Penang City, Malaysia
| | - Junhua Ye
- Medical College, Nanchang Institute Technology, Nanchang, China
| | - Kun Xie
- Medical College, Nanchang Institute Technology, Nanchang, China
| | - Zhuona Zhang
- Medical College, Nanchang Institute Technology, Nanchang, China
| | | | - Ahmad Naqib Shuid
- Institut Perubatan dan Pergigian Termaju, Universiti Sains Malaysia, Penang City, Malaysia
| |
Collapse
|
40
|
Kazdin AE. Indirect Interventions: Lifestyle Options to Treat Mental Disorders. Healthcare (Basel) 2025; 13:505. [PMID: 40077067 PMCID: PMC11899711 DOI: 10.3390/healthcare13050505] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2025] [Revised: 02/19/2025] [Accepted: 02/24/2025] [Indexed: 03/14/2025] Open
Abstract
Mental disorders are highly prevalent worldwide. Unfortunately, most people with these disorders do not receive any treatment. This is due in part to a large set of barriers (e.g., no access to therapists or clinics, lack of insurance, stigma) that impede seeking and obtaining mental health services. Many lifestyle interventions that are not part of traditional mental health services have indirect effects on reducing symptoms of mental disorders. These are interventions that target a direct focus (e.g., physical health, socialization, general well-being) but also have indirect and significant impact on reducing mental disorders. This article discusses indirect interventions as an additional way of reaching people in need of help with mental health problems. Interventions such as physical activity and exercise, diet, addressing sleep problems, yoga, tai chi, qigong, and volunteering have indirect beneficial effects. This article highlights the scope of mental illness as a background, introduces indirect interventions, and details three illustrations with evidence that targeting one focus with indirect effects on improving mental disorders. The interventions point to a category of interventions are not systematically used in the care of mental health problems. Among their many advantages is the prospect of their use at the levels of individuals and populations. Indirect interventions do not replace any of the current advances in treatment but add to ways of reaching people in need.
Collapse
Affiliation(s)
- Alan E Kazdin
- Department of Psychology, Yale University, Henry Koerner Center, 149 Elm Street, New Haven, CT 06511, USA
| |
Collapse
|
41
|
Hirpara A, Bine C, Williams KG, Fry SA, Whitney K, Dragoo JL. Patients with Mood Disorders Have Higher Rates of Healthcare Utilization, Medical Complications, Opioid Prescriptions, and Subsequent Knee Surgery after Arthroscopic Partial Meniscectomy. Arthroscopy 2025:S0749-8063(25)00127-6. [PMID: 39983795 DOI: 10.1016/j.arthro.2025.01.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/22/2024] [Revised: 01/26/2025] [Accepted: 01/31/2025] [Indexed: 02/23/2025]
Abstract
PURPOSE To compare rates of post-operative complications, healthcare utilization, opioid prescribing patterns, and secondary knee surgery in patients with versus without a preexisting anxiety or depressive disorder (ADD) undergoing isolated primary arthroscopic partial meniscectomy (APM). METHODS The TriNetX database was queried from inception to compare patients over 18-years-old who underwent isolated primary APM with versus without a pre-existing ADD. Patients were matched in a 1:1 ratio based on demographic factors and comorbidities, including diabetes and hypertension. The following outcomes were collected: 1) post-operative complications and healthcare utilization within ninety days, 2) proportion of patients prescribed an opioid within one year, and 3) subsequent knee surgery within two years, specifically ipsilateral or contralateral meniscus surgery or total knee arthroplasty. Two subgroup analyses were conducted. Opioid naive patients with and without an ADD were compared based on the proportion of patients prescribed an opioid within one year of APM. Rates of revision meniscus surgery on the ipsilateral knee were also compared within two years of APM. RESULTS Within 90 days, patients with a pre-existing ADD (n=26,507), compared to those without (n=26,507), had higher rates of healthcare utilization, including readmission (p<0.001), and medical complications, like cerebrovascular accident (p=0.002). A greater proportion of patients with an ADD were prescribed opioids at all chosen time points within one year of APM. Similarly, a greater proportion of opioid naive patients with an ADD were prescribed opioids within six months (p<0.001) and one year (p<0.001). Patients with an ADD also had higher rates of total knee arthroplasty (p=0.001) and ipsilateral revision meniscus surgery (left knee: p=0.020; right knee: p=0.019) within two years. CONCLUSION Patients with an anxiety or depressive disorder have higher rates of healthcare utilization, medical complications, opioid prescriptions, and subsequent knee surgery after isolated primary arthroscopic partial meniscectomy. LEVEL OF EVIDENCE III, retrospective cohort study.
Collapse
Affiliation(s)
- Ankit Hirpara
- University of Colorado School of Medicine, Department of Orthopedics, Aurora, CO, U.S.A
| | | | - Kyle G Williams
- University of Colorado School of Medicine, Department of Orthopedics, Aurora, CO, U.S.A
| | - Sydney A Fry
- University of Colorado School of Medicine, Department of Orthopedics, Aurora, CO, U.S.A
| | - Kaitlyn Whitney
- University of Colorado School of Medicine, Department of Orthopedics, Aurora, CO, U.S.A
| | - Jason L Dragoo
- University of Colorado School of Medicine, Department of Orthopedics, Aurora, CO, U.S.A.
| |
Collapse
|
42
|
Wang B, Sheu YH, Lee H, Mealer RG, Castro VM, Smoller JW. Prediction of early-onset bipolar using electronic health records. J Child Psychol Psychiatry 2025. [PMID: 39967306 DOI: 10.1111/jcpp.14131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 12/11/2024] [Indexed: 02/20/2025]
Abstract
BACKGROUND Early identification of bipolar disorder (BD) provides an important opportunity for timely intervention. In this study, we aimed to develop machine learning models using large-scale electronic health record (EHR) data including clinical notes for predicting early-onset BD. METHODS Structured and unstructured data were extracted from the longitudinal EHR of the Mass General Brigham health system. We defined three cohorts aged 10-25 years: (1) the full youth cohort (N = 300,398); (2) a subcohort defined by having a mental health visit (N = 105,461); and (3) a subcohort defined by having a diagnosis of mood disorder or ADHD (N = 35,213). By adopting a prospective landmark modeling approach that aligns with clinical practice, we developed and validated a range of machine learning models, across different cohorts and prediction windows. RESULTS We found the two tree-based models, random forests (RF) and light gradient-boosting machine (LGBM), achieving good discriminative performance across different clinical settings (area under the receiver operating characteristic curve 0.76-0.88 for RF and 0.74-0.89 for LGBM). In addition, we showed comparable performance can be achieved with a greatly reduced set of features, demonstrating computational efficiency can be attained without significant compromise of model accuracy. CONCLUSIONS Good discriminative performance for models predicting early-onset BD can be achieved utilizing large-scale EHR data. Our study offers a scalable and accurate method for identifying youth at risk for BD that could help inform clinical decision-making and facilitate early intervention. Future work includes evaluating the portability of our approach to other healthcare systems and exploring considerations regarding possible implementation.
Collapse
Affiliation(s)
- Bo Wang
- Center for Precision Psychiatry, Massachusetts General Hospital, Boston, MA, USA
- Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, MA, USA
- Department of Psychiatry, Harvard Medical School, Boston, MA, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
| | - Yi-Han Sheu
- Center for Precision Psychiatry, Massachusetts General Hospital, Boston, MA, USA
- Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, MA, USA
- Department of Psychiatry, Harvard Medical School, Boston, MA, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
| | - Hyunjoon Lee
- Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA
| | - Robert G Mealer
- Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA
| | - Victor M Castro
- Research Information Science and Computing, Mass General Brigham, Somerville, MA, USA
| | - Jordan W Smoller
- Center for Precision Psychiatry, Massachusetts General Hospital, Boston, MA, USA
- Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, MA, USA
- Department of Psychiatry, Harvard Medical School, Boston, MA, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
| |
Collapse
|
43
|
Zhang J, Zhong S, Lai S, Zhang Y, Chen G, Huang D, Yan S, Chen P, Lu X, Yin J, Chen C, Wang Y, Jia Y. MIR218 polygenic risk score is associated with cognitive function and neurochemical metabolites among patients with depressed bipolar disorders. J Affect Disord 2025; 371:104-112. [PMID: 39561923 DOI: 10.1016/j.jad.2024.11.046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/17/2024] [Revised: 09/22/2024] [Accepted: 11/13/2024] [Indexed: 11/21/2024]
Abstract
BACKGROUNDS Evidence from animal and population studies has consistently revealed that microRNA 218 (MIR218) is involved in susceptibility to depression and cognitive functions. Nevertheless, few studies have evaluated the association between MIR218 and clinical features in patients with depressed bipolar disorder (BD). METHODS A total of 66 patients with depressed BD and 49 healthy controls (HCs) were recruited for this study. MIR218 polygenic risk score (PRS) was used to assess the addictive effects of the MIR218 regulated genes. We compared the MIR218 PRS between patients with depressed BD and HCs to investigate whether it can be used to predict the risk of BD, and further explored the association between MIR218 PRS and cognitive performance as well as neurochemical metabolites among depressed BD. RESULTS We found that there was a significant difference in MIR218 PRS between patients with depressed BD and HCs. The correlation analysis indicated that MIR218 PRS was negative associated with the number of disease onset (r = -0.311, P = 0.033) and choline (Cho)/creatine (Cr) in right thalamus (r = -0.285, P = 0.021). Additionally, as supported by previous findings, patients with lower MIR218 PRS presented more domains of impaired cognitive function than those with higher scores. CONCLUSION These findings suggested MIR218 PRS might be useful in differentiating patients with depressed BD from HCs. Moreover, depressed BD with lower MIR218 PRS showed more pronounced cognitive impairment than those with higher scores, which may be associated with disease recurrence and Cho metabolism in right thalamus.
Collapse
Affiliation(s)
- Jianzhao Zhang
- Department of Psychiatry, First Affiliated Hospital of Jinan University, Guangzhou 510630, China
| | - Shuming Zhong
- Department of Psychiatry, First Affiliated Hospital of Jinan University, Guangzhou 510630, China
| | - Shunkai Lai
- Department of Psychiatry, First Affiliated Hospital of Jinan University, Guangzhou 510630, China
| | - Yiliang Zhang
- Department of Psychiatry, First Affiliated Hospital of Jinan University, Guangzhou 510630, China
| | - Guanmao Chen
- Medical Imaging Center, First Affiliated Hospital of Jinan University, Guangzhou 510630, China
| | - Dong Huang
- Department of Psychiatry, First Affiliated Hospital of Jinan University, Guangzhou 510630, China
| | - Shuya Yan
- Department of Psychiatry, First Affiliated Hospital of Jinan University, Guangzhou 510630, China
| | - Pan Chen
- Medical Imaging Center, First Affiliated Hospital of Jinan University, Guangzhou 510630, China
| | - Xiaodan Lu
- Department of Psychiatry, First Affiliated Hospital of Jinan University, Guangzhou 510630, China
| | - Jie Yin
- Department of Psychiatry, First Affiliated Hospital of Jinan University, Guangzhou 510630, China
| | - Chao Chen
- Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan 410083, China.
| | - Ying Wang
- Medical Imaging Center, First Affiliated Hospital of Jinan University, Guangzhou 510630, China.
| | - Yanbin Jia
- Department of Psychiatry, First Affiliated Hospital of Jinan University, Guangzhou 510630, China.
| |
Collapse
|
44
|
Schepers M, Lagerweij P, Geurts D, Krause F, Ouden HD, Cools R, Speckens A, Collin G. Promoting Resilience in Youth through Mindfulness mEditation (PRYME): Study protocol for a randomized controlled trial investigating the effects of mindfulness training as add-on to care-as-usual on internalizing problems, mental illness development, and associated brain and cognitive processes in help-seeking youth. BMC Psychiatry 2025; 25:126. [PMID: 39948492 PMCID: PMC11827368 DOI: 10.1186/s12888-024-06430-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/29/2024] [Accepted: 12/20/2024] [Indexed: 02/16/2025] Open
Abstract
BACKGROUND Internalizing problems, such as worrying, anxiety and low mood, are increasingly common in youth and may constitute an early stage of mental illness development. There is thus an urgent need for effective measures to address mental health complaints as they develop and to prevent progression into more serious mental illness. Enhanced understanding of early-stage mental illness development, associated cognitive and brain processes, and their amenability to early intervention is crucial to this effort. Mindfulness-based interventions offer an accessible intervention option with demonstrated positive effects on internalizing disorders such as depression. Furthermore, mindfulness-based interventions may modulate cognitive processes and brain activity patterns associated with internalizing disorders. This study aims to determine how early-stage mindfulness-based intervention impacts internalizing symptom development, associated cognitive and brain processes, and mental illness progression in help-seeking youth. METHODS This longitudinal two-arm randomized controlled trial will be conducted in 155 help-seeking youth between 16 and 25 years of age. The investigational treatment, the Learning to Offset Stress program, is an adaptation of existing mindfulness-based programs. Developed for youth with internalizing problems, the training combines mindfulness exercises with mindful physical activity and yoga in 8 weekly 2-hour sessions. Participants are randomized to either Learning to Offset Stress program as an add on to care-as-usual, or care-as-usual-only. Assessments take place at baseline, end of treatment, and 2 months and 6 months after completion of treatment. The primary outcome is the level of internalizing problems measured with the internalizing subscale of the Adult Self Report questionnaire at end of treatment. Secondary outcomes include measures of self-compassion, rumination, experiential avoidance, and well-being. In addition, (functional) magnetic resonance imaging and computerized cognitive tasks are conducted at baseline and at end of treatment. DISCUSSION The current randomized controlled trial aims to enhance our understanding of the trajectory of emerging mental illness, associated cognitive and brain processes, and their modulation by early-stage mindfulness-based intervention. TRIAL REGISTRATION ClinicalTrials.gov NCT05916651. Registered on 23 June 2023.
Collapse
Affiliation(s)
- Maud Schepers
- Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, the Netherlands
- Department of Psychiatry, Expertise Center for Mindfulness, Radboud University Medical Center, Postbus 9101, Nijmegen, 6500 HB, the Netherlands
- Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Paul Lagerweij
- Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, the Netherlands
- Department of Psychiatry, Expertise Center for Mindfulness, Radboud University Medical Center, Postbus 9101, Nijmegen, 6500 HB, the Netherlands
- Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Dirk Geurts
- Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, the Netherlands
- Department of Psychiatry, Expertise Center for Mindfulness, Radboud University Medical Center, Postbus 9101, Nijmegen, 6500 HB, the Netherlands
- Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Florian Krause
- Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, the Netherlands
- Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Hanneke den Ouden
- Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, the Netherlands
| | - Roshan Cools
- Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, the Netherlands
- Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Anne Speckens
- Department of Psychiatry, Expertise Center for Mindfulness, Radboud University Medical Center, Postbus 9101, Nijmegen, 6500 HB, the Netherlands
- Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Guusje Collin
- Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, the Netherlands.
- Department of Psychiatry, Expertise Center for Mindfulness, Radboud University Medical Center, Postbus 9101, Nijmegen, 6500 HB, the Netherlands.
- Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands.
| |
Collapse
|
45
|
König M, Smith AJ, Moreno-López L, Davidson E, Dauvermann M, Orellana S, McCormick EM, Peris TS, Kaser M, Ioannidis K, van Harmelen AL. Friendship buffering effects on mental health symptoms before and during the COVID-19 pandemic: A UK longitudinal study of young people with childhood adversity. Dev Psychopathol 2025:1-16. [PMID: 39925030 DOI: 10.1017/s0954579424001986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/11/2025]
Abstract
Young people with childhood adversity (CA) were at increased risk to experience mental health problems during the COVID-19 pandemic. Pre-pandemic research identified high-quality friendship support as a protective factor that can buffer against the emergence of mental health problems in young people with CA. This longitudinal study investigated friendship buffering effects on mental health symptoms before and at three timepoints during the pandemic in 102 young people (aged 16-26) with low to moderate CA. Multilevel analyses revealed a continuous increase in depression symptoms following the outbreak. Friendship quality was perceived as elevated during lockdowns and returned to pre-pandemic baseline levels during reopening. A stress-sensitizing effect of CA on social functioning was evident, as social thinning occurred following the outbreak. Bivariate latent change score modeling revealed that before and during the pandemic, young people with greater friendship quality self-reported lower depression symptoms and vice versa. Furthermore, sequential mediation analysis showed that high-quality friendships before the pandemic buffered depression symptoms during the pandemic through reducing perceived stress. These findings highlight the importance of fostering stable and supportive friendships in young people with CA and suggest that through reducing stress perceptions high-quality friendships can mitigate mental health problems during times of multidimensional stress.
Collapse
Affiliation(s)
- Maximilian König
- Institute of Education and Child Studies, Leiden University, Leiden, Netherlands
| | - Alicia J Smith
- MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK
| | - Laura Moreno-López
- Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, UK
| | - Eugenia Davidson
- Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, UK
| | - Maria Dauvermann
- Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, UK
| | - Sofia Orellana
- Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, UK
| | | | - Tara S Peris
- Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA, USA
| | - Muzaffer Kaser
- Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, UK
| | - Konstantinos Ioannidis
- Department of Psychiatry, University of Southampton, Southampton, UK
- Southern Health NHS Foundation Trust, UK, Southampton
- Cambridgeshire and Peterborough NHS Foundation Trust, UK, Fulbourn
| | - Anne-Laura van Harmelen
- Institute of Education and Child Studies, Leiden University, Leiden, Netherlands
- Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, UK
| |
Collapse
|
46
|
Viana MC, Kazdin AE, Harris MG, Stein DJ, Vigo DV, Hwang I, Manoukian SM, Sampson NA, Alonso J, Andrade LH, Borges G, Bunting B, Caldas-de-Almeida JM, de Girolamo G, de Jonge P, Gureje O, Haro JM, Karam EG, Kovess-Masfety V, Moskalewicz J, Navarro-Mateu F, Nishi D, Piazza M, Posada-Villa J, Scott KM, Vladescu C, Wojtyniak B, Zarkov Z, Kessler RC, Kessler T. Barriers to 12-month treatment of common anxiety, mood, and substance use disorders in the World Mental Health (WMH) surveys. Int J Ment Health Syst 2025; 19:6. [PMID: 39924481 PMCID: PMC11807321 DOI: 10.1186/s13033-024-00658-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/24/2024] [Accepted: 12/19/2024] [Indexed: 02/11/2025] Open
Abstract
BACKGROUND High unmet need for treatment of mental disorders exists throughout the world. An understanding of barriers to treatment is needed to develop effective programs to address this problem. METHODS Data on barriers were obtained from face-to-face interviews in 22 community surveys across 19 countries (n = 102,812 respondents aged ≥ 18 years, 57.7% female, median age [interquartile range]: 43 [31-57] years; 68.5% weighted average response rate) in the World Mental Health (WMH) surveys. We focus on the n = 5,136 respondents with 12-month DSM-IV anxiety, mood, or substance use disorders with perceived need for treatment. The n = 2,444 such respondents who did not receive treatment were asked about barriers to receiving treatment, whereas the n = 926 respondents who received treatment with a delay were asked about barriers leading to delays. Consistent with previous research, we distinguished five broad classes of barriers: low perceived disorder severity, two types of barriers in the domain of predisposing factors (beliefs/attitudes about treatment ineffectiveness and stigma) and two types in the domain of enabling factors (financial and nonfinancial). Baseline predictors of receiving treatment found in a prior report (i.e., comparing the n = 2,692 respondents who received treatment with the n = 2,444 who did not) were examined as predictors of barriers, while barriers were examined as mediators of associations between these predictors and treatment. RESULTS Most respondents reported multiple barriers. Barriers among respondents who did not receive treatment included low perceived severity (52.9%), perceived treatment ineffectiveness (44.8%), nonfinancial (40.2%) and financial (32.9%) barriers in the domain of enabling factors, and stigma (20.6%). Barriers causing delays in treatment had a similar rank-order but were reported by higher proportions of respondents (X21 = 3.8-199.8, p = 0.050- < 0.001). Barriers were predicted by low education, disorder type, age, employment status, and financial obstacles. Predictors varied as a function of barrier type. CONCLUSIONS A wide range of barriers to treatment exist among people with mental disorders even after a need for treatment is acknowledged. Most such individuals have multiple barriers. These results have important implications for the design of programs to decrease unmet need for treatment of mental disorders.
Collapse
Affiliation(s)
- Maria Carmen Viana
- Department of Social Medicine, Postgraduate Program in Public Health, Federal University of Espírito Santo, Av. Marechal Campos, 1468, Vitória, ES, CEP 29.043-900, Brazil
| | - Alan E Kazdin
- Department of Psychology, Yale University, 2 Hillhouse Avenue, 208205, New Haven, CT, 06520, USA
| | - Meredith G Harris
- School of Public Health, The University of Queensland, C/O QCMHR, Locked Bag 500, Archerfield, QLD, 4108, Australia
- Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wolston Park Rd, Wacol, QLD, 4076, Australia
| | - Dan J Stein
- Department of Psychiatry & Mental Health and South African Medical Council Research Unit On Risk and Resilience in Mental Disorders, University of Cape Town, Rondebosch, Cape Town, 7925, ZA, South Africa
| | - Daniel V Vigo
- Department of Psychiatry & School of Population and Public Health, Faculty of Medicine, University of British Columbia, UBC Hospital - Detwiller Pavilion, Room 2813, 2255 Wesbrook Mall, UBC Vancouver Campus, Vancouver, BC, V6T 2A1, Canada
| | - Irving Hwang
- Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA, 02115, USA
| | - Sophie M Manoukian
- Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA, 02115, USA
| | - Nancy A Sampson
- Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA, 02115, USA
| | - Jordi Alonso
- IMIM-Hospital del Mar Medical Research Institute, PRBB Building, Doctor Aiguader, 88, 08003, Barcelona, Spain
- CIBER en Epidemiología y Salud Pública (CIBERESP), Av. Monforte de Lemos, 3-5, Pabellón 11, Planta 0, 28029, Madrid, Spain
- Pompeu Fabra University (UPF), Plaça de La Mercè, 10-12, 08002, Barcelona, Spain
| | - Laura Helena Andrade
- University of São Paulo Medical School, Núcleo de Epidemiologia Psiquiátrica - LIM 23, Rua Dr. Ovidio Pires de Campos, 785, São Paulo, CEP 05403-010, Brazil
| | - Guilherme Borges
- National Institute of Psychiatry Ramón de La Fuente Muñiz, Calz. Mexico-Xochimilco 101, San Lorenzo Huipulco, 14370, Ciudad de Mexico, Mexico
| | - Brendan Bunting
- School of Psychology, Ulster University, Coleraine Campus, Coleraine, BT52 1SA, UK
| | - José Miguel Caldas-de-Almeida
- Lisbon Institute for Global Mental Health, Comprehensive Health Research Centre Nova University of Lisbon, Rua Do Instituto Bacteriológico, 5, 1150-190, Lisbon, Portugal
| | - Giovanni de Girolamo
- IRCCS Istituto Centro San Giovanni Di Dio Fatebenefratelli, Via Pilastroni 4, Brescia, Italy
| | - Peter de Jonge
- Department of Developmental Psychology, University of Groningen, Grote Kruisstraat 2/1, 9712 TS, Groningen, The Netherlands
| | - Oye Gureje
- Department of Psychiatry, University of Ibadan, University College Hospital, PMB 5116, Ibadan, Nigeria
| | - Josep Maria Haro
- Parc Sanitari Sant Joan de Déu, Dr. Antoni Pujadas, 42, 08830, Sant Boi de Llobregat, Barcelona, Spain
- Institute for Development, Research, Advocacy and Applied Care (IDRAAC), Achrafieh, St. George Hospital Street, Beirut, Lebanon
| | - Elie G Karam
- Institute for Development, Research, Advocacy and Applied Care (IDRAAC), Achrafieh, St. George Hospital Street, Beirut, Lebanon
- Department of Psychiatry and Clinical Psychology, St George Hospital University Medical Center, Ashrafieh, 166378, Beirut, Lebanon
| | - Viviane Kovess-Masfety
- Institut de Psychologie, UR 4057, Université Paris Cité, 71 avenue Édouard Vaillant, Boulogne Billancourt, 92100, Paris, France
| | - Jacek Moskalewicz
- Department of Psychiatry, Institute of Psychiatry and Neurology, Jana III Sobieskiego 9, 02-957, Warsaw, Poland
| | - Fernando Navarro-Mateu
- Unidad de Docencia, Investigacion y Formación en Salud Mental, Servicio Murciano de Salud, Murcia Health Service, C/Lorca, no 58. -El Palmar, 30120, Murcia, Spain
- Instituto Murciano de Investigación Biosanitaria, Virgen de La Arrixaca, El Palmar, 30120, Murcia, Spain
- Centro de Investigación Biomédica en ERed en Epidemíologia y Salud Pública, El Palmar, 30120, Murcia, Spain
| | - Daisuke Nishi
- Department of Mental Health, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-Ku, Tokyo, 113-0033, Japan
| | - Marina Piazza
- Facultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, San Martín de Porres, 15102, Lima, Peru
| | - José Posada-Villa
- Colombian Institute of the Nervous System, Clinica Montserrat University Hospital, Calle 134 No. 17-71, Bogotá, Colombia
| | - Kate M Scott
- Department of Psychological Medicine, University of Otago, PO Box 56, Dunedin, 9054, New Zealand
| | - Cristian Vladescu
- National Institute for Health Services Management, 31 Vaselor Str., 21253, Bucharest, Romania
- University Titu Maiorescu, 67A Gheorghe Petraşcu Str., 031593, Bucharest, Romania
| | - Bogdan Wojtyniak
- National Institute of Public Health, National Research Institute, 24 Chocimska St., 00-791, Warsaw, Poland
| | - Zahari Zarkov
- Department of Mental Health, National Center of Public Health and Analyses, 15, Acad. Ivan Geshov Blvd., 1431, Sofia, Bulgaria
| | - Ronald C Kessler
- Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA, 02115, USA.
| | - Timothy Kessler
- The Watson Institute for International and Public Affairs, Brown University, Providence, RI, United States
| |
Collapse
|
47
|
McGorry PD, Hickie IB, Kotov R, Schmaal L, Wood SJ, Allan SM, Altınbaş K, Boyce N, Bringmann LF, Caspi A, Cuthbert B, Gawęda Ł, Groen RN, Guloksuz S, Hartmann JA, Krueger RF, Mei C, Nieman D, Öngür D, Raballo A, Scheffer M, Schreuder MJ, Shah JL, Wigman JTW, Yuen HP, Nelson B. New diagnosis in psychiatry: beyond heuristics. Psychol Med 2025; 55:e26. [PMID: 39911018 PMCID: PMC12017357 DOI: 10.1017/s003329172400223x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/14/2024] [Revised: 08/11/2024] [Accepted: 08/22/2024] [Indexed: 02/07/2025]
Abstract
BACKGROUND Diagnosis in psychiatry faces familiar challenges. Validity and utility remain elusive, and confusion regarding the fluid and arbitrary border between mental health and illness is increasing. The mainstream strategy has been conservative and iterative, retaining current nosology until something better emerges. However, this has led to stagnation. New conceptual frameworks are urgently required to catalyze a genuine paradigm shift. METHODS We outline candidate strategies that could pave the way for such a paradigm shift. These include the Research Domain Criteria (RDoC), the Hierarchical Taxonomy of Psychopathology (HiTOP), and Clinical Staging, which all promote a blend of dimensional and categorical approaches. RESULTS These alternative still heuristic transdiagnostic models provide varying levels of clinical and research utility. RDoC was intended to provide a framework to reorient research beyond the constraints of DSM. HiTOP began as a nosology derived from statistical methods and is now pursuing clinical utility. Clinical Staging aims to both expand the scope and refine the utility of diagnosis by the inclusion of the dimension of timing. None is yet fit for purpose. Yet they are relatively complementary, and it may be possible for them to operate as an ecosystem. Time will tell whether they have the capacity singly or jointly to deliver a paradigm shift. CONCLUSIONS Several heuristic models have been developed that separately or synergistically build infrastructure to enable new transdiagnostic research to define the structure, development, and mechanisms of mental disorders, to guide treatment and better meet the needs of patients, policymakers, and society.
Collapse
Affiliation(s)
- Patrick D. McGorry
- Orygen, Parkville, VIC, Australia
- Centre for Youth Mental Health, The University of Melbourne, Parkville, VIC, Australia
| | - Ian B. Hickie
- Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia
| | - Roman Kotov
- Department of Psychiatry, Stony Brook University, Stony Brook, New York, USA
| | - Lianne Schmaal
- Orygen, Parkville, VIC, Australia
- Centre for Youth Mental Health, The University of Melbourne, Parkville, VIC, Australia
| | - Stephen J. Wood
- Orygen, Parkville, VIC, Australia
- Centre for Youth Mental Health, The University of Melbourne, Parkville, VIC, Australia
- School of Psychology, University of Birmingham, Birmingham, UK
| | - Sophie M. Allan
- Norwich Medical School, University of East Anglia, Norwich, UK
| | - Kürşat Altınbaş
- Department of Psychiatry, Selcuk University Faculty of Medicine, Konya, Turkey
| | | | - Laura F. Bringmann
- Department of Psychometrics and Statistics, University of Groningen, Groningen, The Netherlands
- Interdisciplinary Center of Psychopathology and Emotion Regulation (ICPE), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Avshalom Caspi
- Department of Psychology and Neuroscience, Duke University, Durham, NC, USA
- Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA
- Center for Genomic and Computational Biology, Duke University, Durham, NC, USA
- Social, Genetic, and Developmental Psychiatry Research Centre, Institute of Psychiatry, Psychology, and Neuroscience, King’s College London, London, UK
- PROMENTA Center, University of Oslo, Oslo, Norway
| | | | - Łukasz Gawęda
- Experimental Psychopathology Lab, Institute of Psychology, Polish Academy of Sciences, Warsaw, Poland
| | - Robin N. Groen
- Interdisciplinary Center of Psychopathology and Emotion Regulation (ICPE), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Sinan Guloksuz
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands
- Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA
| | - Jessica A. Hartmann
- Orygen, Parkville, VIC, Australia
- Centre for Youth Mental Health, The University of Melbourne, Parkville, VIC, Australia
- Department of Public Mental Health, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, Heidelberg, Germany
| | - Robert F. Krueger
- Department of Psychology, University of Minnesota, Minneapolis, MN, USA
| | - Cristina Mei
- Orygen, Parkville, VIC, Australia
- Centre for Youth Mental Health, The University of Melbourne, Parkville, VIC, Australia
| | - Dorien Nieman
- Department of Psychiatry, Amsterdam University Medical Centers, Amsterdam, The Netherlands
| | - Dost Öngür
- Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA, USA
| | - Andrea Raballo
- Chair of Psychiatry, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland
- Cantonal Socio-psychiatric Organization, Public Health Division, Department of Health and Social Care, Repubblica e Cantone Ticino, Mendrisio, Switzerland
| | | | - Marieke J. Schreuder
- Interdisciplinary Center of Psychopathology and Emotion Regulation (ICPE), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Jai L. Shah
- Department of Psychiatry, McGill University, Montreal, QC, Canada
- Prevention and Early Intervention Program for Psychosis (PEPP), Douglas Mental Health University Institute, Montreal, QC, Canada
- ACCESS Open Minds, Douglas Mental Health University Institute, Montreal, QC, Canada
| | - Johanna T. W. Wigman
- Interdisciplinary Center of Psychopathology and Emotion Regulation (ICPE), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Hok Pan Yuen
- Orygen, Parkville, VIC, Australia
- Centre for Youth Mental Health, The University of Melbourne, Parkville, VIC, Australia
| | - Barnaby Nelson
- Orygen, Parkville, VIC, Australia
- Centre for Youth Mental Health, The University of Melbourne, Parkville, VIC, Australia
| |
Collapse
|
48
|
Shakeshaft A, Mundy JR, Pedersen EM, Dennison CA, Riglin L, Bragantini D, Corfield EC, Thapar AK, Andreassen OA, Stergiakouli E, Davey Smith G, Hannigan L, Musliner KL, Havdahl A, Thapar A. Long-term physical health conditions and youth anxiety and depression: Is there a causal link? Psychol Med 2025; 55:e7. [PMID: 39901647 PMCID: PMC11968126 DOI: 10.1017/s0033291724003271] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/29/2023] [Revised: 11/12/2024] [Accepted: 11/26/2024] [Indexed: 02/05/2025]
Abstract
BACKGROUND The prevalence of youth anxiety and depression has increased globally, with limited causal explanations. Long-term physical health conditions (LTCs) affect 20-40% of youth, with rates also rising. LTCs are associated with higher rates of youth depression and anxiety; however, it is uncertain whether observed associations are causal or explained by unmeasured confounding or reverse causation. METHODS Using data from the Norwegian Mother, Father, and Child Cohort Study (MoBa) and Norwegian National Patient Registry, we investigated phenotypic associations between childhood LTCs, and depression and anxiety diagnoses in youth (<19 years), defined using ICD-10 diagnoses and self-rated measures. We then conducted two-sample Mendelian Randomization (MR) analyses using SNPs associated with childhood LTCs from existing genome-wide association studies (GWAS) as instrumental variables. Outcomes were: (i) diagnoses of major depressive disorder (MDD) and anxiety disorders or elevated symptoms in MoBa, and (ii) youth-onset MDD using summary statistics from a GWAS in iPSYCH2015 cohort. RESULTS Having any childhood LTC phenotype was associated with elevated youth MDD (OR = 1.48 [95% CIs 1.19, 1.85], p = 4.2×10-4) and anxiety disorder risk (OR = 1.44 [1.20, 1.73], p = 7.9×10-5). Observational and MR analyses in MoBa were consistent with a causal relationship between migraine and depression (IVW OR = 1.38 [1.19, 1.60], pFDR = 1.8x10-4). MR analyses using iPSYCH2015 did not support a causal link between LTC genetic liabilities and youth-onset depression or in the reverse direction. CONCLUSIONS Childhood LTCs are associated with depression and anxiety in youth, however, little evidence of causation between LTCs genetic liability and youth depression/anxiety was identified from MR analyses, except for migraine.
Collapse
Affiliation(s)
- Amy Shakeshaft
- Wolfson Centre for Young People’s Mental Health, Division of Psychological Medicine and Clinical Neuroscience, Cardiff University, UK
- Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| | | | - Emil M. Pedersen
- National Centre for Register-based Research, Department of Public Health, Aarhus University, Denmark
| | - Charlotte A. Dennison
- Wolfson Centre for Young People’s Mental Health, Division of Psychological Medicine and Clinical Neuroscience, Cardiff University, UK
- Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| | - Lucy Riglin
- Wolfson Centre for Young People’s Mental Health, Division of Psychological Medicine and Clinical Neuroscience, Cardiff University, UK
- Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| | - Daniela Bragantini
- Nic Waals Institute, Lovisenberg Diaconal Hospital, Oslo, Norway
- PsychGen Center for Genetic Epidemiology and Mental Health, Norwegian Institute of Public Health, Norway
| | - Elizabeth C. Corfield
- Nic Waals Institute, Lovisenberg Diaconal Hospital, Oslo, Norway
- PsychGen Center for Genetic Epidemiology and Mental Health, Norwegian Institute of Public Health, Norway
- Population Health Sciences and MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, UK
| | - Ajay K. Thapar
- Wolfson Centre for Young People’s Mental Health, Division of Psychological Medicine and Clinical Neuroscience, Cardiff University, UK
- Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| | - Ole A. Andreassen
- Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Norway
| | - Evie Stergiakouli
- Population Health Sciences and MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, UK
| | - George Davey Smith
- Population Health Sciences and MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, UK
| | - Laurie Hannigan
- Nic Waals Institute, Lovisenberg Diaconal Hospital, Oslo, Norway
- PsychGen Center for Genetic Epidemiology and Mental Health, Norwegian Institute of Public Health, Norway
- Population Health Sciences and MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, UK
| | | | - Alexandra Havdahl
- Nic Waals Institute, Lovisenberg Diaconal Hospital, Oslo, Norway
- PsychGen Center for Genetic Epidemiology and Mental Health, Norwegian Institute of Public Health, Norway
- PROMENTA Research Centre, Department of Psychology, University of Oslo
| | - Anita Thapar
- Wolfson Centre for Young People’s Mental Health, Division of Psychological Medicine and Clinical Neuroscience, Cardiff University, UK
- Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| |
Collapse
|
49
|
Dan Y, Xiong Y, Xu D, Wang Y, Yin M, Sun P, Ding Y, Feng Z, Sun P, Xia W, Yu G, Li L. Potential common targets of music therapy intervention in neuropsychiatric disorders: the prefrontal cortex-hippocampus -amygdala circuit (a review). Front Hum Neurosci 2025; 19:1471433. [PMID: 39963392 PMCID: PMC11832007 DOI: 10.3389/fnhum.2025.1471433] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2024] [Accepted: 01/17/2025] [Indexed: 02/20/2025] Open
Abstract
As life becomes more stressful, neurological disorders, psychiatric disorders, and comorbidities of the two are becoming more and more of a concern. Multiple neuropsychiatric disorders share the same mental and somatic dysfunction and may involve common brain circuits and mechanistic targets. Music therapy, as an art form with proven efficacy, low cost and few side effects, is promoted for use in interventions for neuropsychiatric disorders. This may be closely related to the release of signaling molecules such as monoamine neurotransmitters, the glutamatergic system, the gut-microbiota-brain axis, pro-inflammatory cytokines and the endogenous opioid peptide system. However, fewer studies have mentioned the main targets of music to promote functional changes in brain regions. Therefore, this paper is a review of the mechanisms by which music therapy interacts with the prefrontal cortex-hippocampus-amygdala circuit through the aforementioned molecules. It is also hypothesized that glial cells, mitochondria and microRNAs are microscopic targets for musical intervention in neuropsychiatric disorders. The aim is to give new ideas for future research into the biological mechanisms of music therapy intervention in neuropsychiatric disorders.
Collapse
Affiliation(s)
- Yuqin Dan
- The College of Rehabilitation Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Ying Xiong
- School of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Danghan Xu
- Rehabilitation Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
| | - Yuqi Wang
- The College of Rehabilitation Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Meng Yin
- Shandong First Medical University & Shandong Academy of Medical Sciences, Shandong Academy of Occupational Health and Occupational Medicine, Jinan, China
| | - Pengwei Sun
- School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Yi Ding
- Department Rehabilitation Medicine, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Ziyun Feng
- Department Rehabilitation Medicine, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Peng Sun
- Innovation Research Institute of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Weili Xia
- Shandong Mental Health Center, Shandong University, Jinan, China
| | - Gongchang Yu
- Shandong Mental Health Center, Shandong University, Jinan, China
- Neck-Shoulder and Lumbocrural Pain Hospital of Shandong First Medical University, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China
| | - Li Li
- The College of Rehabilitation Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China
- Department Rehabilitation Medicine, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China
| |
Collapse
|
50
|
Wiker T, Alnæs D, Pedersen ML, Norbom LB, Boer OD, Kjelkenes R, Voldsbekk I, Karl V, Bukhari SH, Moberget T, Westlye LT, Huster RJ, Tamnes CK. Shared Patterns of Cognitive Control Behavior and Electrophysiological Markers in Adolescence. J Cogn Neurosci 2025; 37:372-413. [PMID: 39509106 DOI: 10.1162/jocn_a_02272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2024]
Abstract
Behavioral parameters obtained from cognitive control tasks have been linked to electrophysiological markers. Yet, most previous research has investigated only a few specific behavioral parameters at a time. An integrated approach with simultaneous consideration of multiple aspects of behavior may better elucidate the development and function of cognitive control. Here, we aimed to identify shared patterns between cognitive control behavior and electrophysiological markers using stop-signal task data and EEG recordings from an adolescent sample (n = 193, aged 11-25 years). We extracted behavioral variables covering various aspects of RT, accuracy, inhibition, and decision-making processes, as well as amplitude and latency of the ERPs N1, N2, and P3. To identify shared patterns between the two sets of variables, we employed a principal component analysis and a canonical correlation analysis. First, we replicated previously reported associations between various cognitive control behavioral parameters. Next, results from the canonical correlation analysis showed that overall good task performance was associated with fast and strong neural processing. Furthermore, the canonical correlation was affected by age, indicating that the association varies depending on age. The present study suggests that although distributional and computational methods can be applied to extract specific behavioral parameters, they might not capture specific patterns of cognitive control or electrophysiological brain activity in adolescents.
Collapse
Affiliation(s)
- Thea Wiker
- University of Oslo
- Diakonhjemmet Hospital, Oslo, Norway
| | | | | | | | - Olga D Boer
- Erasmus University Rotterdam
- University Medical Center Rotterdam
| | | | | | | | | | | | | | | | | |
Collapse
|